<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn pub-type="epub" publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">63266</article-id><article-id pub-id-type="doi">10.7554/eLife.63266</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Tools and Resources</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group></article-categories><title-group><article-title>Dissecting the DNA binding landscape and gene regulatory network of p63 and p53</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-208269"><name><surname>Riege</surname><given-names>Konstantin</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-208270"><name><surname>Kretzmer</surname><given-names>Helene</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-105073"><name><surname>Sahm</surname><given-names>Arne</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-7330-1790</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-202912"><name><surname>McDade</surname><given-names>Simon S</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3024-4773</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-183239"><name><surname>Hoffmann</surname><given-names>Steve</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-175941"><name><surname>Fischer</surname><given-names>Martin</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3429-1876</contrib-id><email>Martin.Fischer@leibniz-fli.de</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="other" rid="fund3"/><xref ref-type="fn" rid="con6"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution>Computational Biology Group, Leibniz Institute on Aging – Fritz Lipmann Institute (FLI)</institution><addr-line><named-content content-type="city">Jena</named-content></addr-line><country>Germany</country></aff><aff id="aff2"><label>2</label><institution>Department of Genome Regulation, Max Planck Institute for Molecular Genetics</institution><addr-line><named-content content-type="city">Berlin</named-content></addr-line><country>Germany</country></aff><aff id="aff3"><label>3</label><institution>Patrick G Johnston Centre for Cancer Research, Queen's University Belfast</institution><addr-line><named-content content-type="city">Belfast</named-content></addr-line><country>United Kingdom</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Lal</surname><given-names>Ashish</given-names></name><role>Reviewing Editor</role><aff><institution>National Institutes of Health</institution><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Murphy</surname><given-names>Maureen E</given-names></name><role>Senior Editor</role><aff><institution>The Wistar Institute</institution><country>United States</country></aff></contrib></contrib-group><pub-date date-type="publication" publication-format="electronic"><day>02</day><month>12</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>9</volume><elocation-id>e63266</elocation-id><history><date date-type="received" iso-8601-date="2020-09-21"><day>21</day><month>09</month><year>2020</year></date><date date-type="accepted" iso-8601-date="2020-12-01"><day>01</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>© 2020, Riege et al</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Riege et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-63266-v2.pdf"/><abstract><p>The transcription factor p53 is the best-known tumor suppressor, but its sibling p63 is a master regulator of epidermis development and a key oncogenic driver in squamous cell carcinomas (SCC). Despite multiple gene expression studies becoming available, the limited overlap of reported p63-dependent genes has made it difficult to decipher the p63 gene regulatory network. Particularly, analyses of p63 response elements differed substantially among the studies. To address this intricate data situation, we provide an integrated resource that enables assessing the p63-dependent regulation of any human gene of interest. We use a novel iterative de novo motif search approach in conjunction with extensive ChIP-seq data to achieve a precise global distinction between p53-and p63-binding sites, recognition motifs, and potential co-factors. We integrate these data with enhancer:gene associations to predict p63 target genes and identify those that are commonly de-regulated in SCC representing candidates for prognosis and therapeutic interventions.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>p63</kwd><kwd>p53</kwd><kwd>gene regulatory network</kwd><kwd>DNA binding landscape</kwd><kwd>resource</kwd><kwd>squamous cell carcinoma</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft</institution></institution-wrap></funding-source><award-id>FI 1993/2-1</award-id><principal-award-recipient><name><surname>Fischer</surname><given-names>Martin</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100002347</institution-id><institution>Bundesministerium für Bildung und Forschung</institution></institution-wrap></funding-source><award-id>031L016D</award-id><principal-award-recipient><name><surname>Hoffmann</surname><given-names>Steve</given-names></name></principal-award-recipient></award-group><award-group id="fund3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001664</institution-id><institution>Leibniz Association</institution></institution-wrap></funding-source><award-id>Open Access Fund</award-id><principal-award-recipient><name><surname>Fischer</surname><given-names>Martin</given-names></name><name><surname>Hoffmann</surname><given-names>Steve</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>A resource of p63-regulated genes, genomic loci bound by p63, p63 DNA recognition motifs, and potential co-factors is generated through a meta-analysis of high-throughput datasets.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>In contrast to the tumor suppressor p53 with its extensive set of target genes controlling the cell cycle and apoptosis (<xref ref-type="bibr" rid="bib25">Fischer, 2017</xref>; <xref ref-type="bibr" rid="bib83">Sammons et al., 2020</xref>), its phylogenetically ancient sibling p63 (ΔNp63) governs epidermis development (<xref ref-type="bibr" rid="bib71">Mills et al., 1999</xref>; <xref ref-type="bibr" rid="bib109">Yang et al., 1999</xref>) and is an oncogenic driver of squamous cell carcinoma (SCC) (<xref ref-type="bibr" rid="bib10">Cancer Genome Atlas Research Network et al., 2018</xref>; <xref ref-type="bibr" rid="bib33">Gatti et al., 2019</xref>) that is overexpressed or amplified in SCCs, which depend on its expression (<xref ref-type="bibr" rid="bib80">Ramsey et al., 2013</xref>). Together with p73, p63, and p53 form the p53 transcription factor (TF) family that shares a highly conserved DNA binding domain (DBD) through which they bind to very similar DNA recognition motifs. The mechanisms that enable these sibling TFs to shape their unique gene regulatory network (GRN) leading to the different phenotypic control, however, remain poorly understood.</p><p>The <italic>TP53</italic> and <italic>TP63</italic> genes encode for two major isoform groups that are controlled by distinct promoters leading to transcripts differing in their N-terminus (<xref ref-type="bibr" rid="bib73">Murray-Zmijewski et al., 2006</xref>). In the case of <italic>TP53</italic>, the longest isoform, p53α, is ubiquitously expressed while the alternative intronic promoter has little activity across virtually all tissues. Conversely, the usage of the two <italic>TP63</italic> promoters is highly cell type-dependent. For instance, the long isoform TAp63 is predominantly expressed in germ cells, while the smaller transcript, ΔNp63, is most copious in stratifying epithelia (<xref ref-type="bibr" rid="bib89">Sethi et al., 2015</xref>). Similar to p53, alternative splicing leads to α, β, and γ protein isoforms that differ in their C-terminus (<xref ref-type="bibr" rid="bib73">Murray-Zmijewski et al., 2006</xref>). While both TAp63 and ΔNp63 may bind to DNA through a specific binding domain, ΔNp63 lacks the canonical N-terminal transactivation domain (TAD) (<xref ref-type="bibr" rid="bib108">Yang et al., 1998</xref>) and has long been thought to be a dominant-negative regulator of other p53 family members or its own isoforms (<xref ref-type="bibr" rid="bib34">Gebel et al., 2016</xref>; <xref ref-type="bibr" rid="bib108">Yang et al., 1998</xref>). However, ΔNp63 has also been shown to harbor alternative TADs, that endow transactivation activity (<xref ref-type="bibr" rid="bib37">Helton et al., 2006</xref>; <xref ref-type="bibr" rid="bib42">King et al., 2003</xref>; <xref ref-type="bibr" rid="bib110">Yang et al., 2006</xref>). Notably, many ΔNp63-binding sites are associated with enhancer regions, where ΔNp63 has been proposed to ‘bookmark’ genes that are expressed in stratifying epithelia (<xref ref-type="bibr" rid="bib40">Karsli Uzunbas et al., 2019</xref>; <xref ref-type="bibr" rid="bib48">Kouwenhoven et al., 2015a</xref>; <xref ref-type="bibr" rid="bib60">Lin-Shiao et al., 2019</xref>; <xref ref-type="bibr" rid="bib78">Qu et al., 2018</xref>; <xref ref-type="bibr" rid="bib91">Somerville et al., 2018</xref>). Here, we focus on the most widely expressed isoforms p53α (hereafter p53) and ΔNp63 (hereafter p63).</p><p>The p53 TF family shares many binding sites, but all three family members have been shown to bind to substantial sets of unique target genes (<xref ref-type="bibr" rid="bib58">Lin et al., 2009</xref>; <xref ref-type="bibr" rid="bib68">McDade et al., 2014</xref>). Indeed, there are differences in the DBDs, for example regarding thermostability, hydrophobic potentials (<xref ref-type="bibr" rid="bib21">Enthart et al., 2016</xref>), zinc-coordination (<xref ref-type="bibr" rid="bib62">Lokshin et al., 2007</xref>), and redox sensitivity (<xref ref-type="bibr" rid="bib96">Tichý et al., 2013</xref>). In addition, the different C-terminal domains (CTD) of p53 family members may also affect their DNA binding specificity (<xref ref-type="bibr" rid="bib85">Sauer et al., 2008</xref>). p53 binds to a canonical 20 bp response element (RE) made of two decameric half-sites that both contain the sequence RRRCWWGYYY (R = A/G; W = A/T; Y = C/T). p53 has also been shown to bind to decameric half-sites separated by spacers or to single half-sites (<xref ref-type="bibr" rid="bib44">Kitayner et al., 2010</xref>; <xref ref-type="bibr" rid="bib70">Menendez et al., 2013</xref>; <xref ref-type="bibr" rid="bib101">Vyas et al., 2017</xref>). Results from systematic evolution of ligands by exponential enrichment (SELEX) (<xref ref-type="bibr" rid="bib75">Ortt and Sinha, 2006</xref>; <xref ref-type="bibr" rid="bib77">Perez et al., 2007</xref>) and high-throughput analyses of chromatin immunoprecipitation (ChIP) (<xref ref-type="bibr" rid="bib47">Kouwenhoven et al., 2010</xref>; <xref ref-type="bibr" rid="bib67">McDade et al., 2012</xref>; <xref ref-type="bibr" rid="bib110">Yang et al., 2006</xref>) yielded p63 binding motifs with high similarity to the p53RE but still showed some unique characteristics. These unique characteristics identified for p63REs, however, differed substantially between the studies.</p><p>While multiple genome-wide p63 gene expression datasets became available in recent years, our understanding of the p63 GRN remains incomplete. This is in part due to the limited overlap of the p63-dependent genes identified in individual studies (<xref ref-type="bibr" rid="bib49">Kouwenhoven et al., 2015b</xref>). Also, the frequent binding of p63 to enhancers (<xref ref-type="bibr" rid="bib48">Kouwenhoven et al., 2015a</xref>; <xref ref-type="bibr" rid="bib60">Lin-Shiao et al., 2019</xref>; <xref ref-type="bibr" rid="bib59">Lin-Shiao et al., 2018</xref>; <xref ref-type="bibr" rid="bib78">Qu et al., 2018</xref>; <xref ref-type="bibr" rid="bib91">Somerville et al., 2018</xref>) and the difficulty to associate such enhancers with target gene regulation adds another level of complexity to the quest of describing the GRN. To overcome these limitations, we utilize a recently developed meta-analysis approach (<xref ref-type="bibr" rid="bib23">Fischer et al., 2016a</xref>), which helped us to dissect the GRNs of the mouse and human orthologue of p53 (<xref ref-type="bibr" rid="bib28">Fischer, 2020</xref>; <xref ref-type="bibr" rid="bib27">Fischer, 2019</xref>). The analysis rests upon a ranking of potential p63 target genes based on the number of datasets supporting a p63-dependent regulation. In addition, we utilize the wealth of recent p63 and p53 ChIP-seq studies to establish a more precise global distinction between p53- and p63-binding sites and their underlying REs. This approach could serve as a blueprint to distinguish binding site specificities of TF siblings. Further integration of gene expression studies with the binding data and enhancer:gene associations enables us to predict high-probability direct p63 target genes.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>The p63 gene regulatory network</title><p>To identify genes commonly regulated by p63 across cell types and tissues, we employed a previously established meta-analysis approach, that has been helpful to infer core GRNs for human and mouse p53, the viral oncoprotein E7 and the cell cycle GRN (<xref ref-type="bibr" rid="bib27">Fischer, 2019</xref>; <xref ref-type="bibr" rid="bib26">Fischer et al., 2017</xref>; <xref ref-type="bibr" rid="bib23">Fischer et al., 2016a</xref>; <xref ref-type="bibr" rid="bib22">Fischer et al., 2014</xref>). From 11 genome-wide studies (<xref ref-type="bibr" rid="bib2">Abraham et al., 2018</xref>; <xref ref-type="bibr" rid="bib3">Bao et al., 2015</xref>; <xref ref-type="bibr" rid="bib11">Carroll et al., 2006</xref>; <xref ref-type="bibr" rid="bib32">Gallant-Behm et al., 2012</xref>; <xref ref-type="bibr" rid="bib40">Karsli Uzunbas et al., 2019</xref>; <xref ref-type="bibr" rid="bib60">Lin-Shiao et al., 2019</xref>; <xref ref-type="bibr" rid="bib82">Saladi et al., 2017</xref>; <xref ref-type="bibr" rid="bib91">Somerville et al., 2018</xref>; <xref ref-type="bibr" rid="bib103">Watanabe et al., 2014</xref>; <xref ref-type="bibr" rid="bib106">Wu et al., 2012</xref>; <xref ref-type="bibr" rid="bib111">Zarnegar et al., 2012</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>), 16 publically available gene expression datasets were integrated to generate a specific <italic>p63 Expression Score</italic> (<xref ref-type="supplementary-material" rid="supp2">Supplementary file 2</xref>). The datasets have been obtained from knockdown (n = 12) or overexpression experiments (n = 4) of p63 in primary keratinocytes (n = 3), the keratinocyte cell line HaCaT (n = 2), the foreskin fibroblast cell line BJ (n = 1), the breast epithelial cell line MCF10A (n = 4), the squamous carcinoma cell lines H226 (n = 2), KYSE70 (n = 1), and FaDu (n = 1), as well as the pancreatic ductal adenocarcinoma cell lines BxPC3 (n = 1) and SUIT2 (n = 1) (<xref ref-type="fig" rid="fig1">Figure 1A and B</xref> and <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>).</p><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Meta-analysis of p63-dependent gene regulation.</title><p>(<bold>A</bold>) Distribution of the number of genes found in each of the <italic>p63 Expression Score</italic> groups. Because <italic>p63 Expression Score</italic> group ‘14’ and ‘−12’ contained only two genes they were included in group ‘13’ and ‘−11’, respectively, for further analyses. (<bold>B</bold>) 16 datasets on p63-dependent gene expression from 11 studies. EE – exogenous p63 expression; sh KD – shRNA-mediated knockdown; si KD – siRNA-mediated knockdown; KO - sgRNA-mediated knockout (<bold>C</bold>) A heatmap displaying the regulation of 15 genes with positive and 15 genes with negative <italic>p63 Expression Scores. GAPDH</italic> and <italic>GAPDHS</italic> represent negative controls.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63266-fig1-v2.tif"/></fig><p>To illustrate the utility of our approach, we selected 30 genes from various <italic>p63 Expression Score</italic> groups reflecting commonly up- and down-regulated ones (<xref ref-type="fig" rid="fig1">Figure 1C</xref>). We noted lower consistency across the data on p63-dependent gene regulation as compared to previous meta-analyses on human and mouse p53 (<xref ref-type="bibr" rid="bib27">Fischer, 2019</xref>; <xref ref-type="bibr" rid="bib23">Fischer et al., 2016a</xref>). In contrast to the recent investigations, data integrated here are based on a higher number of experiments in primary cells and a comparably lower number of replicates. Thus, the reduced consistency may also reflect the higher variance as opposed to data from more homogenous cell lines. Furthermore, p63-depleted cells are less viable, and the global decrease in mRNA levels may confound effects. Despite this, our approach identified genes that are commonly altered by p63.</p><p>We next performed gene set enrichment analysis (GSEA) for p63-dependently regulated genes using MSigDB gene sets (<xref ref-type="bibr" rid="bib94">Subramanian et al., 2005</xref>). In agreement with the function of p63 as an essential proliferation factor (<xref ref-type="bibr" rid="bib66">McDade et al., 2011</xref>; <xref ref-type="bibr" rid="bib88">Senoo et al., 2007</xref>; <xref ref-type="bibr" rid="bib97">Truong et al., 2006</xref>), epidermal development regulator (<xref ref-type="bibr" rid="bib71">Mills et al., 1999</xref>; <xref ref-type="bibr" rid="bib109">Yang et al., 1999</xref>), and MYC network activator (<xref ref-type="bibr" rid="bib106">Wu et al., 2012</xref>), we find that genes commonly up-regulated by p63 significantly enrich gene sets associated with cell cycle, epidermis development, and MYC targets (<xref ref-type="fig" rid="fig2">Figure 2A</xref>). In line with previous reports (<xref ref-type="bibr" rid="bib69">Mehta et al., 2018</xref>), genes down-regulated by p63 enrich gene sets connected with interferon response (<xref ref-type="fig" rid="fig2">Figure 2B</xref>). Corroborating the role of p63 in mammary stem cell activity (<xref ref-type="bibr" rid="bib12">Chakrabarti et al., 2014</xref>) and SCC growth (<xref ref-type="bibr" rid="bib80">Ramsey et al., 2013</xref>), we find that p63 up- and down-regulated genes enrich respective gene sets up- and down-regulated in mammary stem cells (<xref ref-type="fig" rid="fig2">Figure 2C</xref>) and across SCCs (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). In addition to pathways that have been linked to p63 earlier, we find that p63 up-regulated genes enrich for mTORC1 signaling genes and p63 down-regulated genes enrich for gene sets associated with oxidative phosphorylation and aerobic respiration (<xref ref-type="fig" rid="fig2">Figure 2E</xref>).</p><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Gene sets enriched among genes commonly regulated by p63.</title><p>Enrichment of (<bold>A, B, C, E</bold>) MSigDB gene sets or (<bold>D</bold>) genes up- and down-regulated across squamous cell cancers (SCC) (<xref ref-type="bibr" rid="bib10">Cancer Genome Atlas Research Network et al., 2018</xref>) among genes ranked by the <italic>p63 Expression Score</italic>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63266-fig2-v2.tif"/></fig><p>Further, we performed TF binding enrichment analysis for p63-dependently regulated genes using Enrichr (<xref ref-type="bibr" rid="bib50">Kuleshov et al., 2016</xref>). In agreement with its established roles, we identify cell cycle gene regulators (E2F4, E2F6, SIN3A, E2F1, FOXM1, NFYA, and NFYB <xref ref-type="bibr" rid="bib29">Fischer and Müller, 2017</xref>) and the MYC/MAX TFs as being enriched among p63-upregulated genes. Consistent with previous reports, our analysis also identifies KLF4 (<xref ref-type="bibr" rid="bib87">Sen et al., 2012</xref>) and SMAD4 (<xref ref-type="bibr" rid="bib81">Rodriguez Calleja et al., 2016</xref>) as potential mediators of p63-dependent gene regulation. In addition, our analysis reveals that androgen receptor (AR), its co-factor ZMIZ1, as well as SP1, FLI1, and NANOG are novel candidates for mediating the p63-dependent up-regulation of multiple genes. Surprisingly, our analysis identified only SOX2 as a frequent binder of genes down-regulated by p63 (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). Consistent with the strong association of p63 up-regulated genes with the cell cycle (<xref ref-type="fig" rid="fig2">Figure 2A</xref>) and with cell cycle regulators (<xref ref-type="fig" rid="fig3">Figure 3A</xref>), we find that p63 up-regulated genes enrich DREAM (<underline>d</underline>imerization partner, <underline>R</underline>B-like, <underline>E</underline>2F, <underline>a</underline>nd <underline>m</underline>ulti-vulval class <underline>B</underline>) and E2F target genes (<xref ref-type="fig" rid="fig3">Figure 3B</xref>), and DREAM target genes appear to be modestly but consistently down-regulated when p63 is lost (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). Notably, most datasets on p63-dependent gene expression were derived from cells in which p63 was overexpressed or depleted, without additional treatments. However, one dataset was derived from Nutlin-treated MCF10A cells (<xref ref-type="bibr" rid="bib40">Karsli Uzunbas et al., 2019</xref>). MCF10A cells harbor wild-type p53 and DREAM targets are down-regulated in response to Nutlin treatment. Strikingly, depletion of p63 decreased their expression even further without affecting <italic>CDKN1A</italic> (p21) levels (<xref ref-type="fig" rid="fig3">Figure 3D</xref>), which indicates a possible cumulative effect that is independent of p53 regulatory functions.</p><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Transcription factors in the p63 GRN.</title><p>(<bold>A</bold>) Significant (adj.p-value≤0.05) enrichment of TF binding at genes with a <italic>p63 Expression Score</italic> ≥8 (green) or ≤ −8 (red) as identified by Enrichr (<xref ref-type="bibr" rid="bib50">Kuleshov et al., 2016</xref>). (<bold>B</bold>) Enrichment of MSigDB gene sets among genes ranked by the <italic>p63 Expression Score</italic>. Scatter plots displays the log<sub>2</sub>(fold-change) of previously collected high confidence DREAM target genes (<xref ref-type="bibr" rid="bib23">Fischer et al., 2016a</xref>) (<bold>C</bold>) across the 16 p63-dependent gene expression profiling datasets and (<bold>D</bold>) MCF10A cells treated with DMSO or Nutlin in addition to shControl and shp63 (<xref ref-type="bibr" rid="bib40">Karsli Uzunbas et al., 2019</xref>). <italic>CDKN1A</italic> levels serve as control. The black line indicates the median.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63266-fig3-v2.tif"/></fig><p>Together, the meta-analysis approach overcomes the limitations of individual studies and identifies target genes supported by multiple datasets. The extensive and integrated resource on p63-regulated genes enables researchers to compare their results quickly and to identify the most promising targets.</p></sec><sec id="s2-2"><title>p63 and p53 regulate largely distinct gene sets</title><p>Given that p63 and p53 share a significant number of binding sites and thus potential target genes, we next compared the <italic>p63 Expression Score</italic> to the previously established <italic>p53 Expression Score</italic> (<xref ref-type="bibr" rid="bib23">Fischer et al., 2016a</xref>). In agreement with the up-regulation of cell cycle genes and DREAM targets through p63 (<xref ref-type="fig" rid="fig2">Figures 2A</xref> and <xref ref-type="fig" rid="fig3">3</xref>) and their down-regulation through p53 (<xref ref-type="bibr" rid="bib23">Fischer et al., 2016a</xref>; <xref ref-type="bibr" rid="bib24">Fischer et al., 2016b</xref>; <xref ref-type="bibr" rid="bib86">Schade et al., 2019</xref>; <xref ref-type="bibr" rid="bib99">Uxa et al., 2019</xref>), we noted that negative <italic>p53 Expression Scores</italic> tend to correlate with positive <italic>p63 Expression Scores</italic> (<xref ref-type="fig" rid="fig4">Figure 4A</xref>). Furthermore, the results indicate that p53-induced genes (positive <italic>p53 Expression Scores</italic>) appear to be largely unaffected by p63. Consistently, expression data for 343 target genes with strong evidence for direct up-regulation by p53 (<xref ref-type="bibr" rid="bib25">Fischer, 2017</xref>), do not show consistent expression changes upon knockdown or induction of p63 (<xref ref-type="fig" rid="fig4">Figure 4B</xref>). Together, these results indicate that basal expression of the majority of p53 target genes is not affected by p63.</p><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>p63 and p53 regulate largely distinct target gene sets.</title><p>(<bold>A</bold>) The <italic>p63 Expression Score</italic> compared to the previously published <italic>p53 Expression Score</italic> that was generated using the same meta-analysis approach (<xref ref-type="bibr" rid="bib23">Fischer et al., 2016a</xref>) for all 16,198 genes for which both scores were available. (<bold>B</bold>) The scatter plot displays the log<sub>2</sub>(fold-change) of previously collected high confidence direct p53 target genes (<xref ref-type="bibr" rid="bib25">Fischer, 2017</xref>) across the 16 p63-dependent gene expression profiling datasets. The black line indicates the median. The data indicates a large degree of independence of p53 targets from p63-dependent expression.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63266-fig4-v2.tif"/></fig></sec><sec id="s2-3"><title>Common and distinct properties of p63 and p53 DNA binding</title><p>To identify shared p63- and p53-bound sites, we compared the 20 p63 ChIP-seq datasets (<xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>) to 28 p53 ChIP-seq datasets we compiled recently (<xref ref-type="bibr" rid="bib27">Fischer, 2019</xref>). Notably, p63 and p53 data was collected from cells with strong basal p63 expression and stimulated p53 expression, respectively. While the majority of all p53 ChIP-seq peaks occurs in only one of the experiments, more than half of the p63 peaks are present in two or more datasets (<xref ref-type="fig" rid="fig5">Figure 5A and B</xref>). Even though we were able to integrate substantially more p53 datasets, the number of identified p63 binding sites was still higher (<xref ref-type="fig" rid="fig5">Figure 5C</xref>). This indicates that p63 occupies many more binding sites as compared to p53. Importantly, when more datasets agree on p53- and p63-binding sites, these sequences are more likely to harbor a canonical p53 and p63RE, facilitating the motif discovery by tools such as HOMER (<xref ref-type="bibr" rid="bib36">Heinz et al., 2010</xref>) and enriching bona fide binding sites (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Earlier meta-analyses employed a similar strategy (<xref ref-type="bibr" rid="bib23">Fischer et al., 2016a</xref>; <xref ref-type="bibr" rid="bib74">Nguyen et al., 2018</xref>; <xref ref-type="bibr" rid="bib100">Verfaillie et al., 2016</xref>). To dissect the binding preferences of p63 and p53, we generated three distinct peak sets (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). The ‘p53+p63’ set contained all binding sites with evidence in at least five p63 and five p53 ChIP-seq datasets. The ‘p53 unique’ (hereafter ‘p53’) set contained all binding sites that were supported by at least five p53 ChIP-seq datasets but not a single p63 dataset. We also generated a ‘p63 unique’ (hereafter ‘p63’) set vice versa.</p><fig-group><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>The p63 and p53 DNA-binding landscape.</title><p>(<bold>A and B</bold>) The number of p63 and p53 binding peaks sorted by the number of datasets that commonly identified/support the peak. (<bold>C</bold>) The number of p53 and p63 peaks identified in the 28 p53 and 20 p63 ChIP-seq datasets, respectively. (<bold>D</bold>) The relative number of ‘known’ p53 and p63 motifs found by HOMER v4.10 (<xref ref-type="bibr" rid="bib36">Heinz et al., 2010</xref>) under p53 and p63 peaks, respectively, with increasing dataset support. (<bold>E</bold>) Schematic of ‘p53’, ‘p63’ and ‘p53+p63’ peak selection for further analyses. (<bold>F</bold>) De novo motif search results from HOMER v4.10 for the ‘p53+p63’, ‘p53’, and ‘p63’ peak sets. The first round of motif search identified the ‘primary’ motif in each peak set. Using an iterative approach, all peaks that contained the ‘primary’ motif were removed and the de novo motif search was repeated. This iterative approach was followed until no more p53/p63-like motif was identified.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63266-fig5-v2.tif"/></fig><fig id="fig5s1" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 1.</label><caption><title>Correlation between p53 and p63 binding frequency and motif consensus.</title><p>(<bold>A and B</bold>) Correlation between dataset support for p53 and p63 binding. (<bold>C to F</bold>) Correlation between HOMER motif score for primary and secondary ‘p53+p63’ motifs and dataset support for (<bold>C and D</bold>) p53 binding or (<bold>E and F</bold>) p63 binding.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63266-fig5-figsupp1-v2.tif"/></fig><fig id="fig5s2" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 2.</label><caption><title>Correlation between p53 and p63 binding frequency and motif consensus.</title><p>Correlation between HOMER motif score for primary, secondary, and tertiary (<bold>A to C</bold>) ‘p53’ motifs or (<bold>D to F</bold>) ‘p63’ motifs and dataset support for (<bold>A to C</bold>) p53 binding or (<bold>D to F</bold>) p63 binding.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63266-fig5-figsupp2-v2.tif"/></fig><fig id="fig5s3" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 3.</label><caption><title>Top motifs co-enriched with primary ‘p53+p63’, ‘p53’, and ‘p63’ motifs at the respective DNA sites.</title></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63266-fig5-figsupp3-v2.tif"/></fig><fig id="fig5s4" position="float" specific-use="child-fig"><label>Figure 5—figure supplement 4.</label><caption><title>TFs with significantly similar binding repertoirs.</title><p>Top 20 TFs with ChIP-seq peak sets similar to (<bold>A</bold>) the common p53+p63 sites, (<bold>B</bold>) the unique p53 sites, and (<bold>C</bold>) the unique p63 sites (<xref ref-type="fig" rid="fig5">Figure 5E</xref>) as identified using CistromeDB toolkit.</p><p>Of note, some TP53 ChIP-seq datasets are wrongly labeled ‘T’ in the database.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63266-fig5-figsupp4-v2.tif"/></fig></fig-group><p>We employed an iterative de novo motif search using HOMER to identify frequent binding site motifs. After each round, we removed all peaks harboring the best motif and repeated the search. We identified similar yet distinct binding motifs for the three groups (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). Comparison of the primary ‘p53+p63’, ‘p53’, and ‘p63’ motifs suggests that p63-binding sites display a highly conserved C, G, C, and G at positions 4, 7, 14, and 17, respectively. The second round revealed a p53RE containing a 1 bp spacer (p53 secondary motif), supporting the model that p53 can bind to spacer-containing p53REs (<xref ref-type="bibr" rid="bib101">Vyas et al., 2017</xref>). The results further indicate that p53 can bind to a single half-site (p53 tertiary motif) and that this single half-site is more constrained at positions 5 and 6 as well as the flanking regions than half-sites in the canonical p53RE (e.g. primary p53+p63 and p53 motifs). Of note, these single half-sites may also include p53REs with spacers longer than 1 bp that are not detected separately because of their very low abundance. Sole half-sites together with spacer-containing p53REs underlie only ~5% of p53-bound sites (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Furthermore, p53 and p63 appear to be able to bind to three-quarter sites (secondary and quaternary p53+p63 and p63 motifs), while p63 can generally bind to a broader spectrum of sequences as compared to p53 (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). This broader binding repertoire likely underlies p63’s capacity to engage with substantially more binding sites than does p53.</p><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>The DNA-binding landscape of p53.</title><p>DNA sites occupied by p53 in at least five datasets were searched iterative with the motifs identified by our iterative de novo search (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). We searched first for the primary ‘p53+p63’ motif and among all remaining sites for the primary ‘p53’ motif. All other ‘p53+p63’ and ‘p53’ motifs were searched subsequently.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63266-fig6-v2.tif"/></fig><p>It is important to note that the vast majority (~70%) of p53- and p63-binding sites harbor full-length p53 and p63REs (<xref ref-type="fig" rid="fig6">Figures 6</xref> and <xref ref-type="fig" rid="fig7">7</xref>, <xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>). There is a good correlation between p53- and p63-binding site occupation, and most sites commonly bound by p53 are also frequently bound by p63 (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1</xref>). However, p63 binds many sites that are not bound by p53 (<xref ref-type="fig" rid="fig5">Figure 5E</xref> and <xref ref-type="fig" rid="fig5s2">Figure 5—figure supplement 2</xref>). More importantly, p53 binding is strongly constrained to canonical p53RE (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplements 1C–D</xref> and <xref ref-type="fig" rid="fig5s2">2A–C</xref>). In contrast, p63 binding appears not to benefit from a more canonical p63RE (<xref ref-type="fig" rid="fig5s1">Figure 5—figure supplements 1E–F</xref> and <xref ref-type="fig" rid="fig5s2">2D–F</xref>). These data suggest that sequence-specific binding is particularly important to recruit p53, while p63 only requires minimal sequence identity and could require additional co-factors to bind and ultimately regulate its target genes.</p><fig-group><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>The DNA-binding landscape of p63.</title><p>DNA sites occupied by p63 in at least five datasets were searched iterative with the motifs identified by our iterative de novo search (<xref ref-type="fig" rid="fig5">Figure 5F</xref>). We searched first for the primary ‘p53+p63’ motif and among all remaining sites for the primary ‘p63’ motif. All other ‘p53+p63’ and ‘p63’ motifs were searched subsequently (<xref ref-type="supplementary-material" rid="supp3">Supplementary file 3</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63266-fig7-v2.tif"/></fig><fig id="fig7s1" position="float" specific-use="child-fig"><label>Figure 7—figure supplement 1.</label><caption><title>Complement to <xref ref-type="table" rid="table1">Table 1</xref>.</title><p>Genes identified as significantly up- or down-regulated in at least the half of all datasets (|<italic>p63 Expression Score|</italic>| ≥ 8) that are linked to p63-binding sites supported by at least half of all datasets (≥10) through binding within 5 kb from their TSS or through double-elite enhancer:gene associations (<xref ref-type="bibr" rid="bib30">Fishilevich et al., 2017</xref>). Using these thresholds we identified 138 and 42 high-probability candidates as directly up- and down-regulated by p63, respectively. Gene names marked in red are also up- or down-regulated across SCCs (<xref ref-type="bibr" rid="bib10">Cancer Genome Atlas Research Network et al., 2018</xref>).</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63266-fig7-figsupp1-v2.tif"/></fig></fig-group><p>Therefore, we also searched for potential cooperating TFs that may be co-enriched at p53- and p63-binding sites. Consistent with earlier analyses (<xref ref-type="bibr" rid="bib100">Verfaillie et al., 2016</xref>), no additional motif was substantially enriched in the vicinity of ‘p53’ or ‘p53+p63’ binding sites. Consistent with the co-enrichment of AP-1 and p63 at enhancers (<xref ref-type="bibr" rid="bib59">Lin-Shiao et al., 2018</xref>), we found that unique p63-binding sites were consistently enriched for AP-1 (bZIP) in addition to bHLH motifs (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>). Using the CistromeDB toolkit (<xref ref-type="bibr" rid="bib114">Zheng et al., 2019b</xref>), we identified TFs that significantly enrich for binding to the ‘p53+p63’, ‘p53’, and ‘p63’ sites. As expected, the analysis identified the p53 family members p53, p63, and p73 as best hits for the common sites, but only p53 and p73 for the unique p53 and only p63 and p73 for the unique p63 peak sets (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4</xref>). In agreement with earlier studies, the analysis identified p300 (<xref ref-type="bibr" rid="bib41">Katoh et al., 2019</xref>), MAF (<xref ref-type="bibr" rid="bib63">Lopez-Pajares et al., 2015</xref>), SOX2 (<xref ref-type="bibr" rid="bib103">Watanabe et al., 2014</xref>), BANF1 (also known as BAF) (<xref ref-type="bibr" rid="bib3">Bao et al., 2015</xref>), and KMT2D (<xref ref-type="bibr" rid="bib59">Lin-Shiao et al., 2018</xref>) as potential co-binders of p63; as well as TRIM28 (<xref ref-type="bibr" rid="bib20">Doyle et al., 2010</xref>), BRD4 (<xref ref-type="bibr" rid="bib93">Stewart et al., 2013</xref>), p300 (<xref ref-type="bibr" rid="bib57">Lill et al., 1997</xref>), ZBTB33 (KAISO) (<xref ref-type="bibr" rid="bib45">Koh et al., 2014</xref>), CDK9 (<xref ref-type="bibr" rid="bib13">Claudio et al., 2006</xref>), and HEXIM1 (<xref ref-type="bibr" rid="bib54">Lew et al., 2012</xref>) as potential co-binders of p53. Moreover, our analysis identified potential co-binders that to our knowledge have not been identified before, such as KDM1A, PRMT1, and GRHL2 for p63 and BRD9, ZNF131, and C17orf49 for p53. Importantly, these new potential co-binders appear to be unique to either p63 or p53, suggesting that they may contribute to shaping the DNA-binding landscapes that are specific to p63 and p53 (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4</xref>).</p></sec><sec id="s2-4"><title>Identification of direct p63 target genes</title><p>Given that p63 regulates many target genes through enhancers (<xref ref-type="bibr" rid="bib48">Kouwenhoven et al., 2015a</xref>; <xref ref-type="bibr" rid="bib60">Lin-Shiao et al., 2019</xref>; <xref ref-type="bibr" rid="bib59">Lin-Shiao et al., 2018</xref>; <xref ref-type="bibr" rid="bib78">Qu et al., 2018</xref>; <xref ref-type="bibr" rid="bib91">Somerville et al., 2018</xref>), straight forward integration of differential gene regulation data and p63 binding data based on proximity binding to a gene’s TSS is unlikely to capture all direct p63 target genes. To resolve this issue, we integrated the p63 binding data and the <italic>p63 Expression Score</italic> based on enhancer:gene association information (<xref ref-type="bibr" rid="bib30">Fishilevich et al., 2017</xref>) in addition to proximity binding to TSSs to predict direct p63 target genes. Given the large number of p63-binding sites identified (<xref ref-type="fig" rid="fig5">Figure 5C and E</xref>) and the high variance in p63-dependent gene regulation (<xref ref-type="fig" rid="fig1">Figure 1B</xref>), we employed conservative thresholds to identify high-probability target genes of p63. We only used p63-binding sites supported by at least half of the datasets (≥10) that are linked through TSS proximity (within 5 kb) or double-elite enhancer:gene associations (<xref ref-type="bibr" rid="bib30">Fishilevich et al., 2017</xref>) to genes with a |<italic>p63 Expression Score|</italic>| ≥ 8 (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). Of note, many genes are associated with proximal and enhancer p63 binding, because many proximal promoters are also identified as double-elite enhancers in the database. The 180 (138 up-regulated and 42 down-regulated) genes that passed our conservative filtering contain many genes that are known direct p63 targets, such as <italic>RAB38</italic> (<xref ref-type="bibr" rid="bib5">Barton et al., 2010</xref>), <italic>S100A2</italic> (<xref ref-type="bibr" rid="bib43">Kirschner et al., 2008</xref>; <xref ref-type="bibr" rid="bib51">Lapi et al., 2006</xref>), <italic>HAS3</italic> (<xref ref-type="bibr" rid="bib16">Compagnone et al., 2017</xref>), <italic>IRF6</italic> (<xref ref-type="bibr" rid="bib95">Thomason et al., 2010</xref>), <italic>PTHLH</italic> (<xref ref-type="bibr" rid="bib91">Somerville et al., 2018</xref>), <italic>GPX2</italic> (<xref ref-type="bibr" rid="bib107">Yan and Chen, 2006</xref>), <italic>JAG1</italic> (<xref ref-type="bibr" rid="bib84">Sasaki et al., 2002</xref>), <italic>MMP14</italic> (<xref ref-type="bibr" rid="bib61">Lodillinsky et al., 2016</xref>), <italic>NRG1</italic> (<xref ref-type="bibr" rid="bib31">Forster et al., 2014</xref>), and <italic>PLAC8</italic> (<xref ref-type="bibr" rid="bib32">Gallant-Behm et al., 2012</xref>). The identification of these well-established p63 target genes indicates the ability of our approach to identify bona fide candidates. Importantly, the integration of enhancer:gene associations enabled the identification of genes that are likely regulated by p63 through enhancers, such as <italic>IL1B</italic>, <italic>MREG</italic>, <italic>MYO5A</italic>, <italic>RRP12</italic>, <italic>SNCA</italic>, <italic>AK4</italic>, and <italic>EHD4</italic> (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>).</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>High-probability direct p63 target genes.</title><p>Genes identified as significantly up- or down-regulated in at least the half of all datasets (|p63 Expression Score| ≥ 8) that are linked to p63-binding sites supported by at least half of all datasets (≥10) through binding within 5 kb from their TSS or through double-elite enhancer-gene associations (<xref ref-type="bibr" rid="bib30">Fishilevich et al., 2017</xref>). Using these thresholds we identified 138 and 42 high-probability candidates as directly up- and down-regulated by p63, respectively. Gene names marked in bold are also up- or down-regulated across SCCs (<xref ref-type="bibr" rid="bib10">Cancer Genome Atlas Research Network et al., 2018</xref>).</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Gene symbol</th><th><italic>p63 Expression Score</italic></th><th>p63 binding within<break/>5 kb from TSS</th><th>p63 binding linked <break/>through enhancer</th><th>Gene symbol</th><th><italic>p63 Expression Score</italic></th><th>p63 binding within<break/>5 kb from TSS</th><th>p63 binding linked <break/>through enhancer</th></tr></thead><tbody><tr><td><italic>DUSP6</italic></td><td>14</td><td>yes</td><td>yes</td><td><italic>FSCN1</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><italic>RAB38</italic></td><td>14</td><td>yes</td><td>yes</td><td><italic>GINS3</italic></td><td>8</td><td>yes</td><td>no</td></tr><tr><td><italic>GSDME</italic></td><td>13</td><td>yes</td><td>yes</td><td><italic>GM2A</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><bold><italic>LAD1</italic></bold></td><td>13</td><td>yes</td><td>yes</td><td><bold><italic>HMGA2</italic></bold></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><bold><italic>S100A2</italic></bold></td><td>13</td><td>yes</td><td>yes</td><td><italic>HSPA4L</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><bold><italic>TMEM40</italic></bold></td><td>13</td><td>yes</td><td>yes</td><td><italic>JAG1</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><bold><italic>FGFBP1</italic></bold></td><td>12</td><td>yes</td><td>yes</td><td><italic>KCTD12</italic></td><td>8</td><td>yes</td><td>no</td></tr><tr><td><italic>HAS3</italic></td><td>12</td><td>yes</td><td>no</td><td><italic>KIAA0930</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><italic>NECTIN1</italic></td><td>12</td><td>yes</td><td>yes</td><td><italic>KIF14</italic></td><td>8</td><td>no</td><td>yes</td></tr><tr><td><italic>TCOF1</italic></td><td>12</td><td>yes</td><td>yes</td><td><italic>KIRREL1</italic></td><td>8</td><td>no</td><td>yes</td></tr><tr><td><italic>DUSP7</italic></td><td>11</td><td>yes</td><td>yes</td><td><italic>LIG1</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><bold><italic>IL1B</italic></bold></td><td>11</td><td>no</td><td>yes</td><td><bold><italic>LPAR3</italic></bold></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><italic>MREG</italic></td><td>11</td><td>no</td><td>yes</td><td><italic>LRRFIP2</italic></td><td>8</td><td>no</td><td>yes</td></tr><tr><td><italic>PA2G4</italic></td><td>11</td><td>yes</td><td>no</td><td><italic>MALT1</italic></td><td>8</td><td>no</td><td>yes</td></tr><tr><td><italic>RGS20</italic></td><td>11</td><td>yes</td><td>no</td><td><italic>MAST4</italic></td><td>8</td><td>no</td><td>yes</td></tr><tr><td><italic>SDC1</italic></td><td>11</td><td>no</td><td>yes</td><td><italic>MCM3</italic></td><td>8</td><td>no</td><td>yes</td></tr><tr><td><bold><italic>SFN</italic></bold></td><td>11</td><td>yes</td><td>yes</td><td><bold><italic>MMP14</italic></bold></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><italic>STK17A</italic></td><td>11</td><td>yes</td><td>yes</td><td><italic>MMRN2</italic></td><td>8</td><td>yes</td><td>no</td></tr><tr><td><bold><italic>VSNL1</italic></bold></td><td>11</td><td>yes</td><td>yes</td><td><italic>NOM1</italic></td><td>8</td><td>yes</td><td>no</td></tr><tr><td><italic>ARHGAP25</italic></td><td>10</td><td>yes</td><td>yes</td><td><italic>NRCAM</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><italic>CDCA4</italic></td><td>10</td><td>yes</td><td>yes</td><td><italic>NRG1</italic></td><td>8</td><td>no</td><td>yes</td></tr><tr><td><italic>DUSP11</italic></td><td>10</td><td>yes</td><td>no</td><td><italic>OAS3</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><bold><italic>FAT2</italic></bold></td><td>10</td><td>yes</td><td>no</td><td><italic>PPFIBP1</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><bold><italic>FERMT1</italic></bold></td><td>10</td><td>yes</td><td>yes</td><td><italic>PROCR</italic></td><td>8</td><td>yes</td><td>no</td></tr><tr><td><italic>IL4R</italic></td><td>10</td><td>yes</td><td>yes</td><td><italic>QSOX2</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><italic>INPP1</italic></td><td>10</td><td>yes</td><td>yes</td><td><italic>RAD51C</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><bold><italic>IRF6</italic></bold></td><td>10</td><td>no</td><td>yes</td><td><bold><italic>RASSF6</italic></bold></td><td>8</td><td>no</td><td>yes</td></tr><tr><td><italic>ITGA6</italic></td><td>10</td><td>no</td><td>yes</td><td><italic>RFX7</italic></td><td>8</td><td>yes</td><td>no</td></tr><tr><td><italic>KIZ</italic></td><td>10</td><td>yes</td><td>no</td><td><italic>SH3PXD2A</italic></td><td>8</td><td>no</td><td>yes</td></tr><tr><td><italic>MAPKBP1</italic></td><td>10</td><td>no</td><td>yes</td><td><italic>SLC1A5</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><italic>MYO10</italic></td><td>10</td><td>yes</td><td>yes</td><td><italic>SLC2A9</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><italic>MYO19</italic></td><td>10</td><td>yes</td><td>yes</td><td><italic>SLC37A2</italic></td><td>8</td><td>yes</td><td>no</td></tr><tr><td><italic>ORC1</italic></td><td>10</td><td>no</td><td>yes</td><td><italic>SMAD5</italic></td><td>8</td><td>yes</td><td>no</td></tr><tr><td><italic>PAK1</italic></td><td>10</td><td>yes</td><td>no</td><td><italic>SPATS2</italic></td><td>8</td><td>no</td><td>yes</td></tr><tr><td><bold><italic>PTHLH</italic></bold></td><td>10</td><td>yes</td><td>yes</td><td><italic>SSRP1</italic></td><td>8</td><td>no</td><td>yes</td></tr><tr><td><italic>SMTN</italic></td><td>10</td><td>yes</td><td>no</td><td><italic>TGFB1</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><italic>WDFY2</italic></td><td>10</td><td>yes</td><td>no</td><td><italic>TMEM237</italic></td><td>8</td><td>yes</td><td>no</td></tr><tr><td><bold><italic>XDH</italic></bold></td><td>10</td><td>yes</td><td>yes</td><td><italic>TOMM34</italic></td><td>8</td><td>yes</td><td>no</td></tr><tr><td><italic>ARHGDIB</italic></td><td>9</td><td>yes</td><td>yes</td><td><bold><italic>TRIM7</italic></bold></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><italic>AURKB</italic></td><td>9</td><td>yes</td><td>no</td><td><italic>TRIP13</italic></td><td>8</td><td>yes</td><td>no</td></tr><tr><td><italic>BTBD11</italic></td><td>9</td><td>yes</td><td>no</td><td><italic>TSPAN5</italic></td><td>8</td><td>yes</td><td>no</td></tr><tr><td><italic>C6orf106</italic></td><td>9</td><td>yes</td><td>no</td><td><italic>TSR1</italic></td><td>8</td><td>no</td><td>yes</td></tr><tr><td><italic>CARD10</italic></td><td>9</td><td>yes</td><td>yes</td><td><italic>TYMS</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><italic>CHAF1A</italic></td><td>9</td><td>no</td><td>yes</td><td><italic>UCK2</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><bold><italic>CSTA</italic></bold></td><td>9</td><td>yes</td><td>no</td><td><italic>UTP4</italic></td><td>8</td><td>no</td><td>yes</td></tr><tr><td><bold><italic>CYP27B1</italic></bold></td><td>9</td><td>yes</td><td>no</td><td><italic>YAP1</italic></td><td>8</td><td>yes</td><td>no</td></tr><tr><td><bold><italic>FEZ1</italic></bold></td><td>9</td><td>yes</td><td>yes</td><td><italic>YES1</italic></td><td>8</td><td>yes</td><td>yes</td></tr><tr><td><italic>GNA15</italic></td><td>9</td><td>yes</td><td>no</td><td><italic>ZFP36L2</italic></td><td>8</td><td>no</td><td>yes</td></tr><tr><td><bold><italic>GPX2</italic></bold></td><td>9</td><td>yes</td><td>no</td><td><italic>APH1B</italic></td><td>-8</td><td>no</td><td>yes</td></tr><tr><td><italic>GSTP1</italic></td><td>9</td><td>yes</td><td>no</td><td><italic>BIRC3</italic></td><td>-8</td><td>yes</td><td>yes</td></tr><tr><td><italic>HRAS</italic></td><td>9</td><td>yes</td><td>yes</td><td><italic>C9orf3</italic></td><td>-8</td><td>yes</td><td>yes</td></tr><tr><td><italic>IFI16</italic></td><td>9</td><td>yes</td><td>yes</td><td><italic>CHST3</italic></td><td>-8</td><td>no</td><td>yes</td></tr><tr><td><italic>KREMEN1</italic></td><td>9</td><td>yes</td><td>yes</td><td><italic>CPQ</italic></td><td>-8</td><td>no</td><td>yes</td></tr><tr><td><italic>LDLR</italic></td><td>9</td><td>yes</td><td>no</td><td><italic>DUSP8</italic></td><td>-8</td><td>yes</td><td>no</td></tr><tr><td><italic>MAPK6</italic></td><td>9</td><td>yes</td><td>yes</td><td><italic>EPCAM</italic></td><td>-8</td><td>no</td><td>yes</td></tr><tr><td><italic>MYO5A</italic></td><td>9</td><td>no</td><td>yes</td><td><italic>ERBB2</italic></td><td>-8</td><td>no</td><td>yes</td></tr><tr><td><italic>NCAPH2</italic></td><td>9</td><td>yes</td><td>no</td><td><italic>FBN1</italic></td><td>-8</td><td>no</td><td>yes</td></tr><tr><td><italic>NDE1</italic></td><td>9</td><td>yes</td><td>yes</td><td><italic>ITFG1</italic></td><td>-8</td><td>yes</td><td>no</td></tr><tr><td><italic>NDST1</italic></td><td>9</td><td>yes</td><td>yes</td><td><italic>LLGL2</italic></td><td>-8</td><td>yes</td><td>yes</td></tr><tr><td><bold><italic>NIPAL4</italic></bold></td><td>9</td><td>yes</td><td>yes</td><td><italic>NCSTN</italic></td><td>-8</td><td>no</td><td>yes</td></tr><tr><td><italic>PPIF</italic></td><td>9</td><td>no</td><td>yes</td><td><italic>OPN3</italic></td><td>-8</td><td>no</td><td>yes</td></tr><tr><td><bold><italic>PPP4R4</italic></bold></td><td>9</td><td>yes</td><td>no</td><td><bold><italic>PBX1</italic></bold></td><td>-8</td><td>yes</td><td>yes</td></tr><tr><td><italic>PTTG1</italic></td><td>9</td><td>yes</td><td>yes</td><td><italic>PDXK</italic></td><td>-8</td><td>no</td><td>yes</td></tr><tr><td><italic>RAPGEF5</italic></td><td>9</td><td>yes</td><td>yes</td><td><italic>PLAC8</italic></td><td>-8</td><td>yes</td><td>yes</td></tr><tr><td><bold><italic>RNASE7</italic></bold></td><td>9</td><td>yes</td><td>yes</td><td><italic>S100A4</italic></td><td>-8</td><td>no</td><td>yes</td></tr><tr><td><italic>RRP12</italic></td><td>9</td><td>no</td><td>yes</td><td><bold><italic>SPOCK1</italic></bold></td><td>-8</td><td>no</td><td>yes</td></tr><tr><td><bold><italic>SERPINB13</italic></bold></td><td>9</td><td>yes</td><td>no</td><td><italic>TNS3</italic></td><td>-8</td><td>no</td><td>yes</td></tr><tr><td><italic>SNCA</italic></td><td>9</td><td>no</td><td>yes</td><td><italic>ARL6IP5</italic></td><td>-9</td><td>no</td><td>yes</td></tr><tr><td><italic>STX6</italic></td><td>9</td><td>yes</td><td>no</td><td><bold><italic>COBL</italic></bold></td><td>-9</td><td>no</td><td>yes</td></tr><tr><td><italic>AK4</italic></td><td>8</td><td>no</td><td>yes</td><td><italic>CUEDC1</italic></td><td>-9</td><td>yes</td><td>yes</td></tr><tr><td><italic>ARHGAP23</italic></td><td>8</td><td>yes</td><td>yes</td><td><italic>GSN</italic></td><td>-9</td><td>yes</td><td>no</td></tr><tr><td><italic>ASCC3</italic></td><td>8</td><td>yes</td><td>yes</td><td><italic>PDGFC</italic></td><td>-9</td><td>yes</td><td>yes</td></tr><tr><td><italic>BRCA1</italic></td><td>8</td><td>yes</td><td>no</td><td><italic>PGPEP1</italic></td><td>-9</td><td>no</td><td>yes</td></tr><tr><td><italic>BTBD10</italic></td><td>8</td><td>yes</td><td>yes</td><td><italic>PLXNB2</italic></td><td>-9</td><td>yes</td><td>yes</td></tr><tr><td><italic>CCNK</italic></td><td>8</td><td>yes</td><td>no</td><td><italic>PXDN</italic></td><td>-9</td><td>no</td><td>yes</td></tr><tr><td><italic>CCT4</italic></td><td>8</td><td>yes</td><td>no</td><td><italic>RALGPS1</italic></td><td>-9</td><td>yes</td><td>yes</td></tr><tr><td><italic>CD44</italic></td><td>8</td><td>yes</td><td>yes</td><td><italic>ROR1</italic></td><td>-9</td><td>yes</td><td>no</td></tr><tr><td><italic>CDC42SE1</italic></td><td>8</td><td>yes</td><td>no</td><td><italic>SLC16A5</italic></td><td>-9</td><td>yes</td><td>yes</td></tr><tr><td><italic>CDCA7</italic></td><td>8</td><td>yes</td><td>no</td><td><italic>TM4SF1</italic></td><td>-9</td><td>yes</td><td>yes</td></tr><tr><td><bold><italic>COL17A1</italic></bold></td><td>8</td><td>yes</td><td>no</td><td><italic>ALDH3B1</italic></td><td>−10</td><td>yes</td><td>yes</td></tr><tr><td><italic>CRKL</italic></td><td>8</td><td>yes</td><td>yes</td><td><bold><italic>CYP1B1</italic></bold></td><td>−10</td><td>no</td><td>yes</td></tr><tr><td><italic>DRAP1</italic></td><td>8</td><td>yes</td><td>yes</td><td><italic>HHAT</italic></td><td>−10</td><td>yes</td><td>yes</td></tr><tr><td><italic>EHD4</italic></td><td>8</td><td>no</td><td>yes</td><td><italic>MEGF8</italic></td><td>−10</td><td>no</td><td>yes</td></tr><tr><td><italic>ERCC6L</italic></td><td>8</td><td>no</td><td>yes</td><td><italic>PTGES</italic></td><td>−10</td><td>yes</td><td>no</td></tr><tr><td><italic>ESRP1</italic></td><td>8</td><td>no</td><td>yes</td><td><italic>PTTG1IP</italic></td><td>−10</td><td>no</td><td>yes</td></tr><tr><td><bold><italic>FABP5</italic></bold></td><td>8</td><td>yes</td><td>no</td><td><italic>RPS27L</italic></td><td>−10</td><td>yes</td><td>yes</td></tr><tr><td><italic>FANCI</italic></td><td>8</td><td>yes</td><td>yes</td><td><italic>SECTM1</italic></td><td>−10</td><td>yes</td><td>yes</td></tr><tr><td><italic>FLOT2</italic></td><td>8</td><td>yes</td><td>no</td><td><italic>SLC22A5</italic></td><td>−10</td><td>yes</td><td>no</td></tr><tr><td><bold><italic>FOSL1</italic></bold></td><td>8</td><td>yes</td><td>yes</td><td><italic>TNFSF15</italic></td><td>−10</td><td>yes</td><td>yes</td></tr><tr><td><italic>FRMD4B</italic></td><td>8</td><td>yes</td><td>no</td><td><italic>SRD5A3</italic></td><td>−11</td><td>yes</td><td>no</td></tr></tbody></table></table-wrap></sec><sec id="s2-5"><title>A p63/SCC 28-gene set correlates with HNSC patient survival</title><p>Out of the 180 high-probability p63 target genes 32 (28 up- and four down-regulated) are also identified as being commonly up- or down-regulated in SCCs compared to non-SCC cancers (<xref ref-type="bibr" rid="bib10">Cancer Genome Atlas Research Network et al., 2018</xref>; <xref ref-type="table" rid="table1">Table 1</xref>). Importantly, several of the genes commonly up-regulated by p63 as well as in SCC have been identified to promote SCC growth or invasion, such as <italic>LAD1</italic> (<xref ref-type="bibr" rid="bib1">Abe et al., 2019</xref>), <italic>TMEM40</italic> (<xref ref-type="bibr" rid="bib112">Zhang et al., 2019</xref>), <italic>FGFBP1</italic> (<xref ref-type="bibr" rid="bib18">Czubayko et al., 1997</xref>), <italic>IL1B</italic> (<xref ref-type="bibr" rid="bib52">Lee et al., 2015</xref>), <italic>FAT2</italic> (<xref ref-type="bibr" rid="bib19">Dang et al., 2016</xref>), <italic>FOSL1</italic> (<xref ref-type="bibr" rid="bib98">Usui et al., 2012</xref>), <italic>LPAR3</italic> (<xref ref-type="bibr" rid="bib8">Brusevold et al., 2014</xref>), <italic>MMP14</italic> (<xref ref-type="bibr" rid="bib76">Pang et al., 2016</xref>), and <italic>RASSF6</italic> (<xref ref-type="bibr" rid="bib113">Zheng et al., 2019a</xref>). Therefore, we asked whether the set of 28 up-regulated direct p63 targets correlates with patient survival. To this end, we employed data of head and neck SCC (HNSC) patients from The Cancer Genome Atlas (TCGA). Notably, it is known that this cancer type frequently harbors amplified <italic>TP63</italic> (<xref ref-type="bibr" rid="bib9">Cancer Genome Atlas Network et al., 2015</xref>). We find that expression levels of our gene set indeed correlate significantly negatively with HNSC patient survival (COX likelihood ratio test p=0.032). To determine whether expression levels of the set have an influence on the survival of HNSC patients, we subdivided the samples according to the average expression levels into four equally sized groups (low, low-med, med-high, high). While the sample group with low expression had the most favorable prognosis, the null hypothesis could not be rejected in the direct comparison with patients with high average expression levels (p=0.090; <xref ref-type="fig" rid="fig8">Figure 8A</xref>). However, upon contrasting the low-expression group with all remaining samples, a significant improvement of survival was detected (p=0.024; <xref ref-type="fig" rid="fig8">Figure 8B</xref>). Expression of the 28-gene set correlated positively with p63 expression when p63 expression was rather low (FPKM &lt;20), but showed a saturation and no further correlation when p63 expression was high (FPKM &gt;20; <xref ref-type="fig" rid="fig8">Figure 8C and D</xref>, and <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>). This indicates that p63 levels influence the 28-gene set in a switch-like manner where a saturation of p63-dependent activation is quickly reached in HNSC cells. Together, these findings indicate that the genes commonly up-regulated by p63 and in SCC influence the prognosis of HNSC patients. Taken together, this finding calls for a more detailed assessment of ubiquitous p63/SCC genes as biomarkers in the future.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>p63/SCC 28-gene set correlates with poorer survival in HNSC.</title><p>Kaplan-Meier plots of TCGA HNSC patient survival data. (<bold>A</bold>) Patients were subdivided in four equally sized subgroups based on expression levels of the 28-gene set. The results suggest a poorer survival of patients with an up-regulated expression of the set genes. (<bold>B</bold>) To corroborate this finding patients of the subgroups low-med, med-high, and high from (<bold>A</bold>) were joined to form a new high group. Boxplot in bins of 10 of <italic>TP63</italic> FPKM expression values in TCGA HNCS patient sample data compared to (<bold>C</bold>) FPKM values of a meta-gene comprising the 28-gene set and (<bold>D</bold>) ssGSEA scores of the 28-gene set. X-axis is right-censored at 100 to better visualize the effect. The full graph is displayed in <xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63266-fig8-v2.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Extension of <xref ref-type="fig" rid="fig8">Figure 8C and D</xref>.</title><p>Boxplot in bins of 10 of <italic>TP63</italic> FPKM expression values in TCGA HNCS patient sample data compared to (<bold>A</bold>) FPKM values of a meta-gene comprising the 28-gene set and (<bold>B</bold>) ssGSEA scores of the 28-gene set. Complementary to <xref ref-type="fig" rid="fig8">Figure 8C and D</xref>.</p></caption><graphic mime-subtype="tiff" mimetype="image" xlink:href="elife-63266-fig8-figsupp1-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>Although p63 (ΔNp63) is known as master regulator in epidermis development and more recently emerged as a key oncogenic factor in SCC, a comprehensive assessment of the GRN commonly controlled by p63 and its comparison to the GRN commonly controlled by the closely related tumor suppressor p53 has been missing. An increasing number of available high-throughput datasets enabled us to generate ranked lists of p63-regulated genes and p63-bound DNA sites that together reveal high-probability direct p63 target genes regulated by p63 across cells of multiple origins. Because p63 target genes, very much like p53 target genes (<xref ref-type="bibr" rid="bib28">Fischer, 2020</xref>; <xref ref-type="bibr" rid="bib27">Fischer, 2019</xref>), differ substantially between mouse and human (<xref ref-type="bibr" rid="bib90">Sethi et al., 2017</xref>), many p63 target genes initially described in mouse could not be confirmed to be p63-regulated in this study using human data. Given that p63-binding sites are frequently associated with enhancer regions and enhancer identity, we have integrated enhancer:gene associations to identify target genes that are regulated by p63 through direct binding to associated enhancers. This approach enabled the identification of novel direct target genes that are missed by standard analyses that employ only TSS proximity (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>).</p><p>Given the similarity between their DBDs, it has been a long-standing question how p53 and p63 bind to distinct sites in the genome and how these sites differ from another. Several studies found differences in the biochemical properties of p53 and p63 that could affect their DNA binding specificity (<xref ref-type="bibr" rid="bib21">Enthart et al., 2016</xref>; <xref ref-type="bibr" rid="bib62">Lokshin et al., 2007</xref>; <xref ref-type="bibr" rid="bib85">Sauer et al., 2008</xref>; <xref ref-type="bibr" rid="bib96">Tichý et al., 2013</xref>). Various studies aimed to identify the precise p63 recognition motif and its difference from the p53RE using either SELEX (<xref ref-type="bibr" rid="bib75">Ortt and Sinha, 2006</xref>; <xref ref-type="bibr" rid="bib77">Perez et al., 2007</xref>) or ChIP-seq data (<xref ref-type="bibr" rid="bib47">Kouwenhoven et al., 2010</xref>; <xref ref-type="bibr" rid="bib68">McDade et al., 2014</xref>; <xref ref-type="bibr" rid="bib110">Yang et al., 2006</xref>), yet these studies reported different features as being unique for p63 compared to p53 DNA recognition. By combining multiple ChIP-seq datasets we have contributed here to better distinguish between sites commonly bound by p53 and p63 across cell types and sites that are unique to p53 or p63 (<xref ref-type="fig" rid="fig5">Figure 5E</xref>). Most importantly, our results could explain why a substantial fraction of DNA sites is occupied exclusively by p53 or p63. While most sites bound by p53 are also commonly occupied by p63 (<xref ref-type="fig" rid="fig5">Figure 5E</xref> and <xref ref-type="fig" rid="fig5s1">Figure 5—figure supplement 1A</xref>), single half-sites and half-sites separated by spacers underlie many sites that are only bound by p53 (<xref ref-type="fig" rid="fig5">Figures 5F</xref> and <xref ref-type="fig" rid="fig6">6</xref>), supporting earlier findings whereby p53 can be recruited through spacer-containing motifs (<xref ref-type="bibr" rid="bib101">Vyas et al., 2017</xref>). However, while spacers reportedly have been identified in fifty percent of 200 analyzed p53REs (<xref ref-type="bibr" rid="bib101">Vyas et al., 2017</xref>), our genome-wide quantification of motifs underlying 7705 high confidence p53 peaks based on an unbiased motif search using HOMER revealed that only 1.1% to 5.1% of the p53 peaks contain p53REs with 1 bp spacers or half sites that are possibly separated by longer spacers (<xref ref-type="fig" rid="fig6">Figure 6</xref>). Mechanistically, our results imply that relying on the CWWG core motif and the flanking regions may enable p53 to bind to those sites. In contrast, the two CNNG core motifs that underlie p63, but not p53REs, offer an explanation why a substantial fraction of DNA sites is bound exclusively by p63 (<xref ref-type="fig" rid="fig5">Figures 5F</xref> and <xref ref-type="fig" rid="fig7">7</xref>), supporting one of the models established earlier (<xref ref-type="bibr" rid="bib68">McDade et al., 2014</xref>). Notably, p63’s ability to bind to a greater variety of recognition motifs likely underlies the markedly greater number of p63 compared to p53-binding sites in the genome. In addition, our motif search indicates that factors bound to AP-1 (bZIP) and bHLH motifs may specifically support p63 binding (<xref ref-type="fig" rid="fig5s3">Figure 5—figure supplement 3</xref>), and transcription factor enrichment analysis identified the bZIP TF MAF, the TF GRHL2, the chromatin remodeler BANF1, the histone methyltransferase PRMT1, and the ZNF750/KDM1A/KLF4 complex, which was previously shown to operate downstream of p63 (<xref ref-type="bibr" rid="bib7">Boxer et al., 2014</xref>), as potential co-binders that could help to facilitate p63 binding to certain genomic loci (<xref ref-type="fig" rid="fig5s4">Figure 5—figure supplement 4</xref>). Considering its pioneer role, p63 could vice versa enable the binding of these TFs to the respective loci. Given that p63 and p73 form stable heterotetramers (<xref ref-type="bibr" rid="bib34">Gebel et al., 2016</xref>), p73 may possess binding specificities that are highly similar to those identified for p63. Our results indicate that our approach could serve as a blueprint to distinguish DNA recognition motifs, binding sites, co-factors, and target genes of TF siblings more precisely. Our iterative de novo search algorithm enabled the identification of spacer-containing p53REs, indicating that our approach uncovers second-tier TF binding motifs invisible to standard approaches. Moreover, the results provide insights to the p63 DNA binding repertoire in unprecedented depth (<xref ref-type="fig" rid="fig5">Figure 5F</xref>).</p><p>Consistent with results from an earlier genome-wide study (<xref ref-type="bibr" rid="bib110">Yang et al., 2006</xref>), our findings imply that p63 is more frequently involved in a direct up-regulation as opposed to a direct down-regulation of target genes (<xref ref-type="fig" rid="fig3">Figure 3A</xref> and <xref ref-type="fig" rid="fig7s1">Figure 7—figure supplement 1</xref>). Mechanistically, p63 has been shown to up-regulate target genes through its alternative TAD located at the N-terminus while the C-terminus is important for down-regulation (<xref ref-type="bibr" rid="bib37">Helton et al., 2006</xref>). Exogenous expression of different isoforms of p53 family members and their antagonistic effects on target gene promoters in luciferase reporter assays suggested a model whereby p63 exhibits a dominant negative effect on other p53 family members (<xref ref-type="bibr" rid="bib72">Mundt et al., 2010</xref>; <xref ref-type="bibr" rid="bib104">Westfall et al., 2003</xref>; <xref ref-type="bibr" rid="bib108">Yang et al., 1998</xref>). Inconsistent with its reputation as dominant negative regulator of p53, however, genome-wide studies showed that the groups of p63-regulated genes and p53-regulated genes show only very little overlap (<xref ref-type="bibr" rid="bib32">Gallant-Behm et al., 2012</xref>). A recent analysis of DNA sites bound and of genes regulated by p53 and p63 revealed that p63 is more likely to support than to inhibit p53 activity (<xref ref-type="bibr" rid="bib40">Karsli Uzunbas et al., 2019</xref>). Our analysis further supports the notion that p63 does not commonly interfere with target gene up-regulation by p53 but that except for cell cycle genes they regulate largely distinct gene sets (<xref ref-type="fig" rid="fig4">Figure 4</xref>).</p><p>We identify several candidate TFs that may operate downstream of p63 and that may serve as transitional nodes in the p63 GRN. In addition to known mediators of p63-dependent gene regulation, such as MYC and KLF4, we identify AR and its co-factor ZMIZ1, SP1, FLI1, and NANOG as novel candidate nodes in the p63 GRN (<xref ref-type="fig" rid="fig3">Figure 3A</xref>). In agreement with the tumor suppressor role of p53 and the oncogenic role of p63, we find that cell cycle genes are antagonistically regulated by p53 and p63 (<xref ref-type="fig" rid="fig2">Figures 2A</xref> and <xref ref-type="fig" rid="fig4">4A</xref>). On the one hand, cell cycle genes are well-known to be down-regulated by p53 indirectly through the cyclin-dependent kinase inhibitor p21 and the cell cycle repressor complexes DREAM and RB-E2F (<xref ref-type="bibr" rid="bib23">Fischer et al., 2016a</xref>; <xref ref-type="bibr" rid="bib24">Fischer et al., 2016b</xref>; <xref ref-type="bibr" rid="bib86">Schade et al., 2019</xref>; <xref ref-type="bibr" rid="bib99">Uxa et al., 2019</xref>). On the other hand, cell cycle genes are down-regulated upon loss of p63 and this p63-dependent regulation reportedly occurs through regulating p21 signaling and the DREAM component p130 (<xref ref-type="bibr" rid="bib66">McDade et al., 2011</xref>; <xref ref-type="bibr" rid="bib97">Truong et al., 2006</xref>). In addition to indirect effects, we also predicted multiple cell cycle genes as direct p63 targets (<xref ref-type="table" rid="table1">Table 1</xref>). Consequently, a loss of p63 may substantially contribute to the effect of p53 in reducing cell cycle gene expression (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). In addition of p63’s role in driving the expression of some cell cycle genes, the entire set of cell cycle genes may be subsequently up-regulated indirectly through p63’s pro-proliferative targets. While the up-regulation of cell cycle genes occurs in most cancers (<xref ref-type="bibr" rid="bib105">Whitfield et al., 2006</xref>), we find that p63 additionally regulates genes that are specifically altered across SCCs (<xref ref-type="fig" rid="fig2">Figure 2D</xref>). These results underscore the critical role of p63 and its target genes in determining the transcriptional profile of SCC. An example of a p63 target in SCC is NRG1, which can be inhibited to block SCC proliferation and tumor growth (<xref ref-type="bibr" rid="bib35">Hegde et al., 2019</xref>). The resource of genes commonly regulated by p63 provided here may help to identify targets that can be exploited therapeutically. We provided a showcase example, where expression levels of the 28 p63 target genes that are commonly up-regulated by p63 and in SCC (<xref ref-type="table" rid="table1">Table 1</xref>) correlate significantly with poorer survival of HNSC patients (<xref ref-type="fig" rid="fig8">Figure 8</xref>). Thus, this 28-gene set may contain particularly promising candidates for therapeutic interventions and for the use as biomarkers.</p></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><sec id="s4-1"><title>Re-analysis and integration of publicly available gene expression profiling datasets</title><p>We re-analyzed publicly available p63-dependent gene expression profiling datasets. As a first quality requirement, we only included datasets for re-analysis that contained at least two biological replicates for the treatment as well as for the control condition. All microarray datasets were available at a pre-processed stage at the Gene Expression Omnibus (GEO) and we re-analyzed these datasets with GEO2R to obtain fold expression changes and Benjamini Hochberg-corrected p-values (<xref ref-type="bibr" rid="bib14">Clough and Barrett, 2016</xref>). Gene identifiers were mapped to Ensembl Gene IDs using the Ensembl annotation data (<xref ref-type="bibr" rid="bib17">Cunningham et al., 2019</xref>). All RNA-seq datasets have been retrieved through GEO from the Sequence Read Archive (SRA) (<xref ref-type="bibr" rid="bib53">Leinonen et al., 2011</xref>). We employed our RNA-seq analysis pipeline to obtain fold expression changes and p-values adjusted for multiple testing. Briefly, we utilized Trimmomatic (<xref ref-type="bibr" rid="bib6">Bolger et al., 2014</xref>) v0.39 (5nt sliding window approach, mean quality cutoff 22) for read quality trimming according to inspections made from FastQC (<ext-link ext-link-type="uri" xlink:href="https://www.bioinformatics.babraham.ac.uk/projects/fastqc/">https://www.bioinformatics.babraham.ac.uk/projects/fastqc/</ext-link>) v0.11.8 reports. Clipping was performed using Cutadapt v2.3 (<xref ref-type="bibr" rid="bib65">Martin, 2011</xref>). Potential sequencing errors were detected and corrected using Rcorrector v1.0.3.1 (<xref ref-type="bibr" rid="bib92">Song and Florea, 2015</xref>). Ribosomal RNA (rRNA) transcripts were artificially depleted by read alignment against rRNA databases through SortMeRNA v2.1 (<xref ref-type="bibr" rid="bib46">Kopylova et al., 2012</xref>). The preprocessed data was aligned to the reference genome hg38, retrieved along with its gene annotation from Ensembl v.92 (<xref ref-type="bibr" rid="bib17">Cunningham et al., 2019</xref>). For read alignment, we used the splice-aware mapping software segemehl (<xref ref-type="bibr" rid="bib39">Hoffmann et al., 2014</xref>; <xref ref-type="bibr" rid="bib38">Hoffmann et al., 2009</xref>) v0.3.4 with adjusted accuracy (95%). Mappings were filtered by Samtools v1.9 (<xref ref-type="bibr" rid="bib55">Li et al., 2009</xref>) for uniqueness and properly aligned mate pairs. Read quantification was performed on exon level using featureCounts v1.6.5 (<xref ref-type="bibr" rid="bib56">Liao et al., 2014</xref>), parametrized according to the strand specificity inferred through RSeQC v3.0.0 (<xref ref-type="bibr" rid="bib102">Wang et al., 2012</xref>). Differential gene expression and its statistical significance was identified using DESeq2 v1.20.0 (<xref ref-type="bibr" rid="bib64">Love et al., 2014</xref>). Information on the samples that were compared for each dataset is included in <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>. Given that all RNA-seq data was derived from PolyA-enriched samples, we only included Ensembl transcript types ‘protein_coding’, ‘antisense’, ‘lincRNA’ and ‘TEC’ in our analysis. Common thresholds for adj. p-value≤0.05 were applied.</p></sec><sec id="s4-2"><title>Generation of the p63 expression score</title><p>For 19,156 genes covered by at least three datasets including a minimum of one RNA-seq dataset, a <italic>p63 Expression Score</italic> was calculated as the number of datasets that find the gene to be significantly up-regulated minus the number of datasets that find the gene to be significantly down-regulated in dependence on p63. This meta-analysis resulted in 27 <italic>p63 Expression Score</italic> gene groups because no gene was identified as up-regulated in all 16 or 15 datasets or down-regulated in all 16, 15, 14, or 13 datasets.</p></sec><sec id="s4-3"><title>Enrichment analyses</title><p>Gene set enrichment analysis (GSEA) was performed using GSEA (<ext-link ext-link-type="uri" xlink:href="http://software.broadinstitute.org/gsea/">http://software.broadinstitute.org/gsea/</ext-link>) with ‘H’, ‘C2’, and ‘C6’ gene sets from MSigDB v7.0 (<xref ref-type="bibr" rid="bib94">Subramanian et al., 2005</xref>) and custom panSCC gene sets derived from Table S1C in <xref ref-type="bibr" rid="bib10">Cancer Genome Atlas Research Network et al., 2018</xref>. GSEA was performed on a pre-ranked list of genes that were ranked primarily by <italic>p63 Expression Score</italic> and secondarily by median log<sub>2</sub>(fold-change) to obtain unique ranks.</p><p>Enrichment of transcription factor binding to genes with high (≥8) or low (≤ −8) <italic>p63 Expression Score</italic> was identified using the results section ‘ENCODE and ChEA Consensus TFs from ChIP-X’ from Enrichr (<xref ref-type="bibr" rid="bib50">Kuleshov et al., 2016</xref>).</p></sec><sec id="s4-4"><title>Integration of publicly available p63 and p53 binding data</title><p>Peak datasets from p63 ChIP-seq experiments were retrieved from CistromeDB (<xref ref-type="bibr" rid="bib114">Zheng et al., 2019b</xref>; <xref ref-type="supplementary-material" rid="supp1">Supplementary file 1</xref>). When replicate experiments were available, all peaks were used that have been identified in at least two replicates. A similar collection of p53 peak datasets has been described previously (<xref ref-type="bibr" rid="bib27">Fischer, 2019</xref>). To intersect multiple peak files Bedtools ‘multiinter’ was used and to identify overlapping and non-overlapping peaks Bedtools ‘intersect’ was employed (<xref ref-type="bibr" rid="bib79">Quinlan and Hall, 2010</xref>).</p></sec><sec id="s4-5"><title>Motif search</title><p>Known p53 and p63REs were identified using the ‘known motifs’ in HOMER v4.10 with default options and <italic>-size given</italic> (<xref ref-type="bibr" rid="bib36">Heinz et al., 2010</xref>). De novo motif discovery was performed with options <italic>-size given -len 10,15,20,25 -mis 5 S 10</italic>.</p></sec><sec id="s4-6"><title>Identification of potential co-factors</title><p>We used the CistromeDB toolkit (<xref ref-type="bibr" rid="bib114">Zheng et al., 2019b</xref>) to identify TFs that display ChIP-seq peaksets that are significantly similar to our ‘unique p53’, ‘unique p63’, and ‘p53+p63’ peaksets.</p></sec><sec id="s4-7"><title>Survival and expression correlation analysis</title><p>For the 28-gene set, single-sample enrichment scores were derived from FPKM normalized gene expression values of 546 HNSC patient samples. To this end, we utilized the official GenePattern single sample gene set enrichment analysis (ssGSEA) codebase v10.0.3 (<xref ref-type="bibr" rid="bib4">Barbie et al., 2009</xref>; <ext-link ext-link-type="uri" xlink:href="https://github.com/GSEA-MSigDB/ssGSEA-gpmodule">https://github.com/GSEA-MSigDB/ssGSEA-gpmodule</ext-link>). A sample score represents the coordinately up- or down-regulated expression of all genes within one set as its signature (<xref ref-type="bibr" rid="bib4">Barbie et al., 2009</xref>). Kaplan-Meier plots and correlation analyses were performed on TCGA time to event and event occurrence information using the R survival package v3.2–3. Following the TCGA standard for HNSC (<xref ref-type="bibr" rid="bib9">Cancer Genome Atlas Network et al., 2015</xref>), survival analyses were right-censored at 60 months (1800 days) to avoid non-cancer-related events. The Cox proportional hazards model was used to investigate the association of patient survival time and the combined expression levels of the 28-gene set. Subsequently, we subdivided the expression scores into four equally sized categorical groups (high, med-high, med-low, low). The rates of occurrence of events over time were compared between these groups using the fitted COX PH model.</p><p>We retrieved read quantification data 'HTSeq - Counts' from 546 samples of the TCGA project HNSC utilizing the R package TCGAbiolinks v2.18.0 (<xref ref-type="bibr" rid="bib15">Colaprico et al., 2016</xref>). Per sample, all read counts of the 28-gene set were merged into an artificially created metagene. Subsequently, we calculated normalized expression values per gene as fragments per kilobase million, where the length of a gene corresponds to the lengths of its exons assigned to either the canonical transcript (CCDS) or the longest transcript according to hg38 Ensembl annotation v92. <italic>TP63</italic> FPKM values were plotted against the meta-gene FPKM value or the ssGSEA derived gene set scores (see above).</p></sec></sec></body><back><sec id="s5" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Data curation, Software, Formal analysis, Investigation, Visualization, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con2"><p>Formal analysis, Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con3"><p>Methodology, Writing - review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con5"><p>Resources, Supervision, Funding acquisition, Investigation, Writing - review and editing</p></fn><fn fn-type="con" id="con6"><p>Conceptualization, Data curation, Formal analysis, Supervision, Funding acquisition, Validation, Investigation, Visualization, Methodology, Writing - original draft, Project administration, Writing - review and editing</p></fn></fn-group></sec><sec id="s6" sec-type="supplementary-material"><title>Additional files</title><supplementary-material id="supp1"><label>Supplementary file 1.</label><caption><title>Detailed information on publicly available p63-dependent gene expression profiling and p63 ChIP-seq datasets that were integrated in this study.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63266-supp1-v2.xlsx"/></supplementary-material><supplementary-material id="supp2"><label>Supplementary file 2.</label><caption><title>Meta-analysis from 16 p63-dependent gene expression information datasets (listed in Suppelemtary File 1) to generate the <italic>p63 Expression Score</italic> for 19,156 human genes.</title></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63266-supp2-v2.xlsx"/></supplementary-material><supplementary-material id="supp3"><label>Supplementary file 3.</label><caption><title>p63- and p53-binding sites identified in at least 5 out of 20 and 28 ChIP-seq datasets, respectively.</title><p>Binding sites are listed with their ChIP-seq dataset support and highest scoring p63 response elements (p63REs) or p53REs. Genes associated with p63-binding sites through proximal TSS binding or enhancers are listed.</p></caption><media mime-subtype="xlsx" mimetype="application" xlink:href="elife-63266-supp3-v2.xlsx"/></supplementary-material><supplementary-material id="transrepform"><label>Transparent reporting form</label><media mime-subtype="docx" mimetype="application" xlink:href="elife-63266-transrepform-v2.docx"/></supplementary-material></sec><sec id="s7" sec-type="data-availability"><title>Data availability</title><p>All data generated or analysed during this study are included in the manuscript and supporting files.</p><p>The following previously published datasets were used:</p><p><element-citation id="dataset1" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Bao</surname><given-names>X</given-names></name><name><surname>Rubin</surname><given-names>AJ</given-names></name><name><surname>Qu</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Giresi</surname><given-names>PG</given-names></name><name><surname>Chang</surname><given-names>HY</given-names></name><name><surname>Khavari</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>A novel ATAC-seq approach reveals lineage-specific reinforcement of the open chromatin landscape via cooperation between BAF and p63</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67382">GSE67382</pub-id></element-citation></p><p><element-citation id="dataset2" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Kouwenhoven</surname><given-names>EN</given-names></name><name><surname>van Heeringen</surname><given-names>SJ</given-names></name><name><surname>Tena</surname><given-names>JJ</given-names></name><name><surname>Oti</surname><given-names>M</given-names></name><name><surname>Dutilh</surname><given-names>BE</given-names></name><name><surname>Alonso</surname><given-names>ME</given-names></name><name><surname>de la Calle-Mustienes</surname><given-names>E</given-names></name><name><surname>Smeenk</surname><given-names>L</given-names></name><name><surname>Rinne</surname><given-names>T</given-names></name><name><surname>Parsaulian</surname><given-names>L</given-names></name><name><surname>Bolat</surname><given-names>E</given-names></name><name><surname>Jurgelenaite</surname><given-names>R</given-names></name><name><surname>Huynen</surname><given-names>MA</given-names></name><name><surname>Hoischen</surname><given-names>A</given-names></name><name><surname>Veltman</surname><given-names>JA</given-names></name><name><surname>Brunner</surname><given-names>HG</given-names></name><name><surname>Roscioli</surname><given-names>T</given-names></name><name><surname>Oates</surname><given-names>E</given-names></name><name><surname>Wilson</surname><given-names>M</given-names></name><name><surname>Manzanares</surname><given-names>M</given-names></name><name><surname>Gómez-Skarmeta</surname><given-names>JL</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>Lohrum</surname><given-names>M</given-names></name><name><surname>van Bokhoven</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><data-title>Genome-Wide Profiling of p63 DNA-Binding Sites Identifies an Element that Regulates Gene Expression during Limb Development in the 7q21 SHFM1 Locus</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE17611">GSE17611</pub-id></element-citation></p><p><element-citation id="dataset3" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Kouwenhoven</surname><given-names>EN</given-names></name><name><surname>Oti</surname><given-names>M</given-names></name><name><surname>Niehues</surname><given-names>H</given-names></name><name><surname>van Heeringen</surname><given-names>SJ</given-names></name><name><surname>Schalkwijk</surname><given-names>J</given-names></name><name><surname>Stunnenberg</surname><given-names>HG</given-names></name><name><surname>Bokhoven</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>Transcription factor p63 bookmarks and regulates dynamic enhancers during epidermal differentiation</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE59824">GSE59824</pub-id></element-citation></p><p><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>McDade</surname><given-names>SS</given-names></name><name><surname>Henry</surname><given-names>AE</given-names></name><name><surname>Pivato</surname><given-names>GP</given-names></name><name><surname>Kozarewa</surname><given-names>I</given-names></name><name><surname>Mitsopoulos</surname><given-names>C</given-names></name><name><surname>Fenwick</surname><given-names>K</given-names></name><name><surname>Assiotis</surname><given-names>I</given-names></name><name><surname>Hakas</surname><given-names>J</given-names></name><name><surname>Zvelebil</surname><given-names>M</given-names></name><name><surname>Orr</surname><given-names>N</given-names></name><name><surname>Lord</surname><given-names>CJ</given-names></name><name><surname>Patel</surname><given-names>D</given-names></name><name><surname>Ashworth</surname><given-names>A</given-names></name><name><surname>McCance</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><data-title>Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE32061">GSE32061</pub-id></element-citation></p><p><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>McDade</surname><given-names>SS</given-names></name><name><surname>Patel</surname><given-names>D</given-names></name><name><surname>Moran</surname><given-names>M</given-names></name><name><surname>Campbell</surname><given-names>J</given-names></name><name><surname>Fenwick</surname><given-names>K</given-names></name><name><surname>Kozarewa</surname><given-names>I</given-names></name><name><surname>Orr</surname><given-names>NJ</given-names></name><name><surname>Lord</surname><given-names>CJ</given-names></name><name><surname>Ashworth</surname><given-names>AA</given-names></name><name><surname>McCance</surname><given-names>DJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><data-title>Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stress</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE56674">GSE56674</pub-id></element-citation></p><p><element-citation id="dataset6" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>JR</given-names></name><name><surname>Oyan</surname><given-names>AM</given-names></name><name><surname>Rostad</surname><given-names>K</given-names></name><name><surname>Hellem</surname><given-names>MR</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Micklem</surname><given-names>DR</given-names></name><name><surname>Haugen</surname><given-names>H</given-names></name><name><surname>Lorens</surname><given-names>JB</given-names></name><name><surname>Rotter</surname><given-names>V</given-names></name><name><surname>Ke</surname><given-names>XS</given-names></name><name><surname>Lin</surname><given-names>B</given-names></name><name><surname>Kalland</surname><given-names>KH</given-names></name></person-group><year iso-8601-date="2013">2013</year><data-title>p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE43111">GSE43111</pub-id></element-citation></p><p><element-citation id="dataset7" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Saladi</surname><given-names>SV</given-names></name><name><surname>Ross</surname><given-names>K</given-names></name><name><surname>Karaayvaz</surname><given-names>M</given-names></name><name><surname>Tata</surname><given-names>PR</given-names></name><name><surname>Mou</surname><given-names>H</given-names></name><name><surname>Rajagopal</surname><given-names>J</given-names></name><name><surname>Ramaswamy</surname><given-names>S</given-names></name><name><surname>Ellisen</surname><given-names>LW</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE88859">GSE88859</pub-id></element-citation></p><p><element-citation id="dataset8" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Vasilaki</surname><given-names>E</given-names></name><name><surname>Morikawa</surname><given-names>M</given-names></name><name><surname>Koinuma</surname><given-names>D</given-names></name><name><surname>Mizutani</surname><given-names>A</given-names></name><name><surname>Hirano</surname><given-names>Y</given-names></name><name><surname>Ehata</surname><given-names>S</given-names></name><name><surname>Sundqvist</surname><given-names>A</given-names></name><name><surname>Kawasaki</surname><given-names>N</given-names></name><name><surname>Cedervall</surname><given-names>J</given-names></name><name><surname>Olsson</surname><given-names>AK</given-names></name><name><surname>Aburatani</surname><given-names>H</given-names></name><name><surname>Moustakas</surname><given-names>A</given-names></name><name><surname>Miyazono</surname><given-names>K</given-names></name><name><surname>Heldin</surname><given-names>CH</given-names></name></person-group><year iso-8601-date="2016">2016</year><data-title>Ras and TGF-β signaling enhance cancer progression by promoting the ΔNp63 transcriptional program</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE60814">GSE60814</pub-id></element-citation></p><p><element-citation id="dataset9" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Peng</surname><given-names>S</given-names></name><name><surname>Adelmant</surname><given-names>G</given-names></name><name><surname>Swain</surname><given-names>D</given-names></name><name><surname>Song</surname><given-names>W</given-names></name><name><surname>Fox</surname><given-names>C</given-names></name><name><surname>Francis</surname><given-names>JM</given-names></name><name><surname>Pedamallu</surname><given-names>CS</given-names></name><name><surname>DeLuca</surname><given-names>DS</given-names></name><name><surname>Brooks</surname><given-names>AN</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Que</surname><given-names>J</given-names></name><name><surname>Rustgi</surname><given-names>AK</given-names></name><name><surname>Wong</surname><given-names>K</given-names></name><name><surname>Ligon</surname><given-names>KL</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name><name><surname>Marto</surname><given-names>JA</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name><name><surname>Bass</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><data-title>SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE46837">GSE46837</pub-id></element-citation></p><p><element-citation id="dataset10" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Zarnegar</surname><given-names>BJ</given-names></name><name><surname>Webster</surname><given-names>DE</given-names></name><name><surname>Lopez-Pajares</surname><given-names>V</given-names></name><name><surname>Vander Stoep Hunt</surname><given-names>B</given-names></name><name><surname>Qu</surname><given-names>K</given-names></name><name><surname>Yan</surname><given-names>KJ</given-names></name><name><surname>Berk</surname><given-names>DR</given-names></name><name><surname>Sen</surname><given-names>GL</given-names></name><name><surname>Khavari</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2012">2012</year><data-title>Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE33571">GSE33571</pub-id></element-citation></p><p><element-citation id="dataset11" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>CG</given-names></name><name><surname>Ludwig</surname><given-names>MP</given-names></name><name><surname>Andrysik</surname><given-names>Z</given-names></name><name><surname>Pandey</surname><given-names>A</given-names></name><name><surname>Joshi</surname><given-names>M</given-names></name><name><surname>Galbraith</surname><given-names>MD</given-names></name><name><surname>Sullivan</surname><given-names>KD</given-names></name><name><surname>Espinosa</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>ΔNp63α Suppresses TGFB2 Expression and RHOA Activity to Drive Cell Proliferation in Squamous Cell Carcinomas</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE111619">GSE111619</pub-id></element-citation></p><p><element-citation id="dataset12" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Abraham</surname><given-names>CG</given-names></name><name><surname>Ludwig</surname><given-names>MP</given-names></name><name><surname>Andrysik</surname><given-names>Z</given-names></name><name><surname>Pandey</surname><given-names>A</given-names></name><name><surname>Joshi</surname><given-names>M</given-names></name><name><surname>Galbraith</surname><given-names>MD</given-names></name><name><surname>Sullivan</surname><given-names>KD</given-names></name><name><surname>Espinosa</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2006">2006</year><data-title>p63 regulates an adhesion programme and cell survival in epithelial cells</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE20286">GSE20286</pub-id></element-citation></p><p><element-citation id="dataset13" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Gallant-Behm</surname><given-names>CL</given-names></name><name><surname>Ramsey</surname><given-names>MR</given-names></name><name><surname>Bensard</surname><given-names>CL</given-names></name><name><surname>Nojek</surname><given-names>I</given-names></name><name><surname>Tran</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Ellisen</surname><given-names>LW</given-names></name><name><surname>Espinosa</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2012">2012</year><data-title>ΔNp63α represses anti-proliferative genes via H2A.Z deposition</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE40462">GSE40462</pub-id></element-citation></p><p><element-citation id="dataset14" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Karsli Uzunbas</surname><given-names>G</given-names></name><name><surname>Ahmed</surname><given-names>F</given-names></name><name><surname>Sammons</surname><given-names>MA</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Control of p53-dependent transcription and enhancer activity by the p53 family member p63</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE111009">GSE111009</pub-id></element-citation></p><p><element-citation id="dataset15" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Lin-Shiao</surname><given-names>E</given-names></name><name><surname>Lan</surname><given-names>Y</given-names></name><name><surname>Welzenbach</surname><given-names>J</given-names></name><name><surname>Alexander</surname><given-names>KA</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Knapp</surname><given-names>M</given-names></name><name><surname>Mangold</surname><given-names>E</given-names></name><name><surname>Sammons</surname><given-names>M</given-names></name><name><surname>Ludwig</surname><given-names>KU</given-names></name><name><surname>Berger</surname><given-names>SL</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>p63 establishes epithelial enhancers at critical craniofacial development genes</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE126397">GSE126397</pub-id></element-citation></p><p><element-citation id="dataset16" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Saladi</surname><given-names>SV</given-names></name><name><surname>Ross</surname><given-names>K</given-names></name><name><surname>Karaayvaz</surname><given-names>M</given-names></name><name><surname>Tata</surname><given-names>PR</given-names></name><name><surname>Mou</surname><given-names>H</given-names></name><name><surname>Rajagopal</surname><given-names>J</given-names></name><name><surname>Ramaswamy</surname><given-names>S</given-names></name><name><surname>Ellisen</surname><given-names>LW</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE88833">GSE88833</pub-id></element-citation></p><p><element-citation id="dataset17" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Saladi</surname><given-names>SV</given-names></name><name><surname>Ross</surname><given-names>K</given-names></name><name><surname>Karaayvaz</surname><given-names>M</given-names></name><name><surname>Tata</surname><given-names>PR</given-names></name><name><surname>Mou</surname><given-names>H</given-names></name><name><surname>Rajagopal</surname><given-names>J</given-names></name><name><surname>Ramaswamy</surname><given-names>S</given-names></name><name><surname>Ellisen</surname><given-names>LW</given-names></name></person-group><year iso-8601-date="2017">2017</year><data-title>ACTL6A Is Co-Amplified with p63 in Squamous Cell Carcinoma to Drive YAP Activation, Regenerative Proliferation, and Poor Prognosis</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE88832">GSE88832</pub-id></element-citation></p><p><element-citation id="dataset18" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Somerville</surname><given-names>TDD</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Miyabayashi</surname><given-names>K</given-names></name><name><surname>Tiriac</surname><given-names>H</given-names></name><name><surname>Cleary</surname><given-names>CR</given-names></name><name><surname>Maia-Silva</surname><given-names>D</given-names></name><name><surname>Milazzo</surname><given-names>JP</given-names></name><name><surname>Tuveson</surname><given-names>DA</given-names></name><name><surname>Vakoc</surname><given-names>CR</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>TP63-Mediated Enhancer Reprogramming Drives the Squamous Subtype of Pancreatic Ductal Adenocarcinoma</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE115462">GSE115462</pub-id></element-citation></p><p><element-citation id="dataset19" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Watanabe</surname><given-names>H</given-names></name><name><surname>Ma</surname><given-names>Q</given-names></name><name><surname>Peng</surname><given-names>S</given-names></name><name><surname>Adelmant</surname><given-names>G</given-names></name><name><surname>Swain</surname><given-names>D</given-names></name><name><surname>Song</surname><given-names>W</given-names></name><name><surname>Fox</surname><given-names>C</given-names></name><name><surname>Francis</surname><given-names>JM</given-names></name><name><surname>Pedamallu</surname><given-names>CS</given-names></name><name><surname>DeLuca</surname><given-names>DS</given-names></name><name><surname>Brooks</surname><given-names>AN</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Que</surname><given-names>J</given-names></name><name><surname>Rustgi</surname><given-names>AK</given-names></name><name><surname>Wong</surname><given-names>K</given-names></name><name><surname>Ligon</surname><given-names>KL</given-names></name><name><surname>Liu</surname><given-names>XS</given-names></name><name><surname>Marto</surname><given-names>JA</given-names></name><name><surname>Meyerson</surname><given-names>M</given-names></name><name><surname>Bass</surname><given-names>AJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><data-title>SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE47058">GSE47058</pub-id></element-citation></p><p><element-citation id="dataset20" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>N</given-names></name><name><surname>Rollin</surname><given-names>J</given-names></name><name><surname>Masse</surname><given-names>I</given-names></name><name><surname>Lamartine</surname><given-names>J</given-names></name><name><surname>Gidrol</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2012">2012</year><data-title>p63 regulates human keratinocyte proliferation via MYC-regulated gene network and differentiation commitment through cell adhesion-related gene network</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE17394">GSE17394</pub-id></element-citation></p><p><element-citation id="dataset21" publication-type="data" specific-use="references"><person-group person-group-type="author"><name><surname>Zarnegar</surname><given-names>BJ</given-names></name><name><surname>Webster</surname><given-names>DE</given-names></name><name><surname>Lopez-Pajares</surname><given-names>V</given-names></name><name><surname>Vander Stoep Hunt</surname><given-names>B</given-names></name><name><surname>Qu</surname><given-names>K</given-names></name><name><surname>Yan</surname><given-names>KJ</given-names></name><name><surname>Berk</surname><given-names>DR</given-names></name><name><surname>Sen</surname><given-names>GL</given-names></name><name><surname>Khavari</surname><given-names>PA</given-names></name></person-group><year iso-8601-date="2012">2012</year><data-title>Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63</data-title><source>NCBI Gene Expression Omnibus</source><pub-id assigning-authority="NCBI" pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE33495">GSE33495</pub-id></element-citation></p></sec><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abe</surname> <given-names>DT</given-names></name><name><surname>Yamazaki</surname> <given-names>DM</given-names></name><name><surname>Maruyama</surname> <given-names>DS</given-names></name><name><surname>Ajioka</surname> <given-names>PY</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ladinin-1 is involved in cell motility and proliferation of oral squamous cell carcinoma cells</article-title><source>Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology</source><volume>128</volume><fpage>e81</fpage><lpage>e82</lpage><pub-id pub-id-type="doi">10.1016/j.oooo.2019.02.205</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abraham</surname> <given-names>CG</given-names></name><name><surname>Ludwig</surname> <given-names>MP</given-names></name><name><surname>Andrysik</surname> <given-names>Z</given-names></name><name><surname>Pandey</surname> <given-names>A</given-names></name><name><surname>Joshi</surname> <given-names>M</given-names></name><name><surname>Galbraith</surname> <given-names>MD</given-names></name><name><surname>Sullivan</surname> <given-names>KD</given-names></name><name><surname>Espinosa</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>??np63α suppresses TGFB2 expression and RHOA activity to drive cell proliferation in squamous cell carcinomas</article-title><source>Cell Reports</source><volume>24</volume><fpage>3224</fpage><lpage>3236</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.08.058</pub-id><pub-id pub-id-type="pmid">30232004</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bao</surname> <given-names>X</given-names></name><name><surname>Rubin</surname> <given-names>AJ</given-names></name><name><surname>Qu</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Giresi</surname> <given-names>PG</given-names></name><name><surname>Chang</surname> <given-names>HY</given-names></name><name><surname>Khavari</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A novel ATAC-seq approach reveals lineage-specific reinforcement of the open chromatin landscape via cooperation between BAF and p63</article-title><source>Genome Biology</source><volume>16</volume><elocation-id>284</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-015-0840-9</pub-id><pub-id pub-id-type="pmid">26683334</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barbie</surname> <given-names>DA</given-names></name><name><surname>Tamayo</surname> <given-names>P</given-names></name><name><surname>Boehm</surname> <given-names>JS</given-names></name><name><surname>Kim</surname> <given-names>SY</given-names></name><name><surname>Moody</surname> <given-names>SE</given-names></name><name><surname>Dunn</surname> <given-names>IF</given-names></name><name><surname>Schinzel</surname> <given-names>AC</given-names></name><name><surname>Sandy</surname> <given-names>P</given-names></name><name><surname>Meylan</surname> <given-names>E</given-names></name><name><surname>Scholl</surname> <given-names>C</given-names></name><name><surname>Fröhling</surname> <given-names>S</given-names></name><name><surname>Chan</surname> <given-names>EM</given-names></name><name><surname>Sos</surname> <given-names>ML</given-names></name><name><surname>Michel</surname> <given-names>K</given-names></name><name><surname>Mermel</surname> <given-names>C</given-names></name><name><surname>Silver</surname> <given-names>SJ</given-names></name><name><surname>Weir</surname> <given-names>BA</given-names></name><name><surname>Reiling</surname> <given-names>JH</given-names></name><name><surname>Sheng</surname> <given-names>Q</given-names></name><name><surname>Gupta</surname> <given-names>PB</given-names></name><name><surname>Wadlow</surname> <given-names>RC</given-names></name><name><surname>Le</surname> <given-names>H</given-names></name><name><surname>Hoersch</surname> <given-names>S</given-names></name><name><surname>Wittner</surname> <given-names>BS</given-names></name><name><surname>Ramaswamy</surname> <given-names>S</given-names></name><name><surname>Livingston</surname> <given-names>DM</given-names></name><name><surname>Sabatini</surname> <given-names>DM</given-names></name><name><surname>Meyerson</surname> <given-names>M</given-names></name><name><surname>Thomas</surname> <given-names>RK</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Mesirov</surname> <given-names>JP</given-names></name><name><surname>Root</surname> <given-names>DE</given-names></name><name><surname>Gilliland</surname> <given-names>DG</given-names></name><name><surname>Jacks</surname> <given-names>T</given-names></name><name><surname>Hahn</surname> <given-names>WC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1</article-title><source>Nature</source><volume>462</volume><fpage>108</fpage><lpage>112</lpage><pub-id pub-id-type="doi">10.1038/nature08460</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barton</surname> <given-names>CE</given-names></name><name><surname>Johnson</surname> <given-names>KN</given-names></name><name><surname>Mays</surname> <given-names>DM</given-names></name><name><surname>Boehnke</surname> <given-names>K</given-names></name><name><surname>Shyr</surname> <given-names>Y</given-names></name><name><surname>Boukamp</surname> <given-names>P</given-names></name><name><surname>Pietenpol</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Novel p63 target genes involved in Paracrine signaling and keratinocyte differentiation</article-title><source>Cell Death &amp; Disease</source><volume>1</volume><elocation-id>e74</elocation-id><pub-id pub-id-type="doi">10.1038/cddis.2010.49</pub-id><pub-id pub-id-type="pmid">21151771</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolger</surname> <given-names>AM</given-names></name><name><surname>Lohse</surname> <given-names>M</given-names></name><name><surname>Usadel</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Trimmomatic: a flexible trimmer for illumina sequence data</article-title><source>Bioinformatics</source><volume>30</volume><fpage>2114</fpage><lpage>2120</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btu170</pub-id><pub-id pub-id-type="pmid">24695404</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boxer</surname> <given-names>LD</given-names></name><name><surname>Barajas</surname> <given-names>B</given-names></name><name><surname>Tao</surname> <given-names>S</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Khavari</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>ZNF750 interacts with KLF4 and RCOR1, KDM1A, and CTBP1/2 chromatin regulators to repress epidermal progenitor genes and induce differentiation genes</article-title><source>Genes &amp; Development</source><volume>28</volume><fpage>2013</fpage><lpage>2026</lpage><pub-id pub-id-type="doi">10.1101/gad.246579.114</pub-id><pub-id pub-id-type="pmid">25228645</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brusevold</surname> <given-names>IJ</given-names></name><name><surname>Tveteraas</surname> <given-names>IH</given-names></name><name><surname>Aasrum</surname> <given-names>M</given-names></name><name><surname>Ødegård</surname> <given-names>J</given-names></name><name><surname>Sandnes</surname> <given-names>DL</given-names></name><name><surname>Christoffersen</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Role of LPAR3, PKC and EGFR in LPA-induced cell migration in oral squamous carcinoma cells</article-title><source>BMC Cancer</source><volume>14</volume><elocation-id>432</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2407-14-432</pub-id><pub-id pub-id-type="pmid">24928086</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Cancer Genome Atlas Network</collab><name><surname>Lawrence</surname> <given-names>MS</given-names></name><name><surname>Sougnez</surname> <given-names>C</given-names></name><name><surname>Lichtenstein</surname> <given-names>L</given-names></name><name><surname>Cibulskis</surname> <given-names>K</given-names></name><name><surname>Lander</surname> <given-names>E</given-names></name><name><surname>Gabriel</surname> <given-names>SB</given-names></name><name><surname>Getz</surname> <given-names>G</given-names></name><name><surname>Ally</surname> <given-names>A</given-names></name><name><surname>Balasundaram</surname> <given-names>M</given-names></name><name><surname>Birol</surname> <given-names>I</given-names></name><name><surname>Bowlby</surname> <given-names>R</given-names></name><name><surname>Brooks</surname> <given-names>D</given-names></name><name><surname>Butterfield</surname> <given-names>YSN</given-names></name><name><surname>Carlsen</surname> <given-names>R</given-names></name><name><surname>Cheng</surname> <given-names>D</given-names></name><name><surname>Chu</surname> <given-names>A</given-names></name><name><surname>Dhalla</surname> <given-names>N</given-names></name><name><surname>Guin</surname> <given-names>R</given-names></name><name><surname>Holt</surname> <given-names>RA</given-names></name><name><surname>Jones</surname> <given-names>SJM</given-names></name><name><surname>Lee</surname> <given-names>D</given-names></name><name><surname>Hi</surname> <given-names>L</given-names></name><name><surname>Marra</surname> <given-names>MA</given-names></name><name><surname>Mayo</surname> <given-names>M</given-names></name><name><surname>Moore</surname> <given-names>RA</given-names></name><name><surname>Mungall</surname> <given-names>AJ</given-names></name><name><surname>Robertson</surname> <given-names>AG</given-names></name><name><surname>Schein</surname> <given-names>JE</given-names></name><name><surname>Sipahimalani</surname> <given-names>P</given-names></name><name><surname>Tam</surname> <given-names>A</given-names></name><name><surname>Thiessen</surname> <given-names>N</given-names></name><name><surname>Wong</surname> <given-names>T</given-names></name><name><surname>Protopopov</surname> <given-names>A</given-names></name><name><surname>Santoso</surname> <given-names>N</given-names></name><name><surname>Lee</surname> <given-names>S</given-names></name><name><surname>Parfenov</surname> <given-names>M</given-names></name><name><surname>Jianhua</surname> <given-names>Z</given-names></name><name><surname>Mahadeshwar</surname> <given-names>HS</given-names></name><name><surname>Tang</surname> <given-names>J</given-names></name><name><surname>Ren</surname> <given-names>X</given-names></name><name><surname>Seth</surname> <given-names>S</given-names></name><name><surname>Haseley</surname> <given-names>P</given-names></name><name><surname>Zeng</surname> <given-names>D</given-names></name><name><surname>Lixing</surname> <given-names>Y</given-names></name><name><surname>Aw</surname> <given-names>X</given-names></name><name><surname>Song</surname> <given-names>X</given-names></name><name><surname>Pantazi</surname> <given-names>A</given-names></name><name><surname>Bristow</surname> <given-names>CA</given-names></name><name><surname>Hadjipanayis</surname> <given-names>A</given-names></name><name><surname>Seidman</surname> <given-names>J</given-names></name><name><surname>Chin</surname> <given-names>L</given-names></name><name><surname>Park</surname> <given-names>PJ</given-names></name><name><surname>Kucherlapati</surname> <given-names>R</given-names></name><name><surname>Akbani</surname> <given-names>R</given-names></name><name><surname>Casasent</surname> <given-names>T</given-names></name><name><surname>Liu</surname> <given-names>W</given-names></name><name><surname>Lu</surname> <given-names>Y</given-names></name><name><surname>Mills</surname> <given-names>G</given-names></name><name><surname>Motter</surname> <given-names>T</given-names></name><name><surname>Weinstein</surname> <given-names>J</given-names></name><name><surname>Diao</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Hong Fan</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>K</given-names></name><name><surname>Auman</surname> <given-names>JT</given-names></name><name><surname>Balu</surname> <given-names>S</given-names></name><name><surname>Bodenheimer</surname> <given-names>T</given-names></name><name><surname>Buda</surname> <given-names>E</given-names></name><name><surname>Hayes</surname> <given-names>DN</given-names></name><name><surname>Hoadley</surname> <given-names>KA</given-names></name><name><surname>Hoyle</surname> <given-names>AP</given-names></name><name><surname>Jefferys</surname> <given-names>SR</given-names></name><name><surname>Jones</surname> <given-names>CD</given-names></name><name><surname>Kimes</surname> <given-names>PK</given-names></name><name><surname>Yufeng</surname> <given-names>L</given-names></name><name><surname>Marron</surname> <given-names>JS</given-names></name><name><surname>Meng</surname> <given-names>S</given-names></name><name><surname>Mieczkowski</surname> <given-names>PA</given-names></name><name><surname>Mose</surname> <given-names>LE</given-names></name><name><surname>Parker</surname> <given-names>JS</given-names></name><name><surname>Perou</surname> <given-names>CM</given-names></name><name><surname>Prins</surname> <given-names>JF</given-names></name><name><surname>Roach</surname> <given-names>J</given-names></name><name><surname>Shi</surname> <given-names>Y</given-names></name><name><surname>Simons</surname> <given-names>J</given-names></name> <name><surname>Singh</surname> <given-names>D</given-names></name><name><surname>Soloway</surname> <given-names>MG</given-names></name><name><surname>Tan</surname> <given-names>D</given-names></name><name><surname>Veluvolu</surname> <given-names>U</given-names></name><name><surname>Walter</surname> <given-names>V</given-names></name><name><surname>Waring</surname> <given-names>S</given-names></name><name><surname>Wilkerson</surname> <given-names>MD</given-names></name><name><surname>Wu</surname> <given-names>J</given-names></name><name><surname>Zhao</surname> <given-names>N</given-names></name><name><surname>Cherniack</surname> <given-names>AD</given-names></name><name><surname>Hammerman</surname> <given-names>PS</given-names></name><name><surname>Tward</surname> <given-names>AD</given-names></name><name><surname>Pedamallu</surname> <given-names>CS</given-names></name><name><surname>Saksena</surname> <given-names>G</given-names></name><name><surname>Jung</surname> <given-names>J</given-names></name><name><surname>Ojesina</surname> <given-names>AI</given-names></name><name><surname>Carter</surname> <given-names>SL</given-names></name><name><surname>Zack</surname> <given-names>TI</given-names></name><name><surname>Schumacher</surname> <given-names>SE</given-names></name><name><surname>Beroukhim</surname> <given-names>R</given-names></name><name><surname>Freeman</surname> <given-names>SS</given-names></name><name><surname>Meyerson</surname> <given-names>M</given-names></name><name><surname>Cho</surname> <given-names>J</given-names></name><name><surname>Noble</surname> <given-names>MS</given-names></name><name><surname>DiCara</surname> <given-names>D</given-names></name><name><surname>Zhang</surname> <given-names>H</given-names></name><name><surname>Heiman</surname> <given-names>DI</given-names></name><name><surname>Gehlenborg</surname> <given-names>N</given-names></name><name><surname>Voet</surname> <given-names>D</given-names></name><name><surname>Lin</surname> <given-names>P</given-names></name><name><surname>Frazer</surname> <given-names>S</given-names></name><name><surname>Stojanov</surname> <given-names>P</given-names></name><name><surname>Yingchun</surname> <given-names>L</given-names></name><name><surname>Zou</surname> <given-names>L</given-names></name><name><surname>Kim</surname> <given-names>J</given-names></name><name><surname>Muzny</surname> <given-names>D</given-names></name><name><surname>Doddapaneni</surname> <given-names>HV</given-names></name><name><surname>Kovar</surname> <given-names>C</given-names></name><name><surname>Reid</surname> <given-names>J</given-names></name><name><surname>Morton</surname> <given-names>D</given-names></name><name><surname>Han</surname> <given-names>Y</given-names></name><name><surname>Hale</surname> <given-names>W</given-names></name><name><surname>Chao</surname> <given-names>H</given-names></name><name><surname>Chang</surname> <given-names>K</given-names></name><name><surname>Drummond</surname> <given-names>JA</given-names></name><name><surname>Gibbs</surname> <given-names>RA</given-names></name><name><surname>Kakkar</surname> <given-names>N</given-names></name><name><surname>Wheeler</surname> <given-names>D</given-names></name><name><surname>Xi</surname> <given-names>L</given-names></name><name><surname>Ciriello</surname> <given-names>G</given-names></name><name><surname>Ladanyi</surname> <given-names>M</given-names></name><name><surname>Lee</surname> <given-names>W</given-names></name><name><surname>Ramirez</surname> <given-names>R</given-names></name><name><surname>Sander</surname> <given-names>C</given-names></name><name><surname>Shen</surname> <given-names>R</given-names></name><name><surname>Sinha</surname> <given-names>R</given-names></name><name><surname>Weinhold</surname> <given-names>N</given-names></name><name><surname>Taylor</surname> <given-names>BS</given-names></name><name><surname>Aksoy</surname> <given-names>BA</given-names></name><name><surname>Dresdner</surname> <given-names>G</given-names></name><name><surname>Gao</surname> <given-names>J</given-names></name><name><surname>Gross</surname> <given-names>B</given-names></name><name><surname>Jacobsen</surname> <given-names>A</given-names></name><name><surname>Reva</surname> <given-names>B</given-names></name><name><surname>Schultz</surname> <given-names>N</given-names></name><name><surname>Sumer</surname> <given-names>SO</given-names></name><name><surname>Sun</surname> <given-names>Y</given-names></name><name><surname>Chan</surname> <given-names>TA</given-names></name><name><surname>Morris</surname> <given-names>LG</given-names></name><name><surname>Stuart</surname> <given-names>J</given-names></name><name><surname>Benz</surname> <given-names>S</given-names></name><name><surname>Benz</surname> <given-names>C</given-names></name><name><surname>Yau</surname> <given-names>C</given-names></name><name><surname>Baylin</surname> <given-names>SB</given-names></name><name><surname>Cope</surname> <given-names>L</given-names></name><name><surname>Danilova</surname> <given-names>L</given-names></name><name><surname>Herman</surname> <given-names>JG</given-names></name><name><surname>Bootwalla</surname> <given-names>M</given-names></name><name><surname>Maglinte</surname> <given-names>DT</given-names></name><name><surname>Laird</surname> <given-names>PW</given-names></name><name><surname>Triche</surname> <given-names>T</given-names></name><name><surname>Weisenberger</surname> <given-names>DJ</given-names></name><name><surname>Van Den Berg</surname> <given-names>DJ</given-names></name><name><surname>Agrawal</surname> <given-names>N</given-names></name><name><surname>Bishop</surname> <given-names>J</given-names></name><name><surname>Boutros</surname> <given-names>PC</given-names></name><name><surname>Bruce</surname> <given-names>JP</given-names></name><name><surname>Byers</surname> <given-names>LA</given-names></name><name><surname>Califano</surname> <given-names>J</given-names></name><name><surname>Carey</surname> <given-names>TE</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Cheng</surname> <given-names>H</given-names></name><name><surname>Chiosea</surname> <given-names>SI</given-names></name><name><surname>Cohen</surname> <given-names>E</given-names></name><name><surname>Diergaarde</surname> <given-names>B</given-names></name><name><surname>Egloff</surname> <given-names>AM</given-names></name><name><surname>El-Naggar</surname> <given-names>AK</given-names></name><name><surname>Ferris</surname> <given-names>RL</given-names></name><name><surname>Frederick</surname> <given-names>MJ</given-names></name><name><surname>Grandis</surname> <given-names>JR</given-names></name><name><surname>Guo</surname> <given-names>Y</given-names></name><name><surname>Haddad</surname> <given-names>RI</given-names></name><name><surname>Harris</surname> <given-names>T</given-names></name><name><surname>Aby</surname> <given-names>H</given-names></name><name><surname>Lee</surname> <given-names>JJ</given-names></name><name><surname>Lippman</surname> <given-names>SM</given-names></name><name><surname>Liu</surname> <given-names>FF</given-names></name><name><surname>McHugh</surname> <given-names>JB</given-names></name><name><surname>Myers</surname> <given-names>J</given-names></name><name><surname>Pks</surname> <given-names>N</given-names></name><name><surname>Perez-Ordonez</surname> <given-names>B</given-names></name><name><surname>Pickering</surname> <given-names>CR</given-names></name><name><surname>Prystowsky</surname> <given-names>M</given-names></name><name><surname>Romkes</surname> <given-names>M</given-names></name><name><surname>Saleh</surname> <given-names>AD</given-names></name><name><surname>Sartor</surname> <given-names>MA</given-names></name><name><surname>Seethala</surname> <given-names>R</given-names></name><name><surname>Seiwert</surname> <given-names>TY</given-names></name><name><surname>Si</surname> <given-names>H</given-names></name><name><surname>Van Waes</surname> <given-names>C</given-names></name><name><surname>Waggott</surname> <given-names>DM</given-names></name><name><surname>Wiznerowicz</surname> <given-names>M</given-names></name><name><surname>Yarbrough</surname> <given-names>WG</given-names></name><name><surname>Jiexin</surname> <given-names>Z</given-names></name><name><surname>Zuo</surname> <given-names>Z</given-names></name><name><surname>Burnett</surname> <given-names>K</given-names></name><name><surname>Crain</surname> <given-names>D</given-names></name><name><surname>Gardner</surname> <given-names>J</given-names></name><name><surname>Lau</surname> <given-names>K</given-names></name><name><surname>Mallery</surname> <given-names>D</given-names></name><name><surname>Morris</surname> <given-names>S</given-names></name><name><surname>Paulauskis</surname> <given-names>J</given-names></name><name><surname>Penny</surname> <given-names>R</given-names></name><name><surname>Shelton</surname> <given-names>C</given-names></name><name><surname>Shelton</surname> <given-names>T</given-names></name><name><surname>Sherman</surname> <given-names>M</given-names></name><name><surname>Yena</surname> <given-names>P</given-names></name><name><surname>Black</surname> <given-names>AD</given-names></name><name><surname>Bowen</surname> <given-names>J</given-names></name><name><surname>Frick</surname> <given-names>J</given-names></name><name><surname>Gastier-Foster</surname> <given-names>JM</given-names></name><name><surname>Harper</surname> <given-names>HA</given-names></name><name><surname>Leraas</surname> <given-names>K</given-names></name><name><surname>Lichtenberg</surname> <given-names>TM</given-names></name><name><surname>Ramirez</surname> <given-names>NC</given-names></name><name><surname>Wise</surname> <given-names>L</given-names></name><name><surname>Zmuda</surname> <given-names>E</given-names></name><name><surname>Baboud</surname> <given-names>J</given-names></name><name><surname>Jensen</surname> <given-names>MA</given-names></name><name><surname>Kahn</surname> <given-names>AB</given-names></name><name><surname>Pihl</surname> <given-names>TD</given-names></name><name><surname>Pot</surname> <given-names>DA</given-names></name><name><surname>Srinivasan</surname> <given-names>D</given-names></name><name><surname>Walton</surname> <given-names>JS</given-names></name><name><surname>Wan</surname> <given-names>Y</given-names></name><name><surname>Burton</surname> <given-names>RA</given-names></name><name><surname>Davidsen</surname> <given-names>T</given-names></name><name><surname>Demchok</surname> <given-names>JA</given-names></name><name><surname>Eley</surname> <given-names>G</given-names></name><name><surname>Ferguson</surname> <given-names>ML</given-names></name><name><surname>Mills Shaw</surname> <given-names>KR</given-names></name><name><surname>Ozenberger</surname> <given-names>BA</given-names></name><name><surname>Sheth</surname> <given-names>M</given-names></name><name><surname>Sofia</surname> <given-names>HJ</given-names></name><name><surname>Tarnuzzer</surname> <given-names>R</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Liming</surname> <given-names>Y</given-names></name><name><surname>Zenklusen</surname> <given-names>JC</given-names></name><name><surname>Saller</surname> <given-names>C</given-names></name><name><surname>Tarvin</surname> <given-names>K</given-names></name><name><surname>Chen</surname> <given-names>C</given-names></name><name><surname>Bollag</surname> <given-names>R</given-names></name><name><surname>Weinberger</surname> <given-names>P</given-names></name><name><surname>Golusiński</surname> <given-names>W</given-names></name><name><surname>Golusiński</surname> <given-names>P</given-names></name><name><surname>Ibbs</surname> <given-names>M</given-names></name><name><surname>Korski</surname> <given-names>K</given-names></name><name><surname>Mackiewicz</surname> <given-names>A</given-names></name><name><surname>Suchorska</surname> <given-names>W</given-names></name><name><surname>Szybiak</surname> <given-names>B</given-names></name><name><surname>Curley</surname> <given-names>E</given-names></name><name><surname>Beard</surname> <given-names>C</given-names></name><name><surname>Mitchell</surname> <given-names>C</given-names></name><name><surname>Sandusky</surname> <given-names>G</given-names></name><name><surname>Ahn</surname> <given-names>J</given-names></name><name><surname>Khan</surname> <given-names>Z</given-names></name><name><surname>Irish</surname> <given-names>J</given-names></name><name><surname>Waldron</surname> <given-names>J</given-names></name><name><surname>William</surname> <given-names>WN</given-names></name><name><surname>Egea</surname> <given-names>S</given-names></name><name><surname>Gomez-Fernandez</surname> <given-names>C</given-names></name><name><surname>Herbert</surname> <given-names>L</given-names></name><name><surname>Bradford</surname> <given-names>CR</given-names></name><name><surname>Chepeha</surname> <given-names>DB</given-names></name><name><surname>Haddad</surname> <given-names>AS</given-names></name><name><surname>Jones</surname> <given-names>TR</given-names></name><name><surname>Komarck</surname> <given-names>CM</given-names></name><name><surname>Malakh</surname> <given-names>M</given-names></name><name><surname>Moyer</surname> <given-names>JS</given-names></name><name><surname>Nguyen</surname> <given-names>A</given-names></name><name><surname>Peterson</surname> <given-names>LA</given-names></name><name><surname>Prince</surname> <given-names>ME</given-names></name><name><surname>Rozek</surname> <given-names>LS</given-names></name><name><surname>Taylor</surname> <given-names>EG</given-names></name><name><surname>Walline</surname> <given-names>HM</given-names></name><name><surname>Wolf</surname> <given-names>GT</given-names></name><name><surname>Boice</surname> <given-names>L</given-names></name><name><surname>Chera</surname> <given-names>BS</given-names></name><name><surname>Funkhouser</surname> <given-names>WK</given-names></name><name><surname>Gulley</surname> <given-names>ML</given-names></name><name><surname>Hackman</surname> <given-names>TG</given-names></name><name><surname>Hayward</surname> <given-names>MC</given-names></name><name><surname>Huang</surname> <given-names>M</given-names></name><name><surname>Rathmell</surname> <given-names>WK</given-names></name><name><surname>Salazar</surname> <given-names>AH</given-names></name><name><surname>Shockley</surname> <given-names>WW</given-names></name><name><surname>Shores</surname> <given-names>CG</given-names></name><name><surname>Thorne</surname> <given-names>L</given-names></name><name><surname>Weissler</surname> <given-names>MC</given-names></name><name><surname>Wrenn</surname> <given-names>S</given-names></name><name><surname>Zanation</surname> <given-names>AM</given-names></name><name><surname>Brown</surname> <given-names>BT</given-names></name><name><surname>Pham</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Comprehensive genomic characterization of head and neck squamous cell carcinomas</article-title><source>Nature</source><volume>517</volume><fpage>576</fpage><lpage>582</lpage><pub-id pub-id-type="doi">10.1038/nature14129</pub-id><pub-id pub-id-type="pmid">25631445</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><collab>Cancer Genome Atlas Research Network</collab><name><surname>Campbell</surname> <given-names>JD</given-names></name><name><surname>Yau</surname> <given-names>C</given-names></name><name><surname>Bowlby</surname> <given-names>R</given-names></name><name><surname>Liu</surname> <given-names>Y</given-names></name><name><surname>Brennan</surname> <given-names>K</given-names></name><name><surname>Fan</surname> <given-names>H</given-names></name><name><surname>Taylor</surname> <given-names>AM</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Walter</surname> <given-names>V</given-names></name><name><surname>Akbani</surname> <given-names>R</given-names></name><name><surname>Byers</surname> <given-names>LA</given-names></name><name><surname>Creighton</surname> <given-names>CJ</given-names></name><name><surname>Coarfa</surname> <given-names>C</given-names></name><name><surname>Shih</surname> <given-names>J</given-names></name><name><surname>Cherniack</surname> <given-names>AD</given-names></name><name><surname>Gevaert</surname> <given-names>O</given-names></name><name><surname>Prunello</surname> <given-names>M</given-names></name><name><surname>Shen</surname> <given-names>H</given-names></name><name><surname>Anur</surname> <given-names>P</given-names></name><name><surname>Chen</surname> <given-names>J</given-names></name><name><surname>Cheng</surname> <given-names>H</given-names></name><name><surname>Hayes</surname> <given-names>DN</given-names></name><name><surname>Bullman</surname> <given-names>S</given-names></name><name><surname>Pedamallu</surname> <given-names>CS</given-names></name><name><surname>Ojesina</surname> <given-names>AI</given-names></name><name><surname>Sadeghi</surname> <given-names>S</given-names></name><name><surname>Mungall</surname> <given-names>KL</given-names></name><name><surname>Robertson</surname> <given-names>AG</given-names></name><name><surname>Benz</surname> <given-names>C</given-names></name><name><surname>Schultz</surname> <given-names>A</given-names></name><name><surname>Kanchi</surname> <given-names>RS</given-names></name><name><surname>Gay</surname> <given-names>CM</given-names></name><name><surname>Hegde</surname> <given-names>A</given-names></name><name><surname>Diao</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Ma</surname> <given-names>W</given-names></name><name><surname>Sumazin</surname> <given-names>P</given-names></name><name><surname>Chiu</surname> <given-names>HS</given-names></name><name><surname>Chen</surname> <given-names>TW</given-names></name><name><surname>Gunaratne</surname> <given-names>P</given-names></name><name><surname>Donehower</surname> <given-names>L</given-names></name><name><surname>Rader</surname> <given-names>JS</given-names></name><name><surname>Zuna</surname> <given-names>R</given-names></name><name><surname>Al-Ahmadie</surname> <given-names>H</given-names></name><name><surname>Lazar</surname> <given-names>AJ</given-names></name><name><surname>Flores</surname> <given-names>ER</given-names></name><name><surname>Tsai</surname> <given-names>KY</given-names></name><name><surname>Zhou</surname> <given-names>JH</given-names></name><name><surname>Rustgi</surname> <given-names>AK</given-names></name><name><surname>Drill</surname> <given-names>E</given-names></name><name><surname>Shen</surname> <given-names>R</given-names></name><name><surname>Wong</surname> <given-names>CK</given-names></name><name><surname>Stuart</surname> <given-names>JM</given-names></name><name><surname>Laird</surname> <given-names>PW</given-names></name><name><surname>Hoadley</surname> <given-names>KA</given-names></name><name><surname>Weinstein</surname> <given-names>JN</given-names></name><name><surname>Peto</surname> <given-names>M</given-names></name><name><surname>Pickering</surname> <given-names>CR</given-names></name><name><surname>Chen</surname> <given-names>Z</given-names></name><name><surname>Van Waes</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Genomic, pathway network, and immunologic features distinguishing squamous carcinomas</article-title><source>Cell Reports</source><volume>23</volume><fpage>194</fpage><lpage>212</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.03.063</pub-id><pub-id pub-id-type="pmid">29617660</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carroll</surname> <given-names>DK</given-names></name><name><surname>Carroll</surname> <given-names>JS</given-names></name><name><surname>Leong</surname> <given-names>CO</given-names></name><name><surname>Cheng</surname> <given-names>F</given-names></name><name><surname>Brown</surname> <given-names>M</given-names></name><name><surname>Mills</surname> <given-names>AA</given-names></name><name><surname>Brugge</surname> <given-names>JS</given-names></name><name><surname>Ellisen</surname> <given-names>LW</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>p63 regulates an adhesion programme and cell survival in epithelial cells</article-title><source>Nature Cell Biology</source><volume>8</volume><fpage>551</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1038/ncb1420</pub-id><pub-id pub-id-type="pmid">16715076</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chakrabarti</surname> <given-names>R</given-names></name><name><surname>Wei</surname> <given-names>Y</given-names></name><name><surname>Hwang</surname> <given-names>J</given-names></name><name><surname>Hang</surname> <given-names>X</given-names></name><name><surname>Andres Blanco</surname> <given-names>M</given-names></name><name><surname>Choudhury</surname> <given-names>A</given-names></name><name><surname>Tiede</surname> <given-names>B</given-names></name><name><surname>Romano</surname> <given-names>RA</given-names></name><name><surname>DeCoste</surname> <given-names>C</given-names></name><name><surname>Mercatali</surname> <given-names>L</given-names></name><name><surname>Ibrahim</surname> <given-names>T</given-names></name><name><surname>Amadori</surname> <given-names>D</given-names></name><name><surname>Kannan</surname> <given-names>N</given-names></name><name><surname>Eaves</surname> <given-names>CJ</given-names></name><name><surname>Sinha</surname> <given-names>S</given-names></name><name><surname>Kang</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>??np63 promotes stem cell activity in mammary gland development and basal-like breast Cancer by enhancing Fzd7 expression and wnt signalling</article-title><source>Nature Cell Biology</source><volume>16</volume><fpage>1004</fpage><lpage>1015</lpage><pub-id pub-id-type="doi">10.1038/ncb3040</pub-id><pub-id pub-id-type="pmid">25241036</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Claudio</surname> <given-names>PP</given-names></name><name><surname>Cui</surname> <given-names>J</given-names></name><name><surname>Ghafouri</surname> <given-names>M</given-names></name><name><surname>Mariano</surname> <given-names>C</given-names></name><name><surname>White</surname> <given-names>MK</given-names></name><name><surname>Safak</surname> <given-names>M</given-names></name><name><surname>Sheffield</surname> <given-names>JB</given-names></name><name><surname>Giordano</surname> <given-names>A</given-names></name><name><surname>Khalili</surname> <given-names>K</given-names></name><name><surname>Amini</surname> <given-names>S</given-names></name><name><surname>Sawaya</surname> <given-names>BE</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Cdk9 phosphorylates p53 on serine 392 independently of CKII</article-title><source>Journal of Cellular Physiology</source><volume>208</volume><fpage>602</fpage><lpage>612</lpage><pub-id pub-id-type="doi">10.1002/jcp.20698</pub-id><pub-id pub-id-type="pmid">16741955</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Clough</surname> <given-names>E</given-names></name><name><surname>Barrett</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The gene expression omnibus database</article-title><source>Methods in Molecular Biology</source><volume>1418</volume><fpage>93</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1007/978-1-4939-3578-9_5</pub-id><pub-id pub-id-type="pmid">27008011</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colaprico</surname> <given-names>A</given-names></name><name><surname>Silva</surname> <given-names>TC</given-names></name><name><surname>Olsen</surname> <given-names>C</given-names></name><name><surname>Garofano</surname> <given-names>L</given-names></name><name><surname>Cava</surname> <given-names>C</given-names></name><name><surname>Garolini</surname> <given-names>D</given-names></name><name><surname>Sabedot</surname> <given-names>TS</given-names></name><name><surname>Malta</surname> <given-names>TM</given-names></name><name><surname>Pagnotta</surname> <given-names>SM</given-names></name><name><surname>Castiglioni</surname> <given-names>I</given-names></name><name><surname>Ceccarelli</surname> <given-names>M</given-names></name><name><surname>Bontempi</surname> <given-names>G</given-names></name><name><surname>Noushmehr</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data</article-title><source>Nucleic Acids Research</source><volume>44</volume><elocation-id>e71</elocation-id><pub-id pub-id-type="doi">10.1093/nar/gkv1507</pub-id><pub-id pub-id-type="pmid">26704973</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Compagnone</surname> <given-names>M</given-names></name><name><surname>Gatti</surname> <given-names>V</given-names></name><name><surname>Presutti</surname> <given-names>D</given-names></name><name><surname>Ruberti</surname> <given-names>G</given-names></name><name><surname>Fierro</surname> <given-names>C</given-names></name><name><surname>Markert</surname> <given-names>EK</given-names></name><name><surname>Vousden</surname> <given-names>KH</given-names></name><name><surname>Zhou</surname> <given-names>H</given-names></name><name><surname>Mauriello</surname> <given-names>A</given-names></name><name><surname>Anemone</surname> <given-names>L</given-names></name><name><surname>Bongiorno-Borbone</surname> <given-names>L</given-names></name><name><surname>Melino</surname> <given-names>G</given-names></name><name><surname>Peschiaroli</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>ΔNp63-mediated regulation of hyaluronic acid metabolism and signaling supports HNSCC tumorigenesis</article-title><source>PNAS</source><volume>114</volume><fpage>13254</fpage><lpage>13259</lpage><pub-id pub-id-type="doi">10.1073/pnas.1711777114</pub-id><pub-id pub-id-type="pmid">29162693</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cunningham</surname> <given-names>F</given-names></name><name><surname>Achuthan</surname> <given-names>P</given-names></name><name><surname>Akanni</surname> <given-names>W</given-names></name><name><surname>Allen</surname> <given-names>J</given-names></name><name><surname>Amode</surname> <given-names>MR</given-names></name><name><surname>Armean</surname> <given-names>IM</given-names></name><name><surname>Bennett</surname> <given-names>R</given-names></name><name><surname>Bhai</surname> <given-names>J</given-names></name><name><surname>Billis</surname> <given-names>K</given-names></name><name><surname>Boddu</surname> <given-names>S</given-names></name><name><surname>Cummins</surname> <given-names>C</given-names></name><name><surname>Davidson</surname> <given-names>C</given-names></name><name><surname>Dodiya</surname> <given-names>KJ</given-names></name><name><surname>Gall</surname> <given-names>A</given-names></name><name><surname>Girón</surname> <given-names>CG</given-names></name><name><surname>Gil</surname> <given-names>L</given-names></name><name><surname>Grego</surname> <given-names>T</given-names></name><name><surname>Haggerty</surname> <given-names>L</given-names></name><name><surname>Haskell</surname> <given-names>E</given-names></name><name><surname>Hourlier</surname> <given-names>T</given-names></name><name><surname>Izuogu</surname> <given-names>OG</given-names></name><name><surname>Janacek</surname> <given-names>SH</given-names></name><name><surname>Juettemann</surname> <given-names>T</given-names></name><name><surname>Kay</surname> <given-names>M</given-names></name><name><surname>Laird</surname> <given-names>MR</given-names></name><name><surname>Lavidas</surname> <given-names>I</given-names></name><name><surname>Liu</surname> <given-names>Z</given-names></name><name><surname>Loveland</surname> <given-names>JE</given-names></name><name><surname>Marugán</surname> <given-names>JC</given-names></name><name><surname>Maurel</surname> <given-names>T</given-names></name><name><surname>McMahon</surname> <given-names>AC</given-names></name><name><surname>Moore</surname> <given-names>B</given-names></name><name><surname>Morales</surname> <given-names>J</given-names></name><name><surname>Mudge</surname> <given-names>JM</given-names></name><name><surname>Nuhn</surname> <given-names>M</given-names></name><name><surname>Ogeh</surname> <given-names>D</given-names></name><name><surname>Parker</surname> <given-names>A</given-names></name><name><surname>Parton</surname> <given-names>A</given-names></name><name><surname>Patricio</surname> <given-names>M</given-names></name><name><surname>Abdul Salam</surname> <given-names>AI</given-names></name><name><surname>Schmitt</surname> <given-names>BM</given-names></name><name><surname>Schuilenburg</surname> <given-names>H</given-names></name><name><surname>Sheppard</surname> <given-names>D</given-names></name><name><surname>Sparrow</surname> <given-names>H</given-names></name><name><surname>Stapleton</surname> <given-names>E</given-names></name><name><surname>Szuba</surname> <given-names>M</given-names></name><name><surname>Taylor</surname> <given-names>K</given-names></name><name><surname>Threadgold</surname> <given-names>G</given-names></name><name><surname>Thormann</surname> <given-names>A</given-names></name><name><surname>Vullo</surname> <given-names>A</given-names></name><name><surname>Walts</surname> <given-names>B</given-names></name><name><surname>Winterbottom</surname> <given-names>A</given-names></name><name><surname>Zadissa</surname> <given-names>A</given-names></name><name><surname>Chakiachvili</surname> <given-names>M</given-names></name><name><surname>Frankish</surname> <given-names>A</given-names></name><name><surname>Hunt</surname> <given-names>SE</given-names></name><name><surname>Kostadima</surname> <given-names>M</given-names></name><name><surname>Langridge</surname> <given-names>N</given-names></name><name><surname>Martin</surname> <given-names>FJ</given-names></name><name><surname>Muffato</surname> <given-names>M</given-names></name><name><surname>Perry</surname> <given-names>E</given-names></name><name><surname>Ruffier</surname> <given-names>M</given-names></name><name><surname>Staines</surname> <given-names>DM</given-names></name><name><surname>Trevanion</surname> <given-names>SJ</given-names></name><name><surname>Aken</surname> <given-names>BL</given-names></name><name><surname>Yates</surname> <given-names>AD</given-names></name><name><surname>Zerbino</surname> <given-names>DR</given-names></name><name><surname>Flicek</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Ensembl 2019</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D745</fpage><lpage>D751</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1113</pub-id><pub-id pub-id-type="pmid">30407521</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Czubayko</surname> <given-names>F</given-names></name><name><surname>Liaudet-Coopman</surname> <given-names>ED</given-names></name><name><surname>Aigner</surname> <given-names>A</given-names></name><name><surname>Tuveson</surname> <given-names>AT</given-names></name><name><surname>Berchem</surname> <given-names>GJ</given-names></name><name><surname>Wellstein</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>A secreted FGF-binding protein can serve as the angiogenic switch in human Cancer</article-title><source>Nature Medicine</source><volume>3</volume><fpage>1137</fpage><lpage>1140</lpage><pub-id pub-id-type="doi">10.1038/nm1097-1137</pub-id><pub-id pub-id-type="pmid">9334727</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dang</surname> <given-names>TT</given-names></name><name><surname>Westcott</surname> <given-names>JM</given-names></name><name><surname>Maine</surname> <given-names>EA</given-names></name><name><surname>Kanchwala</surname> <given-names>M</given-names></name><name><surname>Xing</surname> <given-names>C</given-names></name><name><surname>Pearson</surname> <given-names>GW</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>??np63α induces the expression of FAT2 and slug to promote tumor invasion</article-title><source>Oncotarget</source><volume>7</volume><fpage>28592</fpage><lpage>28611</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.8696</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doyle</surname> <given-names>JM</given-names></name><name><surname>Gao</surname> <given-names>J</given-names></name><name><surname>Wang</surname> <given-names>J</given-names></name><name><surname>Yang</surname> <given-names>M</given-names></name><name><surname>Potts</surname> <given-names>PR</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>MAGE-RING protein complexes comprise a family of E3 ubiquitin ligases</article-title><source>Molecular Cell</source><volume>39</volume><fpage>963</fpage><lpage>974</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.08.029</pub-id><pub-id pub-id-type="pmid">20864041</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enthart</surname> <given-names>A</given-names></name><name><surname>Klein</surname> <given-names>C</given-names></name><name><surname>Dehner</surname> <given-names>A</given-names></name><name><surname>Coles</surname> <given-names>M</given-names></name><name><surname>Gemmecker</surname> <given-names>G</given-names></name><name><surname>Kessler</surname> <given-names>H</given-names></name><name><surname>Hagn</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Solution structure and binding specificity of the p63 DNA binding domain</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>26707</elocation-id><pub-id pub-id-type="doi">10.1038/srep26707</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>M</given-names></name><name><surname>Steiner</surname> <given-names>L</given-names></name><name><surname>Engeland</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>The transcription factor p53: not a repressor, solely an activator</article-title><source>Cell Cycle</source><volume>13</volume><fpage>3037</fpage><lpage>3058</lpage><pub-id pub-id-type="doi">10.4161/15384101.2014.949083</pub-id><pub-id pub-id-type="pmid">25486564</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>M</given-names></name><name><surname>Grossmann</surname> <given-names>P</given-names></name><name><surname>Padi</surname> <given-names>M</given-names></name><name><surname>DeCaprio</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2016">2016a</year><article-title>Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>6070</fpage><lpage>6086</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw523</pub-id><pub-id pub-id-type="pmid">27280975</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>M</given-names></name><name><surname>Quaas</surname> <given-names>M</given-names></name><name><surname>Steiner</surname> <given-names>L</given-names></name><name><surname>Engeland</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2016">2016b</year><article-title>The p53-p21-DREAM-CDE/CHR pathway regulates G2/M cell cycle genes</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>164</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1093/nar/gkv927</pub-id><pub-id pub-id-type="pmid">26384566</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Census and evaluation of p53 target genes</article-title><source>Oncogene</source><volume>36</volume><fpage>3943</fpage><lpage>3956</lpage><pub-id pub-id-type="doi">10.1038/onc.2016.502</pub-id><pub-id pub-id-type="pmid">28288132</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>M</given-names></name><name><surname>Uxa</surname> <given-names>S</given-names></name><name><surname>Stanko</surname> <given-names>C</given-names></name><name><surname>Magin</surname> <given-names>TM</given-names></name><name><surname>Engeland</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Human papilloma virus E7 oncoprotein abrogates the p53-p21-DREAM pathway</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>2603</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-02831-9</pub-id><pub-id pub-id-type="pmid">28572607</pub-id></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Conservation and divergence of the p53 gene regulatory network between mice and humans</article-title><source>Oncogene</source><volume>38</volume><fpage>4095</fpage><lpage>4109</lpage><pub-id pub-id-type="doi">10.1038/s41388-019-0706-9</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Mice are not humans: the case of p53</article-title><source>Trends in Cancer</source><volume>17</volume><elocation-id>30239</elocation-id><pub-id pub-id-type="doi">10.1016/j.trecan.2020.08.007</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fischer</surname> <given-names>M</given-names></name><name><surname>Müller</surname> <given-names>GA</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Cell cycle transcription control: dream/MuvB and RB-E2F complexes</article-title><source>Critical Reviews in Biochemistry and Molecular Biology</source><volume>52</volume><fpage>638</fpage><lpage>662</lpage><pub-id pub-id-type="doi">10.1080/10409238.2017.1360836</pub-id><pub-id pub-id-type="pmid">28799433</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fishilevich</surname> <given-names>S</given-names></name><name><surname>Nudel</surname> <given-names>R</given-names></name><name><surname>Rappaport</surname> <given-names>N</given-names></name><name><surname>Hadar</surname> <given-names>R</given-names></name><name><surname>Plaschkes</surname> <given-names>I</given-names></name><name><surname>Iny Stein</surname> <given-names>T</given-names></name><name><surname>Rosen</surname> <given-names>N</given-names></name><name><surname>Kohn</surname> <given-names>A</given-names></name><name><surname>Twik</surname> <given-names>M</given-names></name><name><surname>Safran</surname> <given-names>M</given-names></name><name><surname>Lancet</surname> <given-names>D</given-names></name><name><surname>Cohen</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>GeneHancer: genome-wide integration of enhancers and target genes in GeneCards</article-title><source>Database</source><volume>2017</volume><elocation-id>bax028</elocation-id><pub-id pub-id-type="doi">10.1093/database/bax028</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Forster</surname> <given-names>N</given-names></name><name><surname>Saladi</surname> <given-names>SV</given-names></name><name><surname>van Bragt</surname> <given-names>M</given-names></name><name><surname>Sfondouris</surname> <given-names>ME</given-names></name><name><surname>Jones</surname> <given-names>FE</given-names></name><name><surname>Li</surname> <given-names>Z</given-names></name><name><surname>Ellisen</surname> <given-names>LW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Basal Cell Signaling by p63 Controls Luminal Progenitor Function and Lactation via NRG1</article-title><source>Developmental Cell</source><volume>28</volume><fpage>147</fpage><lpage>160</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2013.11.019</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gallant-Behm</surname> <given-names>CL</given-names></name><name><surname>Ramsey</surname> <given-names>MR</given-names></name><name><surname>Bensard</surname> <given-names>CL</given-names></name><name><surname>Nojek</surname> <given-names>I</given-names></name><name><surname>Tran</surname> <given-names>J</given-names></name><name><surname>Liu</surname> <given-names>M</given-names></name><name><surname>Ellisen</surname> <given-names>LW</given-names></name><name><surname>Espinosa</surname> <given-names>JM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title> Np63 represses anti-proliferative genes via H2A.Z deposition</article-title><source>Genes &amp; Development</source><volume>26</volume><fpage>2325</fpage><lpage>2336</lpage><pub-id pub-id-type="doi">10.1101/gad.198069.112</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gatti</surname> <given-names>V</given-names></name><name><surname>Fierro</surname> <given-names>C</given-names></name><name><surname>Annicchiarico‐Petruzzelli</surname> <given-names>M</given-names></name><name><surname>Melino</surname> <given-names>G</given-names></name><name><surname>Peschiaroli</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>??np63 in squamous cell carcinoma: defining the oncogenic routes affecting epigenetic landscape and tumour microenvironment</article-title><source>Molecular Oncology</source><volume>13</volume><fpage>981</fpage><lpage>1001</lpage><pub-id pub-id-type="doi">10.1002/1878-0261.12473</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gebel</surname> <given-names>J</given-names></name><name><surname>Luh</surname> <given-names>LM</given-names></name><name><surname>Coutandin</surname> <given-names>D</given-names></name><name><surname>Osterburg</surname> <given-names>C</given-names></name><name><surname>Löhr</surname> <given-names>F</given-names></name><name><surname>Schäfer</surname> <given-names>B</given-names></name><name><surname>Frombach</surname> <given-names>AS</given-names></name><name><surname>Sumyk</surname> <given-names>M</given-names></name><name><surname>Buchner</surname> <given-names>L</given-names></name><name><surname>Krojer</surname> <given-names>T</given-names></name><name><surname>Salah</surname> <given-names>E</given-names></name><name><surname>Mathea</surname> <given-names>S</given-names></name><name><surname>Güntert</surname> <given-names>P</given-names></name><name><surname>Knapp</surname> <given-names>S</given-names></name><name><surname>Dötsch</surname> <given-names>V</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Mechanism of TAp73 inhibition by δnp63 and structural basis of p63/p73 hetero-tetramerization</article-title><source>Cell Death &amp; Differentiation</source><volume>23</volume><fpage>1930</fpage><lpage>1940</lpage><pub-id pub-id-type="doi">10.1038/cdd.2016.83</pub-id><pub-id pub-id-type="pmid">27716744</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hegde</surname> <given-names>GV</given-names></name><name><surname>de la Cruz</surname> <given-names>C</given-names></name><name><surname>Giltnane</surname> <given-names>JM</given-names></name><name><surname>Crocker</surname> <given-names>L</given-names></name><name><surname>Venkatanarayan</surname> <given-names>A</given-names></name><name><surname>Schaefer</surname> <given-names>G</given-names></name><name><surname>Dunlap</surname> <given-names>D</given-names></name><name><surname>Hoeck</surname> <given-names>JD</given-names></name><name><surname>Piskol</surname> <given-names>R</given-names></name><name><surname>Gnad</surname> <given-names>F</given-names></name><name><surname>Modrusan</surname> <given-names>Z</given-names></name><name><surname>de Sauvage</surname> <given-names>FJ</given-names></name><name><surname>Siebel</surname> <given-names>CW</given-names></name><name><surname>Jackson</surname> <given-names>EL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>NRG1 is a critical regulator of differentiation in TP63-driven squamous cell carcinoma</article-title><source>eLife</source><volume>8</volume><elocation-id>e46551</elocation-id><pub-id pub-id-type="doi">10.7554/eLife.46551</pub-id><pub-id pub-id-type="pmid">31144617</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heinz</surname> <given-names>S</given-names></name><name><surname>Benner</surname> <given-names>C</given-names></name><name><surname>Spann</surname> <given-names>N</given-names></name><name><surname>Bertolino</surname> <given-names>E</given-names></name><name><surname>Lin</surname> <given-names>YC</given-names></name><name><surname>Laslo</surname> <given-names>P</given-names></name><name><surname>Cheng</surname> <given-names>JX</given-names></name><name><surname>Murre</surname> <given-names>C</given-names></name><name><surname>Singh</surname> <given-names>H</given-names></name><name><surname>Glass</surname> <given-names>CK</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Simple combinations of Lineage-Determining transcription factors prime cis-Regulatory elements required for macrophage and B cell identities</article-title><source>Molecular Cell</source><volume>38</volume><fpage>576</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2010.05.004</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Helton</surname> <given-names>ES</given-names></name><name><surname>Zhu</surname> <given-names>J</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The unique NH2 -terminally deleted (ΔN) Residues, the P <italic>XX</italic> P motif, and the PP <italic>X</italic> Y motif are required for the transcriptional activity of the δn variant of p63</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><fpage>2533</fpage><lpage>2542</lpage><pub-id pub-id-type="doi">10.1074/jbc.M507964200</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname> <given-names>S</given-names></name><name><surname>Otto</surname> <given-names>C</given-names></name><name><surname>Kurtz</surname> <given-names>S</given-names></name><name><surname>Sharma</surname> <given-names>CM</given-names></name><name><surname>Khaitovich</surname> <given-names>P</given-names></name><name><surname>Vogel</surname> <given-names>J</given-names></name><name><surname>Stadler</surname> <given-names>PF</given-names></name><name><surname>Hackermüller</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Fast mapping of short sequences with mismatches, insertions and deletions using index structures</article-title><source>PLOS Computational Biology</source><volume>5</volume><elocation-id>e1000502</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pcbi.1000502</pub-id><pub-id pub-id-type="pmid">19750212</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoffmann</surname> <given-names>S</given-names></name><name><surname>Otto</surname> <given-names>C</given-names></name><name><surname>Doose</surname> <given-names>G</given-names></name><name><surname>Tanzer</surname> <given-names>A</given-names></name><name><surname>Langenberger</surname> <given-names>D</given-names></name><name><surname>Christ</surname> <given-names>S</given-names></name><name><surname>Kunz</surname> <given-names>M</given-names></name><name><surname>Holdt</surname> <given-names>LM</given-names></name><name><surname>Teupser</surname> <given-names>D</given-names></name><name><surname>Hackermüller</surname> <given-names>J</given-names></name><name><surname>Stadler</surname> <given-names>PF</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>A multi-split mapping algorithm for circular RNA, splicing, trans-splicing and fusion detection</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>R34</elocation-id><pub-id pub-id-type="doi">10.1186/gb-2014-15-2-r34</pub-id><pub-id pub-id-type="pmid">24512684</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karsli Uzunbas</surname> <given-names>G</given-names></name><name><surname>Ahmed</surname> <given-names>F</given-names></name><name><surname>Sammons</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Control of p53-dependent transcription and enhancer activity by the p53 family member p63</article-title><source>Journal of Biological Chemistry</source><volume>294</volume><fpage>10720</fpage><lpage>10736</lpage><pub-id pub-id-type="doi">10.1074/jbc.RA119.007965</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Katoh</surname> <given-names>I</given-names></name><name><surname>Maehata</surname> <given-names>Y</given-names></name><name><surname>Moriishi</surname> <given-names>K</given-names></name><name><surname>Hata</surname> <given-names>R-I</given-names></name><name><surname>Kurata</surname> <given-names>S</given-names></name><name><surname>ichi</surname> <given-names>KS</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>C-terminal α Domain of p63 Binds to p300 to Coactivate β-Catenin</article-title><source>Neoplasia</source><volume>21</volume><fpage>494</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1016/j.neo.2019.03.010</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>King</surname> <given-names>KE</given-names></name><name><surname>Ponnamperuma</surname> <given-names>RM</given-names></name><name><surname>Yamashita</surname> <given-names>T</given-names></name><name><surname>Tokino</surname> <given-names>T</given-names></name><name><surname>Lee</surname> <given-names>LA</given-names></name><name><surname>Young</surname> <given-names>MF</given-names></name><name><surname>Weinberg</surname> <given-names>WC</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>deltaNp63alpha functions as both a positive and a negative transcriptional regulator and blocks in vitro differentiation of murine keratinocytes</article-title><source>Oncogene</source><volume>22</volume><fpage>3635</fpage><lpage>3644</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1206536</pub-id><pub-id pub-id-type="pmid">12789272</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirschner</surname> <given-names>RD</given-names></name><name><surname>Sänger</surname> <given-names>K</given-names></name><name><surname>Müller</surname> <given-names>GA</given-names></name><name><surname>Engeland</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Transcriptional activation of the tumor suppressor and differentiation gene S100A2 by a novel p63-binding site</article-title><source>Nucleic Acids Research</source><volume>36</volume><fpage>2969</fpage><lpage>2980</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn132</pub-id><pub-id pub-id-type="pmid">18388131</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kitayner</surname> <given-names>M</given-names></name><name><surname>Rozenberg</surname> <given-names>H</given-names></name><name><surname>Rohs</surname> <given-names>R</given-names></name><name><surname>Suad</surname> <given-names>O</given-names></name><name><surname>Rabinovich</surname> <given-names>D</given-names></name><name><surname>Honig</surname> <given-names>B</given-names></name><name><surname>Shakked</surname> <given-names>Z</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Diversity in DNA recognition by p53 revealed by crystal structures with Hoogsteen base pairs</article-title><source>Nature Structural &amp; Molecular Biology</source><volume>17</volume><fpage>423</fpage><lpage>429</lpage><pub-id pub-id-type="doi">10.1038/nsmb.1800</pub-id><pub-id pub-id-type="pmid">20364130</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koh</surname> <given-names>DI</given-names></name><name><surname>Han</surname> <given-names>D</given-names></name><name><surname>Ryu</surname> <given-names>H</given-names></name><name><surname>Choi</surname> <given-names>WI</given-names></name><name><surname>Jeon</surname> <given-names>BN</given-names></name><name><surname>Kim</surname> <given-names>MK</given-names></name><name><surname>Kim</surname> <given-names>Y</given-names></name><name><surname>Kim</surname> <given-names>JY</given-names></name><name><surname>Parry</surname> <given-names>L</given-names></name><name><surname>Clarke</surname> <given-names>AR</given-names></name><name><surname>Reynolds</surname> <given-names>AB</given-names></name><name><surname>Hur</surname> <given-names>MW</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>KAISO, a critical regulator of p53-mediated transcription of <italic>CDKN1A</italic> and apoptotic genes</article-title><source>PNAS</source><volume>111</volume><fpage>15078</fpage><lpage>15083</lpage><pub-id pub-id-type="doi">10.1073/pnas.1318780111</pub-id><pub-id pub-id-type="pmid">25288747</pub-id></element-citation></ref><ref id="bib46"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopylova</surname> <given-names>E</given-names></name><name><surname>Noé</surname> <given-names>L</given-names></name><name><surname>Touzet</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>SortMeRNA: fast and accurate filtering of ribosomal RNAs in Metatranscriptomic data</article-title><source>Bioinformatics</source><volume>28</volume><fpage>3211</fpage><lpage>3217</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts611</pub-id><pub-id pub-id-type="pmid">23071270</pub-id></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouwenhoven</surname> <given-names>EN</given-names></name><name><surname>van Heeringen</surname> <given-names>SJ</given-names></name><name><surname>Tena</surname> <given-names>JJ</given-names></name><name><surname>Oti</surname> <given-names>M</given-names></name><name><surname>Dutilh</surname> <given-names>BE</given-names></name><name><surname>Alonso</surname> <given-names>ME</given-names></name><name><surname>de la Calle-Mustienes</surname> <given-names>E</given-names></name><name><surname>Smeenk</surname> <given-names>L</given-names></name><name><surname>Rinne</surname> <given-names>T</given-names></name><name><surname>Parsaulian</surname> <given-names>L</given-names></name><name><surname>Bolat</surname> <given-names>E</given-names></name><name><surname>Jurgelenaite</surname> <given-names>R</given-names></name><name><surname>Huynen</surname> <given-names>MA</given-names></name><name><surname>Hoischen</surname> <given-names>A</given-names></name><name><surname>Veltman</surname> <given-names>JA</given-names></name><name><surname>Brunner</surname> <given-names>HG</given-names></name><name><surname>Roscioli</surname> <given-names>T</given-names></name><name><surname>Oates</surname> <given-names>E</given-names></name><name><surname>Wilson</surname> <given-names>M</given-names></name><name><surname>Manzanares</surname> <given-names>M</given-names></name><name><surname>Gómez-Skarmeta</surname> <given-names>JL</given-names></name><name><surname>Stunnenberg</surname> <given-names>HG</given-names></name><name><surname>Lohrum</surname> <given-names>M</given-names></name><name><surname>van Bokhoven</surname> <given-names>H</given-names></name><name><surname>Zhou</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Genome-Wide Profiling of p63 DNA–Binding Sites Identifies an Element that Regulates Gene Expression during Limb Development in the 7q21 SHFM1 Locus</article-title><source>PLOS Genetics</source><volume>6</volume><elocation-id>e1001065</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1001065</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouwenhoven</surname> <given-names>EN</given-names></name><name><surname>Oti</surname> <given-names>M</given-names></name><name><surname>Niehues</surname> <given-names>H</given-names></name><name><surname>van Heeringen</surname> <given-names>SJ</given-names></name><name><surname>Schalkwijk</surname> <given-names>J</given-names></name><name><surname>Stunnenberg</surname> <given-names>HG</given-names></name><name><surname>van Bokhoven</surname> <given-names>H</given-names></name><name><surname>Zhou</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015a</year><article-title>Transcription factor p63 bookmarks and regulates dynamic enhancers during epidermal differentiation</article-title><source>EMBO Reports</source><volume>16</volume><fpage>863</fpage><lpage>878</lpage><pub-id pub-id-type="doi">10.15252/embr.201439941</pub-id><pub-id pub-id-type="pmid">26034101</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouwenhoven</surname> <given-names>EN</given-names></name><name><surname>van Bokhoven</surname> <given-names>H</given-names></name><name><surname>Zhou</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2015">2015b</year><article-title>Gene regulatory mechanisms orchestrated by p63 in epithelial development and related disorders</article-title><source>Biochimica Et Biophysica Acta (BBA) - Gene Regulatory Mechanisms</source><volume>1849</volume><fpage>590</fpage><lpage>600</lpage><pub-id pub-id-type="doi">10.1016/j.bbagrm.2015.03.003</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuleshov</surname> <given-names>MV</given-names></name><name><surname>Jones</surname> <given-names>MR</given-names></name><name><surname>Rouillard</surname> <given-names>AD</given-names></name><name><surname>Fernandez</surname> <given-names>NF</given-names></name><name><surname>Duan</surname> <given-names>Q</given-names></name><name><surname>Wang</surname> <given-names>Z</given-names></name><name><surname>Koplev</surname> <given-names>S</given-names></name><name><surname>Jenkins</surname> <given-names>SL</given-names></name><name><surname>Jagodnik</surname> <given-names>KM</given-names></name><name><surname>Lachmann</surname> <given-names>A</given-names></name><name><surname>McDermott</surname> <given-names>MG</given-names></name><name><surname>Monteiro</surname> <given-names>CD</given-names></name><name><surname>Gundersen</surname> <given-names>GW</given-names></name><name><surname>Ma'ayan</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Enrichr: a comprehensive gene set enrichment analysis web server 2016 update</article-title><source>Nucleic Acids Research</source><volume>44</volume><fpage>W90</fpage><lpage>W97</lpage><pub-id pub-id-type="doi">10.1093/nar/gkw377</pub-id><pub-id pub-id-type="pmid">27141961</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lapi</surname> <given-names>E</given-names></name><name><surname>Iovino</surname> <given-names>A</given-names></name><name><surname>Fontemaggi</surname> <given-names>G</given-names></name><name><surname>Soliera</surname> <given-names>AR</given-names></name><name><surname>Iacovelli</surname> <given-names>S</given-names></name><name><surname>Sacchi</surname> <given-names>A</given-names></name><name><surname>Rechavi</surname> <given-names>G</given-names></name><name><surname>Givol</surname> <given-names>D</given-names></name><name><surname>Blandino</surname> <given-names>G</given-names></name><name><surname>Strano</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>S100A2 gene is a direct transcriptional target of p53 homologues during keratinocyte differentiation</article-title><source>Oncogene</source><volume>25</volume><fpage>3628</fpage><lpage>3637</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1209401</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname> <given-names>CH</given-names></name><name><surname>Chang</surname> <given-names>JS</given-names></name><name><surname>Syu</surname> <given-names>SH</given-names></name><name><surname>Wong</surname> <given-names>TS</given-names></name><name><surname>Chan</surname> <given-names>JY</given-names></name><name><surname>Tang</surname> <given-names>YC</given-names></name><name><surname>Yang</surname> <given-names>ZP</given-names></name><name><surname>Yang</surname> <given-names>WC</given-names></name><name><surname>Chen</surname> <given-names>CT</given-names></name><name><surname>Lu</surname> <given-names>SC</given-names></name><name><surname>Tang</surname> <given-names>PH</given-names></name><name><surname>Yang</surname> <given-names>TC</given-names></name><name><surname>Chu</surname> <given-names>PY</given-names></name><name><surname>Hsiao</surname> <given-names>JR</given-names></name><name><surname>Liu</surname> <given-names>KJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Il‐1β promotes malignant transformation and tumor aggressiveness in oral Cancer</article-title><source>Journal of Cellular Physiology</source><volume>230</volume><fpage>875</fpage><lpage>884</lpage><pub-id pub-id-type="doi">10.1002/jcp.24816</pub-id><pub-id pub-id-type="pmid">25204733</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leinonen</surname> <given-names>R</given-names></name><name><surname>Sugawara</surname> <given-names>H</given-names></name><name><surname>Shumway</surname> <given-names>M</given-names></name><collab>on behalf of the International Nucleotide Sequence Database Collaboration</collab></person-group><year iso-8601-date="2011">2011</year><article-title>The Sequence Read Archive</article-title><source>Nucleic Acids Research</source><volume>39</volume><fpage>D19</fpage><lpage>D21</lpage><pub-id pub-id-type="doi">10.1093/nar/gkq1019</pub-id></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lew</surname> <given-names>QJ</given-names></name><name><surname>Chia</surname> <given-names>YL</given-names></name><name><surname>Chu</surname> <given-names>KL</given-names></name><name><surname>Lam</surname> <given-names>YT</given-names></name><name><surname>Gurumurthy</surname> <given-names>M</given-names></name><name><surname>Xu</surname> <given-names>S</given-names></name><name><surname>Lam</surname> <given-names>KP</given-names></name><name><surname>Cheong</surname> <given-names>N</given-names></name><name><surname>Chao</surname> <given-names>S-H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Identification of HEXIM1 as a positive regulator of p53</article-title><source>Journal of Biological Chemistry</source><volume>287</volume><fpage>36443</fpage><lpage>36454</lpage><pub-id pub-id-type="doi">10.1074/jbc.M112.374157</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>H</given-names></name><name><surname>Handsaker</surname> <given-names>B</given-names></name><name><surname>Wysoker</surname> <given-names>A</given-names></name><name><surname>Fennell</surname> <given-names>T</given-names></name><name><surname>Ruan</surname> <given-names>J</given-names></name><name><surname>Homer</surname> <given-names>N</given-names></name><name><surname>Marth</surname> <given-names>G</given-names></name><name><surname>Abecasis</surname> <given-names>G</given-names></name><name><surname>Durbin</surname> <given-names>R</given-names></name><collab>1000 Genome Project Data Processing Subgroup</collab></person-group><year iso-8601-date="2009">2009</year><article-title>The Sequence Alignment/Map format and SAMtools</article-title><source>Bioinformatics</source><volume>25</volume><fpage>2078</fpage><lpage>2079</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btp352</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname> <given-names>Y</given-names></name><name><surname>Smyth</surname> <given-names>GK</given-names></name><name><surname>Shi</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>featureCounts: an efficient general purpose program for assigning sequence reads to genomic features</article-title><source>Bioinformatics</source><volume>30</volume><fpage>923</fpage><lpage>930</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btt656</pub-id><pub-id pub-id-type="pmid">24227677</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lill</surname> <given-names>NL</given-names></name><name><surname>Grossman</surname> <given-names>SR</given-names></name><name><surname>Ginsberg</surname> <given-names>D</given-names></name><name><surname>DeCaprio</surname> <given-names>J</given-names></name><name><surname>Livingston</surname> <given-names>DM</given-names></name></person-group><year iso-8601-date="1997">1997</year><article-title>Binding and modulation of p53 by p300/CBP coactivators</article-title><source>Nature</source><volume>387</volume><fpage>823</fpage><lpage>827</lpage><pub-id pub-id-type="doi">10.1038/42981</pub-id><pub-id pub-id-type="pmid">9194565</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname> <given-names>Y-L</given-names></name><name><surname>Sengupta</surname> <given-names>S</given-names></name><name><surname>Gurdziel</surname> <given-names>K</given-names></name><name><surname>Bell</surname> <given-names>GW</given-names></name><name><surname>Jacks</surname> <given-names>T</given-names></name><name><surname>Flores</surname> <given-names>ER</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>p63 and p73 Transcriptionally Regulate Genes Involved in DNA Repair</article-title><source>PLOS Genetics</source><volume>5</volume><elocation-id>e1000680</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pgen.1000680</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin-Shiao</surname> <given-names>E</given-names></name><name><surname>Lan</surname> <given-names>Y</given-names></name><name><surname>Coradin</surname> <given-names>M</given-names></name><name><surname>Anderson</surname> <given-names>A</given-names></name><name><surname>Donahue</surname> <given-names>G</given-names></name><name><surname>Simpson</surname> <given-names>CL</given-names></name><name><surname>Sen</surname> <given-names>P</given-names></name><name><surname>Saffie</surname> <given-names>R</given-names></name><name><surname>Busino</surname> <given-names>L</given-names></name><name><surname>Garcia</surname> <given-names>BA</given-names></name><name><surname>Berger</surname> <given-names>SL</given-names></name><name><surname>Capell</surname> <given-names>BC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis</article-title><source>Genes &amp; Development</source><volume>32</volume><fpage>181</fpage><lpage>193</lpage><pub-id pub-id-type="doi">10.1101/gad.306241.117</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin-Shiao</surname> <given-names>E</given-names></name><name><surname>Lan</surname> <given-names>Y</given-names></name><name><surname>Welzenbach</surname> <given-names>J</given-names></name><name><surname>Alexander</surname> <given-names>KA</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Knapp</surname> <given-names>M</given-names></name><name><surname>Mangold</surname> <given-names>E</given-names></name><name><surname>Sammons</surname> <given-names>M</given-names></name><name><surname>Ludwig</surname> <given-names>KU</given-names></name><name><surname>Berger</surname> <given-names>SL</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>p63 establishes epithelial enhancers at critical craniofacial development genes</article-title><source>Science Advances</source><volume>5</volume><elocation-id>eaaw0946</elocation-id><pub-id pub-id-type="doi">10.1126/sciadv.aaw0946</pub-id><pub-id pub-id-type="pmid">31049400</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lodillinsky</surname> <given-names>C</given-names></name><name><surname>Infante</surname> <given-names>E</given-names></name><name><surname>Guichard</surname> <given-names>A</given-names></name><name><surname>Chaligné</surname> <given-names>R</given-names></name><name><surname>Fuhrmann</surname> <given-names>L</given-names></name><name><surname>Cyrta</surname> <given-names>J</given-names></name><name><surname>Irondelle</surname> <given-names>M</given-names></name><name><surname>Lagoutte</surname> <given-names>E</given-names></name><name><surname>Vacher</surname> <given-names>S</given-names></name><name><surname>Bonsang-Kitzis</surname> <given-names>H</given-names></name><name><surname>Glukhova</surname> <given-names>M</given-names></name><name><surname>Reyal</surname> <given-names>F</given-names></name><name><surname>Bièche</surname> <given-names>I</given-names></name><name><surname>Vincent-Salomon</surname> <given-names>A</given-names></name><name><surname>Chavrier</surname> <given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>p63/MT1-MMP axis is required for in situ to invasive transition in basal-like breast cancer</article-title><source>Oncogene</source><volume>35</volume><fpage>344</fpage><lpage>357</lpage><pub-id pub-id-type="doi">10.1038/onc.2015.87</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lokshin</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Gaiddon</surname> <given-names>C</given-names></name><name><surname>Prives</surname> <given-names>C</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>p53 and p73 display common and distinct requirements for sequence specific binding to DNA</article-title><source>Nucleic Acids Research</source><volume>35</volume><fpage>340</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1093/nar/gkl1047</pub-id><pub-id pub-id-type="pmid">17170001</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Pajares</surname> <given-names>V</given-names></name><name><surname>Qu</surname> <given-names>K</given-names></name><name><surname>Zhang</surname> <given-names>J</given-names></name><name><surname>Webster</surname> <given-names>DE</given-names></name><name><surname>Barajas</surname> <given-names>BC</given-names></name><name><surname>Siprashvili</surname> <given-names>Z</given-names></name><name><surname>Zarnegar</surname> <given-names>BJ</given-names></name><name><surname>Boxer</surname> <given-names>LD</given-names></name><name><surname>Rios</surname> <given-names>EJ</given-names></name><name><surname>Tao</surname> <given-names>S</given-names></name><name><surname>Kretz</surname> <given-names>M</given-names></name><name><surname>Khavari</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A LncRNA-MAF:mafb transcription factor network regulates epidermal differentiation</article-title><source>Developmental Cell</source><volume>32</volume><fpage>693</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2015.01.028</pub-id><pub-id pub-id-type="pmid">25805135</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Love</surname> <given-names>MI</given-names></name><name><surname>Huber</surname> <given-names>W</given-names></name><name><surname>Anders</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2</article-title><source>Genome Biology</source><volume>15</volume><elocation-id>550</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title><source>EMBnet.journal</source><volume>17</volume><elocation-id>10</elocation-id><pub-id pub-id-type="doi">10.14806/ej.17.1.200</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDade</surname> <given-names>SS</given-names></name><name><surname>Patel</surname> <given-names>D</given-names></name><name><surname>McCance</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>p63 maintains keratinocyte proliferative capacity through regulation of Skp2-p130 levels</article-title><source>Journal of Cell Science</source><volume>124</volume><fpage>1635</fpage><lpage>1643</lpage><pub-id pub-id-type="doi">10.1242/jcs.084723</pub-id><pub-id pub-id-type="pmid">21511729</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDade</surname> <given-names>SS</given-names></name><name><surname>Henry</surname> <given-names>AE</given-names></name><name><surname>Pivato</surname> <given-names>GP</given-names></name><name><surname>Kozarewa</surname> <given-names>I</given-names></name><name><surname>Mitsopoulos</surname> <given-names>C</given-names></name><name><surname>Fenwick</surname> <given-names>K</given-names></name><name><surname>Assiotis</surname> <given-names>I</given-names></name><name><surname>Hakas</surname> <given-names>J</given-names></name><name><surname>Zvelebil</surname> <given-names>M</given-names></name><name><surname>Orr</surname> <given-names>N</given-names></name><name><surname>Lord</surname> <given-names>CJ</given-names></name><name><surname>Patel</surname> <given-names>D</given-names></name><name><surname>Ashworth</surname> <given-names>A</given-names></name><name><surname>McCance</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Genome-wide analysis of p63 binding sites identifies AP-2 factors as co-regulators of epidermal differentiation</article-title><source>Nucleic Acids Research</source><volume>40</volume><fpage>7190</fpage><lpage>7206</lpage><pub-id pub-id-type="doi">10.1093/nar/gks389</pub-id><pub-id pub-id-type="pmid">22573176</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McDade</surname> <given-names>SS</given-names></name><name><surname>Patel</surname> <given-names>D</given-names></name><name><surname>Moran</surname> <given-names>M</given-names></name><name><surname>Campbell</surname> <given-names>J</given-names></name><name><surname>Fenwick</surname> <given-names>K</given-names></name><name><surname>Kozarewa</surname> <given-names>I</given-names></name><name><surname>Orr</surname> <given-names>NJ</given-names></name><name><surname>Lord</surname> <given-names>CJ</given-names></name><name><surname>Ashworth</surname> <given-names>AA</given-names></name><name><surname>McCance</surname> <given-names>DJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Genome-wide characterization reveals complex interplay between TP53 and TP63 in response to genotoxic stress</article-title><source>Nucleic Acids Research</source><volume>42</volume><fpage>6270</fpage><lpage>6285</lpage><pub-id pub-id-type="doi">10.1093/nar/gku299</pub-id><pub-id pub-id-type="pmid">24823795</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehta</surname> <given-names>SY</given-names></name><name><surname>Morten</surname> <given-names>BC</given-names></name><name><surname>Antony</surname> <given-names>J</given-names></name><name><surname>Henderson</surname> <given-names>L</given-names></name><name><surname>Lasham</surname> <given-names>A</given-names></name><name><surname>Campbell</surname> <given-names>H</given-names></name><name><surname>Cunliffe</surname> <given-names>H</given-names></name><name><surname>Horsfield</surname> <given-names>JA</given-names></name><name><surname>Reddel</surname> <given-names>RR</given-names></name><name><surname>Avery-Kiejda</surname> <given-names>KA</given-names></name><name><surname>Print</surname> <given-names>CG</given-names></name><name><surname>Braithwaite</surname> <given-names>AW</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Regulation of the interferon-gamma (IFN-γ) pathway by p63 and δ133p53 isoform in different breast Cancer subtypes</article-title><source>Oncotarget</source><volume>9</volume><fpage>29146</fpage><lpage>29161</lpage><pub-id pub-id-type="doi">10.18632/oncotarget.25635</pub-id><pub-id pub-id-type="pmid">30018742</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Menendez</surname> <given-names>D</given-names></name><name><surname>Nguyen</surname> <given-names>TA</given-names></name><name><surname>Freudenberg</surname> <given-names>JM</given-names></name><name><surname>Mathew</surname> <given-names>VJ</given-names></name><name><surname>Anderson</surname> <given-names>CW</given-names></name><name><surname>Jothi</surname> <given-names>R</given-names></name><name><surname>Resnick</surname> <given-names>MA</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Diverse stresses dramatically alter genome-wide p53 binding and transactivation landscape in human Cancer cells</article-title><source>Nucleic Acids Research</source><volume>41</volume><fpage>7286</fpage><lpage>7301</lpage><pub-id pub-id-type="doi">10.1093/nar/gkt504</pub-id><pub-id pub-id-type="pmid">23775793</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mills</surname> <given-names>AA</given-names></name><name><surname>Zheng</surname> <given-names>B</given-names></name><name><surname>Wang</surname> <given-names>XJ</given-names></name><name><surname>Vogel</surname> <given-names>H</given-names></name><name><surname>Roop</surname> <given-names>DR</given-names></name><name><surname>Bradley</surname> <given-names>A</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>p63 is a p53 homologue required for limb and epidermal morphogenesis</article-title><source>Nature</source><volume>398</volume><fpage>708</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1038/19531</pub-id><pub-id pub-id-type="pmid">10227293</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mundt</surname> <given-names>HM</given-names></name><name><surname>Stremmel</surname> <given-names>W</given-names></name><name><surname>Melino</surname> <given-names>G</given-names></name><name><surname>Krammer</surname> <given-names>PH</given-names></name><name><surname>Schilling</surname> <given-names>T</given-names></name><name><surname>Müller</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Dominant negative (ΔN) p63α induces drug resistance in hepatocellular carcinoma by interference with apoptosis signaling pathways</article-title><source>Biochemical and Biophysical Research Communications</source><volume>396</volume><fpage>335</fpage><lpage>341</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2010.04.093</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murray-Zmijewski</surname> <given-names>F</given-names></name><name><surname>Lane</surname> <given-names>DP</given-names></name><name><surname>Bourdon</surname> <given-names>JC</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>p53/p63/p73 isoforms: an orchestra of isoforms to harmonise cell differentiation and response to stress</article-title><source>Cell Death &amp; Differentiation</source><volume>13</volume><fpage>962</fpage><lpage>972</lpage><pub-id pub-id-type="doi">10.1038/sj.cdd.4401914</pub-id><pub-id pub-id-type="pmid">16601753</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nguyen</surname> <given-names>TT</given-names></name><name><surname>Grimm</surname> <given-names>SA</given-names></name><name><surname>Bushel</surname> <given-names>PR</given-names></name><name><surname>Li</surname> <given-names>J</given-names></name><name><surname>Li</surname> <given-names>Y</given-names></name><name><surname>Bennett</surname> <given-names>BD</given-names></name><name><surname>Lavender</surname> <given-names>CA</given-names></name><name><surname>Ward</surname> <given-names>JM</given-names></name><name><surname>Fargo</surname> <given-names>DC</given-names></name><name><surname>Anderson</surname> <given-names>CW</given-names></name><name><surname>Li</surname> <given-names>L</given-names></name><name><surname>Resnick</surname> <given-names>MA</given-names></name><name><surname>Menendez</surname> <given-names>D</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Revealing a human p53 universe</article-title><source>Nucleic Acids Research</source><volume>46</volume><fpage>8153</fpage><lpage>8167</lpage><pub-id pub-id-type="doi">10.1093/nar/gky720</pub-id><pub-id pub-id-type="pmid">30107566</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ortt</surname> <given-names>K</given-names></name><name><surname>Sinha</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Derivation of the consensus DNA-binding sequence for p63 reveals unique requirements that are distinct from p53</article-title><source>FEBS Letters</source><volume>580</volume><fpage>4544</fpage><lpage>4550</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2006.07.004</pub-id><pub-id pub-id-type="pmid">16870177</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pang</surname> <given-names>L</given-names></name><name><surname>Li</surname> <given-names>Q</given-names></name><name><surname>Li</surname> <given-names>S</given-names></name><name><surname>He</surname> <given-names>J</given-names></name><name><surname>Cao</surname> <given-names>W</given-names></name><name><surname>Lan</surname> <given-names>J</given-names></name><name><surname>Sun</surname> <given-names>B</given-names></name><name><surname>Zou</surname> <given-names>H</given-names></name><name><surname>Wang</surname> <given-names>C</given-names></name><name><surname>Liu</surname> <given-names>R</given-names></name><name><surname>Wei</surname> <given-names>C</given-names></name><name><surname>Wei</surname> <given-names>Y</given-names></name><name><surname>Qi</surname> <given-names>Y</given-names></name><name><surname>Hu</surname> <given-names>J</given-names></name><name><surname>Liang</surname> <given-names>W</given-names></name><name><surname>Zhang</surname> <given-names>WJ</given-names></name><name><surname>Wan</surname> <given-names>M</given-names></name><name><surname>Li</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Membrane type 1-matrix metalloproteinase induces epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: observations from clinical and in vitro analyses</article-title><source>Scientific Reports</source><volume>6</volume><elocation-id>22179</elocation-id><pub-id pub-id-type="doi">10.1038/srep22179</pub-id><pub-id pub-id-type="pmid">26916665</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname> <given-names>CA</given-names></name><name><surname>Ott</surname> <given-names>J</given-names></name><name><surname>Mays</surname> <given-names>DJ</given-names></name><name><surname>Pietenpol</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>p63 consensus DNA-binding site: identification, analysis and application into a p63MH algorithm</article-title><source>Oncogene</source><volume>26</volume><fpage>7363</fpage><lpage>7370</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1210561</pub-id><pub-id pub-id-type="pmid">17563751</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname> <given-names>J</given-names></name><name><surname>Tanis</surname> <given-names>SEJ</given-names></name><name><surname>Smits</surname> <given-names>JPH</given-names></name><name><surname>Kouwenhoven</surname> <given-names>EN</given-names></name><name><surname>Oti</surname> <given-names>M</given-names></name><name><surname>van den Bogaard</surname> <given-names>EH</given-names></name><name><surname>Logie</surname> <given-names>C</given-names></name><name><surname>Stunnenberg</surname> <given-names>HG</given-names></name><name><surname>van Bokhoven</surname> <given-names>H</given-names></name><name><surname>Mulder</surname> <given-names>KW</given-names></name><name><surname>Zhou</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Mutant p63 affects epidermal cell identity through rewiring the enhancer landscape</article-title><source>Cell Reports</source><volume>25</volume><fpage>3490</fpage><lpage>3503</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.11.039</pub-id><pub-id pub-id-type="pmid">30566872</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quinlan</surname> <given-names>AR</given-names></name><name><surname>Hall</surname> <given-names>IM</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>BEDTools: a flexible suite of utilities for comparing genomic features</article-title><source>Bioinformatics</source><volume>26</volume><fpage>841</fpage><lpage>842</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/btq033</pub-id><pub-id pub-id-type="pmid">20110278</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramsey</surname> <given-names>MR</given-names></name><name><surname>Wilson</surname> <given-names>C</given-names></name><name><surname>Ory</surname> <given-names>B</given-names></name><name><surname>Rothenberg</surname> <given-names>SM</given-names></name><name><surname>Faquin</surname> <given-names>W</given-names></name><name><surname>Mills</surname> <given-names>AA</given-names></name><name><surname>Ellisen</surname> <given-names>LW</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma</article-title><source>Journal of Clinical Investigation</source><volume>123</volume><fpage>3525</fpage><lpage>3538</lpage><pub-id pub-id-type="doi">10.1172/JCI68899</pub-id><pub-id pub-id-type="pmid">23867503</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodriguez Calleja</surname> <given-names>L</given-names></name><name><surname>Jacques</surname> <given-names>C</given-names></name><name><surname>Lamoureux</surname> <given-names>F</given-names></name><name><surname>Baud'huin</surname> <given-names>M</given-names></name><name><surname>Tellez Gabriel</surname> <given-names>M</given-names></name><name><surname>Quillard</surname> <given-names>T</given-names></name><name><surname>Sahay</surname> <given-names>D</given-names></name><name><surname>Perrot</surname> <given-names>P</given-names></name><name><surname>Amiaud</surname> <given-names>J</given-names></name><name><surname>Charrier</surname> <given-names>C</given-names></name><name><surname>Brion</surname> <given-names>R</given-names></name><name><surname>Lecanda</surname> <given-names>F</given-names></name><name><surname>Verrecchia</surname> <given-names>F</given-names></name><name><surname>Heymann</surname> <given-names>D</given-names></name><name><surname>Ellisen</surname> <given-names>LW</given-names></name><name><surname>Ory</surname> <given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>??np63α silences a miRNA program to aberrantly initiate a Wound-Healing program that promotes TGFβ-Induced metastasis</article-title><source>Cancer Research</source><volume>76</volume><fpage>3236</fpage><lpage>3251</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-15-2317</pub-id><pub-id pub-id-type="pmid">26988989</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saladi</surname> <given-names>SV</given-names></name><name><surname>Ross</surname> <given-names>K</given-names></name><name><surname>Karaayvaz</surname> <given-names>M</given-names></name><name><surname>Tata</surname> <given-names>PR</given-names></name><name><surname>Mou</surname> <given-names>H</given-names></name><name><surname>Rajagopal</surname> <given-names>J</given-names></name><name><surname>Ramaswamy</surname> <given-names>S</given-names></name><name><surname>Ellisen</surname> <given-names>LW</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>ACTL6A is Co-Amplified with p63 in squamous cell carcinoma to drive YAP activation, regenerative proliferation, and poor prognosis</article-title><source>Cancer Cell</source><volume>31</volume><fpage>35</fpage><lpage>49</lpage><pub-id pub-id-type="doi">10.1016/j.ccell.2016.12.001</pub-id><pub-id pub-id-type="pmid">28041841</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sammons</surname> <given-names>MA</given-names></name><name><surname>Nguyen</surname> <given-names>TT</given-names></name><name><surname>McDade</surname> <given-names>SS</given-names></name><name><surname>Fischer</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Tumor suppressor p53: from engaging DNA to target gene regulation</article-title><source>Nucleic Acids Research</source><volume>48</volume><fpage>8848</fpage><lpage>8869</lpage><pub-id pub-id-type="doi">10.1093/nar/gkaa666</pub-id><pub-id pub-id-type="pmid">32797160</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sasaki</surname> <given-names>Y</given-names></name><name><surname>Ishida</surname> <given-names>S</given-names></name><name><surname>Morimoto</surname> <given-names>I</given-names></name><name><surname>Yamashita</surname> <given-names>T</given-names></name><name><surname>Kojima</surname> <given-names>T</given-names></name><name><surname>Kihara</surname> <given-names>C</given-names></name><name><surname>Tanaka</surname> <given-names>T</given-names></name><name><surname>Imai</surname> <given-names>K</given-names></name><name><surname>Nakamura</surname> <given-names>Y</given-names></name><name><surname>Tokino</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2002">2002</year><article-title>The <italic>p53</italic> family member genes are involved in the notch signal pathway</article-title><source>Journal of Biological Chemistry</source><volume>277</volume><fpage>719</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1074/jbc.M108080200</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sauer</surname> <given-names>M</given-names></name><name><surname>Bretz</surname> <given-names>AC</given-names></name><name><surname>Beinoraviciute-Kellner</surname> <given-names>R</given-names></name><name><surname>Beitzinger</surname> <given-names>M</given-names></name><name><surname>Burek</surname> <given-names>C</given-names></name><name><surname>Rosenwald</surname> <given-names>A</given-names></name><name><surname>Harms</surname> <given-names>GS</given-names></name><name><surname>Stiewe</surname> <given-names>T</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity</article-title><source>Nucleic Acids Research</source><volume>36</volume><fpage>1900</fpage><lpage>1912</lpage><pub-id pub-id-type="doi">10.1093/nar/gkn044</pub-id><pub-id pub-id-type="pmid">18267967</pub-id></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schade</surname> <given-names>AE</given-names></name><name><surname>Fischer</surname> <given-names>M</given-names></name><name><surname>DeCaprio</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>RB, p130 and p107 differentially repress G1/S and G2/M genes after p53 activation</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>11197</fpage><lpage>11208</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz961</pub-id><pub-id pub-id-type="pmid">31667499</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sen</surname> <given-names>GL</given-names></name><name><surname>Boxer</surname> <given-names>LD</given-names></name><name><surname>Webster</surname> <given-names>DE</given-names></name><name><surname>Bussat</surname> <given-names>RT</given-names></name><name><surname>Qu</surname> <given-names>K</given-names></name><name><surname>Zarnegar</surname> <given-names>BJ</given-names></name><name><surname>Johnston</surname> <given-names>D</given-names></name><name><surname>Siprashvili</surname> <given-names>Z</given-names></name><name><surname>Khavari</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>ZNF750 is a p63 target gene that induces KLF4 to drive terminal epidermal differentiation</article-title><source>Developmental Cell</source><volume>22</volume><fpage>669</fpage><lpage>677</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2011.12.001</pub-id><pub-id pub-id-type="pmid">22364861</pub-id></element-citation></ref><ref id="bib88"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senoo</surname> <given-names>M</given-names></name><name><surname>Pinto</surname> <given-names>F</given-names></name><name><surname>Crum</surname> <given-names>CP</given-names></name><name><surname>McKeon</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="2007">2007</year><article-title>p63 is essential for the proliferative potential of stem cells in stratified epithelia</article-title><source>Cell</source><volume>129</volume><fpage>523</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2007.02.045</pub-id><pub-id pub-id-type="pmid">17482546</pub-id></element-citation></ref><ref id="bib89"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sethi</surname> <given-names>I</given-names></name><name><surname>Romano</surname> <given-names>RA</given-names></name><name><surname>Gluck</surname> <given-names>C</given-names></name><name><surname>Smalley</surname> <given-names>K</given-names></name><name><surname>Vojtesek</surname> <given-names>B</given-names></name><name><surname>Buck</surname> <given-names>MJ</given-names></name><name><surname>Sinha</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>A global analysis of the complex landscape of isoforms and regulatory networks of p63 in human cells and tissues</article-title><source>BMC Genomics</source><volume>16</volume><elocation-id>584</elocation-id><pub-id pub-id-type="doi">10.1186/s12864-015-1793-9</pub-id><pub-id pub-id-type="pmid">26251276</pub-id></element-citation></ref><ref id="bib90"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sethi</surname> <given-names>I</given-names></name><name><surname>Gluck</surname> <given-names>C</given-names></name><name><surname>Zhou</surname> <given-names>H</given-names></name><name><surname>Buck</surname> <given-names>MJ</given-names></name><name><surname>Sinha</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Evolutionary re-wiring of p63 and the epigenomic regulatory landscape in keratinocytes and its potential implications on species-specific gene expression and phenotypes</article-title><source>Nucleic Acids Research</source><volume>45</volume><fpage>8208</fpage><lpage>8224</lpage><pub-id pub-id-type="doi">10.1093/nar/gkx416</pub-id><pub-id pub-id-type="pmid">28505376</pub-id></element-citation></ref><ref id="bib91"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Somerville</surname> <given-names>TDD</given-names></name><name><surname>Xu</surname> <given-names>Y</given-names></name><name><surname>Miyabayashi</surname> <given-names>K</given-names></name><name><surname>Tiriac</surname> <given-names>H</given-names></name><name><surname>Cleary</surname> <given-names>CR</given-names></name><name><surname>Maia-Silva</surname> <given-names>D</given-names></name><name><surname>Milazzo</surname> <given-names>JP</given-names></name><name><surname>Tuveson</surname> <given-names>DA</given-names></name><name><surname>Vakoc</surname> <given-names>CR</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>TP63-Mediated enhancer reprogramming drives the squamous subtype of pancreatic ductal adenocarcinoma</article-title><source>Cell Reports</source><volume>25</volume><fpage>1741</fpage><lpage>1755</lpage><pub-id pub-id-type="doi">10.1016/j.celrep.2018.10.051</pub-id><pub-id pub-id-type="pmid">30428345</pub-id></element-citation></ref><ref id="bib92"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname> <given-names>L</given-names></name><name><surname>Florea</surname> <given-names>L</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Rcorrector: efficient and accurate error correction for Illumina RNA-seq reads</article-title><source>GigaScience</source><volume>4</volume><elocation-id>48</elocation-id><pub-id pub-id-type="doi">10.1186/s13742-015-0089-y</pub-id><pub-id pub-id-type="pmid">26500767</pub-id></element-citation></ref><ref id="bib93"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stewart</surname> <given-names>HJ</given-names></name><name><surname>Horne</surname> <given-names>GA</given-names></name><name><surname>Bastow</surname> <given-names>S</given-names></name><name><surname>Chevassut</surname> <given-names>TJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>BRD4 associates with p53 in DNMT3A-mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor JQ1</article-title><source>Cancer Medicine</source><volume>2</volume><fpage>826</fpage><lpage>835</lpage><pub-id pub-id-type="doi">10.1002/cam4.146</pub-id><pub-id pub-id-type="pmid">24403256</pub-id></element-citation></ref><ref id="bib94"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Subramanian</surname> <given-names>A</given-names></name><name><surname>Tamayo</surname> <given-names>P</given-names></name><name><surname>Mootha</surname> <given-names>VK</given-names></name><name><surname>Mukherjee</surname> <given-names>S</given-names></name><name><surname>Ebert</surname> <given-names>BL</given-names></name><name><surname>Gillette</surname> <given-names>MA</given-names></name><name><surname>Paulovich</surname> <given-names>A</given-names></name><name><surname>Pomeroy</surname> <given-names>SL</given-names></name><name><surname>Golub</surname> <given-names>TR</given-names></name><name><surname>Lander</surname> <given-names>ES</given-names></name><name><surname>Mesirov</surname> <given-names>JP</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles</article-title><source>PNAS</source><volume>102</volume><fpage>15545</fpage><lpage>15550</lpage><pub-id pub-id-type="doi">10.1073/pnas.0506580102</pub-id><pub-id pub-id-type="pmid">16199517</pub-id></element-citation></ref><ref id="bib95"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thomason</surname> <given-names>HA</given-names></name><name><surname>Zhou</surname> <given-names>H</given-names></name><name><surname>Kouwenhoven</surname> <given-names>EN</given-names></name><name><surname>Dotto</surname> <given-names>G-P</given-names></name><name><surname>Restivo</surname> <given-names>G</given-names></name><name><surname>Nguyen</surname> <given-names>B-C</given-names></name><name><surname>Little</surname> <given-names>H</given-names></name><name><surname>Dixon</surname> <given-names>MJ</given-names></name><name><surname>van Bokhoven</surname> <given-names>H</given-names></name><name><surname>Dixon</surname> <given-names>J</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Cooperation between the transcription factors p63 and IRF6 is essential to prevent cleft palate in mice</article-title><source>Journal of Clinical Investigation</source><volume>120</volume><fpage>1561</fpage><lpage>1569</lpage><pub-id pub-id-type="doi">10.1172/JCI40266</pub-id></element-citation></ref><ref id="bib96"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tichý</surname> <given-names>V</given-names></name><name><surname>Navrátilová</surname> <given-names>L</given-names></name><name><surname>Adámik</surname> <given-names>M</given-names></name><name><surname>Fojta</surname> <given-names>M</given-names></name><name><surname>Brázdová</surname> <given-names>M</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Redox state of p63 and p73 core domains regulates sequence-specific DNA binding</article-title><source>Biochemical and Biophysical Research Communications</source><volume>433</volume><fpage>445</fpage><lpage>449</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2013.02.097</pub-id></element-citation></ref><ref id="bib97"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truong</surname> <given-names>AB</given-names></name><name><surname>Kretz</surname> <given-names>M</given-names></name><name><surname>Ridky</surname> <given-names>TW</given-names></name><name><surname>Kimmel</surname> <given-names>R</given-names></name><name><surname>Khavari</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>p63 regulates proliferation and differentiation of developmentally mature keratinocytes</article-title><source>Genes &amp; Development</source><volume>20</volume><fpage>3185</fpage><lpage>3197</lpage><pub-id pub-id-type="doi">10.1101/gad.1463206</pub-id></element-citation></ref><ref id="bib98"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usui</surname> <given-names>A</given-names></name><name><surname>Hoshino</surname> <given-names>I</given-names></name><name><surname>Akutsu</surname> <given-names>Y</given-names></name><name><surname>Sakata</surname> <given-names>H</given-names></name><name><surname>Nishimori</surname> <given-names>T</given-names></name><name><surname>Murakami</surname> <given-names>K</given-names></name><name><surname>Kano</surname> <given-names>M</given-names></name><name><surname>Shuto</surname> <given-names>K</given-names></name><name><surname>Matsubara</surname> <given-names>H</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>The molecular role of Fra-1 and its prognostic significance in human esophageal squamous cell carcinoma</article-title><source>Cancer</source><volume>118</volume><fpage>3387</fpage><lpage>3396</lpage><pub-id pub-id-type="doi">10.1002/cncr.26652</pub-id></element-citation></ref><ref id="bib99"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Uxa</surname> <given-names>S</given-names></name><name><surname>Bernhart</surname> <given-names>SH</given-names></name><name><surname>Mages</surname> <given-names>CFS</given-names></name><name><surname>Fischer</surname> <given-names>M</given-names></name><name><surname>Kohler</surname> <given-names>R</given-names></name><name><surname>Hoffmann</surname> <given-names>S</given-names></name><name><surname>Stadler</surname> <given-names>PF</given-names></name><name><surname>Engeland</surname> <given-names>K</given-names></name><name><surname>Müller</surname> <given-names>GA</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>DREAM and RB cooperate to induce gene repression and cell-cycle arrest in response to p53 activation</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>9087</fpage><lpage>9103</lpage><pub-id pub-id-type="doi">10.1093/nar/gkz635</pub-id><pub-id pub-id-type="pmid">31400114</pub-id></element-citation></ref><ref id="bib100"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verfaillie</surname> <given-names>A</given-names></name><name><surname>Svetlichnyy</surname> <given-names>D</given-names></name><name><surname>Imrichova</surname> <given-names>H</given-names></name><name><surname>Davie</surname> <given-names>K</given-names></name><name><surname>Fiers</surname> <given-names>M</given-names></name><name><surname>Kalender Atak</surname> <given-names>Z</given-names></name><name><surname>Hulselmans</surname> <given-names>G</given-names></name><name><surname>Christiaens</surname> <given-names>V</given-names></name><name><surname>Aerts</surname> <given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Multiplex enhancer-reporter assays uncover unsophisticated TP53 enhancer logic</article-title><source>Genome Research</source><volume>26</volume><fpage>882</fpage><lpage>895</lpage><pub-id pub-id-type="doi">10.1101/gr.204149.116</pub-id><pub-id pub-id-type="pmid">27197205</pub-id></element-citation></ref><ref id="bib101"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vyas</surname> <given-names>P</given-names></name><name><surname>Beno</surname> <given-names>I</given-names></name><name><surname>Xi</surname> <given-names>Z</given-names></name><name><surname>Stein</surname> <given-names>Y</given-names></name><name><surname>Golovenko</surname> <given-names>D</given-names></name><name><surname>Kessler</surname> <given-names>N</given-names></name><name><surname>Rotter</surname> <given-names>V</given-names></name><name><surname>Shakked</surname> <given-names>Z</given-names></name><name><surname>Haran</surname> <given-names>TE</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Diverse p53/DNA binding modes expand the repertoire of p53 response elements</article-title><source>PNAS</source><volume>114</volume><fpage>10624</fpage><lpage>10629</lpage><pub-id pub-id-type="doi">10.1073/pnas.1618005114</pub-id><pub-id pub-id-type="pmid">28912355</pub-id></element-citation></ref><ref id="bib102"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname> <given-names>L</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Li</surname> <given-names>W</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>RSeQC: quality control of RNA-seq experiments</article-title><source>Bioinformatics</source><volume>28</volume><fpage>2184</fpage><lpage>2185</lpage><pub-id pub-id-type="doi">10.1093/bioinformatics/bts356</pub-id><pub-id pub-id-type="pmid">22743226</pub-id></element-citation></ref><ref id="bib103"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Watanabe</surname> <given-names>H</given-names></name><name><surname>Ma</surname> <given-names>Q</given-names></name><name><surname>Peng</surname> <given-names>S</given-names></name><name><surname>Adelmant</surname> <given-names>G</given-names></name><name><surname>Swain</surname> <given-names>D</given-names></name><name><surname>Song</surname> <given-names>W</given-names></name><name><surname>Fox</surname> <given-names>C</given-names></name><name><surname>Francis</surname> <given-names>JM</given-names></name><name><surname>Pedamallu</surname> <given-names>CS</given-names></name><name><surname>DeLuca</surname> <given-names>DS</given-names></name><name><surname>Brooks</surname> <given-names>AN</given-names></name><name><surname>Wang</surname> <given-names>S</given-names></name><name><surname>Que</surname> <given-names>J</given-names></name><name><surname>Rustgi</surname> <given-names>AK</given-names></name><name><surname>Wong</surname> <given-names>KK</given-names></name><name><surname>Ligon</surname> <given-names>KL</given-names></name><name><surname>Liu</surname> <given-names>XS</given-names></name><name><surname>Marto</surname> <given-names>JA</given-names></name><name><surname>Meyerson</surname> <given-names>M</given-names></name><name><surname>Bass</surname> <given-names>AJ</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>SOX2 and p63 colocalize at genetic loci in squamous cell carcinomas</article-title><source>Journal of Clinical Investigation</source><volume>124</volume><fpage>1636</fpage><lpage>1645</lpage><pub-id pub-id-type="doi">10.1172/JCI71545</pub-id><pub-id pub-id-type="pmid">24590290</pub-id></element-citation></ref><ref id="bib104"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Westfall</surname> <given-names>MD</given-names></name><name><surname>Mays</surname> <given-names>DJ</given-names></name><name><surname>Sniezek</surname> <given-names>JC</given-names></name><name><surname>Pietenpol</surname> <given-names>JA</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>The Delta Np63 alpha phosphoprotein binds the p21 and 14-3-3 sigma promoters in vivo and has transcriptional repressor activity that is reduced by Hay-Wells syndrome-derived mutations</article-title><source>Molecular and Cellular Biology</source><volume>23</volume><fpage>2264</fpage><lpage>2276</lpage><pub-id pub-id-type="doi">10.1128/MCB.23.7.2264-2276.2003</pub-id><pub-id pub-id-type="pmid">12640112</pub-id></element-citation></ref><ref id="bib105"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitfield</surname> <given-names>ML</given-names></name><name><surname>George</surname> <given-names>LK</given-names></name><name><surname>Grant</surname> <given-names>GD</given-names></name><name><surname>Perou</surname> <given-names>CM</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Common markers of proliferation</article-title><source>Nature Reviews Cancer</source><volume>6</volume><fpage>99</fpage><lpage>106</lpage><pub-id pub-id-type="doi">10.1038/nrc1802</pub-id><pub-id pub-id-type="pmid">16491069</pub-id></element-citation></ref><ref id="bib106"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>N</given-names></name><name><surname>Rollin</surname> <given-names>J</given-names></name><name><surname>Masse</surname> <given-names>I</given-names></name><name><surname>Lamartine</surname> <given-names>J</given-names></name><name><surname>Gidrol</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>p63 Regulates Human Keratinocyte Proliferation via MYC-regulated Gene Network and Differentiation Commitment through Cell Adhesion-related Gene Network</article-title><source>Journal of Biological Chemistry</source><volume>287</volume><fpage>5627</fpage><lpage>5638</lpage><pub-id pub-id-type="doi">10.1074/jbc.M111.328120</pub-id></element-citation></ref><ref id="bib107"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname> <given-names>W</given-names></name><name><surname>Chen</surname> <given-names>X</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>GPX2, a direct target of p63, inhibits oxidative Stress-induced apoptosis in a p53-dependent manner</article-title><source>Journal of Biological Chemistry</source><volume>281</volume><fpage>7856</fpage><lpage>7862</lpage><pub-id pub-id-type="doi">10.1074/jbc.M512655200</pub-id></element-citation></ref><ref id="bib108"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>A</given-names></name><name><surname>Kaghad</surname> <given-names>M</given-names></name><name><surname>Wang</surname> <given-names>Y</given-names></name><name><surname>Gillett</surname> <given-names>E</given-names></name><name><surname>Fleming</surname> <given-names>MD</given-names></name><name><surname>Dötsch</surname> <given-names>V</given-names></name><name><surname>Andrews</surname> <given-names>NC</given-names></name><name><surname>Caput</surname> <given-names>D</given-names></name><name><surname>McKeon</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="1998">1998</year><article-title>p63, a p53 homolog at 3q27-29, encodes multiple products with Transactivating, death-inducing, and dominant-negative activities</article-title><source>Molecular Cell</source><volume>2</volume><fpage>305</fpage><lpage>316</lpage><pub-id pub-id-type="doi">10.1016/S1097-2765(00)80275-0</pub-id><pub-id pub-id-type="pmid">9774969</pub-id></element-citation></ref><ref id="bib109"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>A</given-names></name><name><surname>Schweitzer</surname> <given-names>R</given-names></name><name><surname>Sun</surname> <given-names>D</given-names></name><name><surname>Kaghad</surname> <given-names>M</given-names></name><name><surname>Walker</surname> <given-names>N</given-names></name><name><surname>Bronson</surname> <given-names>RT</given-names></name><name><surname>Tabin</surname> <given-names>C</given-names></name><name><surname>Sharpe</surname> <given-names>A</given-names></name><name><surname>Caput</surname> <given-names>D</given-names></name><name><surname>Crum</surname> <given-names>C</given-names></name><name><surname>McKeon</surname> <given-names>F</given-names></name></person-group><year iso-8601-date="1999">1999</year><article-title>p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development</article-title><source>Nature</source><volume>398</volume><fpage>714</fpage><lpage>718</lpage><pub-id pub-id-type="doi">10.1038/19539</pub-id></element-citation></ref><ref id="bib110"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname> <given-names>A</given-names></name><name><surname>Zhu</surname> <given-names>Z</given-names></name><name><surname>Kapranov</surname> <given-names>P</given-names></name><name><surname>McKeon</surname> <given-names>F</given-names></name><name><surname>Church</surname> <given-names>GM</given-names></name><name><surname>Gingeras</surname> <given-names>TR</given-names></name><name><surname>Struhl</surname> <given-names>K</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Relationships between p63 binding, DNA sequence, transcription activity, and biological function in human cells</article-title><source>Molecular Cell</source><volume>24</volume><fpage>593</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1016/j.molcel.2006.10.018</pub-id><pub-id pub-id-type="pmid">17188034</pub-id></element-citation></ref><ref id="bib111"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zarnegar</surname> <given-names>BJ</given-names></name><name><surname>Webster</surname> <given-names>DE</given-names></name><name><surname>Lopez-Pajares</surname> <given-names>V</given-names></name><name><surname>Vander Stoep Hunt</surname> <given-names>B</given-names></name><name><surname>Qu</surname> <given-names>K</given-names></name><name><surname>Yan</surname> <given-names>KJ</given-names></name><name><surname>Berk</surname> <given-names>DR</given-names></name><name><surname>Sen</surname> <given-names>GL</given-names></name><name><surname>Khavari</surname> <given-names>PA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Genomic profiling of a human organotypic model of AEC syndrome reveals ZNF750 as an essential downstream target of mutant TP63</article-title><source>The American Journal of Human Genetics</source><volume>91</volume><fpage>435</fpage><lpage>443</lpage><pub-id pub-id-type="doi">10.1016/j.ajhg.2012.07.007</pub-id><pub-id pub-id-type="pmid">22922031</pub-id></element-citation></ref><ref id="bib112"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>Q</given-names></name><name><surname>Huang</surname> <given-names>D</given-names></name><name><surname>Zhang</surname> <given-names>Z</given-names></name><name><surname>Feng</surname> <given-names>Y</given-names></name><name><surname>Fu</surname> <given-names>M</given-names></name><name><surname>Wei</surname> <given-names>M</given-names></name><name><surname>Zhou</surname> <given-names>J</given-names></name><name><surname>Huang</surname> <given-names>Y</given-names></name><name><surname>Liu</surname> <given-names>S</given-names></name><name><surname>Shi</surname> <given-names>R</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>High expression of TMEM40 contributes to progressive features of tongue squamous cell carcinoma</article-title><source>Oncology Reports</source><volume>41</volume><fpage>154</fpage><lpage>164</lpage><pub-id pub-id-type="doi">10.3892/or.2018.6788</pub-id><pub-id pub-id-type="pmid">30320346</pub-id></element-citation></ref><ref id="bib113"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>L</given-names></name><name><surname>Zhao</surname> <given-names>Z</given-names></name><name><surname>Rong</surname> <given-names>L</given-names></name><name><surname>Xue</surname> <given-names>L</given-names></name><name><surname>Song</surname> <given-names>Y</given-names></name></person-group><year iso-8601-date="2019">2019a</year><article-title>RASSF6-TRIM16 Axis promotes cell proliferation, migration and invasion in esophageal squamous cell carcinoma</article-title><source>Journal of Genetics and Genomics</source><volume>46</volume><fpage>477</fpage><lpage>488</lpage><pub-id pub-id-type="doi">10.1016/j.jgg.2019.10.004</pub-id><pub-id pub-id-type="pmid">31812473</pub-id></element-citation></ref><ref id="bib114"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname> <given-names>R</given-names></name><name><surname>Wan</surname> <given-names>C</given-names></name><name><surname>Mei</surname> <given-names>S</given-names></name><name><surname>Qin</surname> <given-names>Q</given-names></name><name><surname>Wu</surname> <given-names>Q</given-names></name><name><surname>Sun</surname> <given-names>H</given-names></name><name><surname>Chen</surname> <given-names>CH</given-names></name><name><surname>Brown</surname> <given-names>M</given-names></name><name><surname>Zhang</surname> <given-names>X</given-names></name><name><surname>Meyer</surname> <given-names>CA</given-names></name><name><surname>Liu</surname> <given-names>XS</given-names></name></person-group><year iso-8601-date="2019">2019b</year><article-title>Cistrome data browser: expanded datasets and new tools for gene regulatory analysis</article-title><source>Nucleic Acids Research</source><volume>47</volume><fpage>D729</fpage><lpage>D735</lpage><pub-id pub-id-type="doi">10.1093/nar/gky1094</pub-id><pub-id pub-id-type="pmid">30462313</pub-id></element-citation></ref></ref-list></back><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63266.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group><contrib contrib-type="editor"><name><surname>Lal</surname><given-names>Ashish</given-names></name><role>Reviewing Editor</role><aff><institution>National Institutes of Health</institution><country>United States</country></aff></contrib></contrib-group><contrib-group><contrib contrib-type="reviewer"><name><surname>Bourdon</surname><given-names>Jean-Christophe</given-names> </name><role>Reviewer</role><aff><institution>University of Dundee</institution><country>United Kingdom</country></aff></contrib></contrib-group></front-stub><body><boxed-text><p>In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.</p></boxed-text><p><bold>Acceptance summary:</bold></p><p>This manuscript provides a comprehensive analysis of p53 and p63 targets, identified through a variety of approaches in several studies and in different experimental contexts. The authors have achieved a daunting task by collecting all the ChIP and gene expression data to constitute the first database of p53/p63 response element and thus perform a meta-analysis. It is a much necessary work as such a database paves the way to break the p53/p63 code and thus better predict pathologies and the response to treatment.</p><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article entitled &quot;Dissecting the DNA binding landscape and gene regulatory network of p63 and p53&quot; for consideration by <italic>eLife</italic>. Your revised article has been reviewed by three peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Maureen Murphy as the Senior Editor. There are a few issues that the reviewers feel need to be addressed in the manuscript. These are outlined below.</p><p>Summary:</p><p>This manuscript provides a comprehensive analysis of p53 and p63 targets, identified through a variety of approaches in several studies and in different experimental contexts. This is a very important work. The authors have achieved a daunting task by collecting all the ChIP and gene expression data to constitute the first database of p53/p63 response element and thus perform a meta-analysis. It is a much necessary work as such a database paves the way to break the p53/p63 code and thus better predict pathologies and the response to treatment (particularly when polymorphisms, somatic mutations or DNA methylation occur in the response elements). Statistical analysis sounds adequate and well designed. The data supports the conclusions. Addressing the following comments will further improve the study before publication in <italic>eLife</italic>.</p><p>Essential revisions:</p><p>1) &quot;Notably, when DREAM targets were already down-regulated through Nutlin treatment in MCF10A cells, loss of p63 decreased their expression even further (Figure 3C) (Karsli Uzunbas et al., 2019), which indicates a possible cumulative effect that is independent of p53 regulatory functions as has been suggested previously (McDade et al., 2014).&quot; This concept is not convincing. In Figure 3C you indeed show shp63 and shp63/Nutlin conditions. In the text you mention the effect of only Nutlin, which is not shown in the graph. Please explain. Moreover, why do you hypothesize &quot;a possible cumulative effect that is independent of p53 regulatory functions&quot;? MCF10A should have TP53 wild type. So, why excluding an effect of Nutlin on p53?</p><p>2) Figure 9: Is the identified p63-signature differentially expressed in reference to the state of p63 (over expressed and/or amplified) in publicly available datasets of HNSC with expression and genomic data? Also, in Figure 9, is the identified signature prognostic specifically in HNSC and not in other SCC types?</p><p>3) To increase the long-term usability of this work for future studies, can the authors report the gene and the DNA sequence of the response element in the Table 3 as the reported position may change with the updating of the human genome sequence (GRCh38)?</p><p>4) The authors report that there are many more number of p63 binding sites in the genome as compared to the number of p53 binding sites. Is this because basal p63 levels are much higher than basal p53 levels? Can the authors comment on the relative molecules per cell of p63 and p53? Or is it possible that this difference is because p63 requires shorter sequences in the DNA and is assisted by a number of cofactors?</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.63266.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1) &quot;Notably, when DREAM targets were already down-regulated through Nutlin treatment in MCF10A cells, loss of p63 decreased their expression even further (Figure 3C) (Karsli Uzunbas et al., 2019), which indicates a possible cumulative effect that is independent of p53 regulatory functions as has been suggested previously (McDade et al., 2014).&quot; This concept is not convincing. In Figure 3C you indeed show shp63 and shp63/Nutlin conditions. In the text you mention the effect of only Nutlin, which is not shown in the graph. Please explain. Moreover, why do you hypothesize &quot;a possible cumulative effect that is independent of p53 regulatory functions&quot;? MCF10A should have TP53 wild type. So, why excluding an effect of Nutlin on p53?</p></disp-quote><p>We thank the reviewers for the remark, and we take this opportunity to add a visualization and to improve the description of our results and their underlying data. As correctly noted by the reviewer, MCF10A cells possess functional wild-type p53 in which DREAM target genes are down-regulated following p53 induction by Nutlin treatment. The difference displayed in shControl versus shp63 in Nutlin-treated MCF10A cells indicates that although p53 is active in these cells leading to the activation of DREAM and repression of its targets, we find that these genes are further down-regulated upon depletion of p63. To our understanding, this is indicative of a cumulative effect of p53-dependent DREAM activation and a loss of p63 activator activity at DREAM targets, largely affecting cell cycle genes. Following the reviewers’ comment, we added new Figure 3D that better visualizes this effect and improved the description in the respective Results paragraph:</p><p>“Notably, most datasets on p63-dependent gene expression were derived from cells in which p63 was overexpressed or depleted, without additional treatments. […] Strikingly, depletion of p63 decreased their expression even further without affecting <italic>CDKN1A</italic> (p21) levels (Figure 3D), which indicates a possible cumulative effect that is independent of p53 regulatory functions.”</p><p>Besides, we extended the discussion on this phenomenon in the Discussion section:</p><p>“In addition to indirect effects, we also predicted multiple cell cycle genes as direct p63 targets (Table 1). […] In addition to p63’s role in driving the expression of some cell cycle genes directly, the entire set of cell cycle genes may be subsequently up-regulated indirectly through p63’s pro-proliferative targets.”</p><disp-quote content-type="editor-comment"><p>2) Figure 9: Is the identified p63-signature differentially expressed in reference to the state of p63 (over expressed and/or amplified) in publicly available datasets of HNSC with expression and genomic data? Also, in Figure 9, is the identified signature prognostic specifically in HNSC and not in other SCC types?</p></disp-quote><p>We certainly believe that the reviewer is raising two critical questions here. In the following, however, we would like to argue that this matter’s complexity is best addressed in independent studies.</p><p>In the context of the originally submitted manuscript, we had not explored the correlation between p63 expression and levels of the 28-gene set. HNSC was chosen because of its known dependence on p63 and the availability of a large dataset via the TCGA. The purpose of this brief analysis was to test and showcase the potential of the genes that we identified as being frequently up-regulated by p63. Therefore, already in the original manuscript version we only concluded that “this 28-gene set may contain particularly promising candidates for therapeutic interventions and for the use as biomarkers”. Consequently, we noted that, while interesting, “this finding calls for a more detailed assessment of ubiquitous p63/SCC genes as biomarkers in the future.” (Results section).</p><p>To further clarify that we did not identify a signature for prognostic purposes, we added to the Discussion section:</p><p>“We provided a showcase example” and replaced ‘gene signature’ with ‘gene set’.</p><p>We indeed share the excitement about potential p63 target gene-based prognostic signatures for HNSC and other SCC types. Yet, the development of a meaningful prognostic gene signature requires a whole study, out of the scope of this work and not within our core expertise. To follow the questions of the reviewer nevertheless, we explored the relationship between the expression of the 28-gene set with p63 levels in the new Figures 8C, D, and Figure 8—figure supplement 1:</p><p>“Expression of the 28-gene set correlated positively with p63 expression when p63 expression was rather low (FPKM &lt;20), but showed a saturation and no further correlation when p63 expression was high (FPKM &gt;20; Figure 8C, D, and Figure 8—figure supplement 1). This indicates that p63 levels influence the 28-gene set in a switch-like manner where a saturation of p63-dependent activation is quickly reached in HNSC cells.“</p><disp-quote content-type="editor-comment"><p>3) To increase the long-term usability of this work for future studies, can the authors report the gene and the DNA sequence of the response element in the Table 3 as the reported position may change with the updating of the human genome sequence (GRCh38)?</p></disp-quote><p>Following the reviewers’ comment, we added the DNA sequence of the p63REs and the genes associated with the respective peaks to Supplementary file 3. Notably, to make our analysis contemporary all our data and subsequent analyses are already based on the current human genome version hg38/GRCh38.</p><disp-quote content-type="editor-comment"><p>4) The authors report that there are many more number of p63 binding sites in the genome as compared to the number of p53 binding sites. Is this because basal p63 levels are much higher than basal p53 levels? Can the authors comment on the relative molecules per cell of p63 and p53? Or is it possible that this difference is because p63 requires shorter sequences in the DNA and is assisted by a number of cofactors?</p></disp-quote><p>We thank the reviewer for this important remark. We have incorporated this matter in the description of our data. All p63 and p53 ChIP-seq data are derived from cells with high basal p63 and stimulated/induced p53 levels, respectively. Thus, even though basal p53 levels are low in most of these cells, they were activated/induced prior to the ChIP experiments. Our rationale is that both p63 and p53 levels are sufficiently high to occupy most relevant binding sites in the genome. Since the molecule numbers of p63 or p53 have not been assayed in any of the original studies, we are unfortunately unable to give any specifics. To clarify this, we added an explanatory sentence at the beginning of the respective Results paragraph:</p><p>“Notably, p63 and p53 data was collected from cells with strong basal p63 expression and stimulated p53 expression, respectively.”</p><p>Furthermore, our results suggest that p63 requires full-length recognition sequences, which, however, can deviate more strongly from the canonical motif as compared to p53. Our interpretation of the results is that p63’s ability to recognize a greater variety of motifs underlies its capacity to bind to many more sites in the genome as compared to p53. To clarify this towards the reader, we added each one additional sentence to the Results and Discussion sections:</p><p>“This broader binding repertoire most likely underlies p63’s capacity to engage with substantially more binding sites than does p53.”</p><p>“Notably, p63’s ability to bind to a greater variety of recognition motifs most likely underlies the markedly greater number of p63 compared to p53 binding sites in the genome.”</p></body></sub-article></article>